Skip to content

Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitis

A PHASE 2B, RANDOMIZED, DOUBLE BLIND, VEHICLE CONTROLLED, PARALLEL GROUP, DOSE RANGING STUDY TO ASSESS THE EFFICACY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF PF-06700841 CREAM APPLIED ONCE OR TWICE DAILY FOR 6 WEEKS IN PARTICIPANTS WITH MILD OR MODERATE ATOPIC DERMATITIS

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03903822
Enrollment
292
Registered
2019-04-04
Start date
2019-05-13
Completion date
2020-05-07
Last updated
2021-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic Dermatitis

Keywords

Mild-to-Moderate Atopic Dermatitis, topical

Brief summary

This study is being conducted to provide data on efficacy, safety, tolerability and PK of multiple topical formulation concentrations of PF-06700841 topical cream in the treatment of mild to moderate atopic dermatitis (AD). The study is intended to enable selection of the dose and dosing regimen (once daily \[QD\] vs twice daily \[BID\] application) for the future clinical development of topical PF-06700841.

Interventions

PF-06700841 topical cream

Vehicle topical cream

Sponsors

Pfizer
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
12 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of Atopic Dermatitis for at least 3 months * Investigator's Global Assessment (IGA) Score of 2 or 3 * Eczema Area Severity Index (EASI) score of 3-21 * Body Surface Area (BSA) of 2-20% * Peak pruritus-Numerical Rating Scale (PPNRS) of Grade 2 or more

Exclusion criteria

* Other forms of dermatological diseases (other than atopic dermatitis) * Fitzpatrick skin type score greater than 5 * Clinically significant abnormal ECG, vital signs, and laboratory values * Infection with HBV, HCV, herpes zoster or tuberculosis

Design outcomes

Primary

MeasureTime frameDescription
Percent Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple ImputationBaseline, Week 6EASI evaluates severity of participant's AD (excluded scalp, palms, soles) based on severity of AD clinical signs and % of body surface area (BSA) affected. Severity of clinical signs of AD (erythema, induration/papulation, excoriation and lichenification) scored separately for each of 4 body regions(head and neck, upper limbs, trunk \[including axillae and groin\] and lower limbs \[including buttocks\]) on4-point scale: 0= absent; 1= mild; 2= moderate; 3= severe. EASI area score was based upon % BSA with AD in each 4 body region: 0 (0%), 1 (\>0 to \<10%), 2 (10 to \<30%), 3 (30 to \<50%), 4 (50 to \<70%), 5 (70 to \<90%) and 6 (90 to 100%). Total EASI score =0.1\*Ah\*(Eh+Ih+Exh+Lh) + 0.2\*Au\*(Eu+Iu+ExU+Lu) + 0.3\*At\*(Et+It+Ext+Lt) + 0.4\*Al\*(El+Il+Exl+Ll); A = EASI area score; E = erythema; I = induration/papulation; Ex = excoriation; L = lichenification; h = head and neck; u = upper limbs; t = trunk; l = lower limbs. Total EASI score ranged from 0.0 to 72.0, higher scores = greater severity of AD.

Secondary

MeasureTime frameDescription
Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple ImputationBaseline, Week 6EASI evaluates severity of participant's AD (excluded scalp, palms, soles) based on severity of AD clinical signs and % of body surface area (BSA) affected. Severity of clinical signs of AD (erythema, induration/papulation, excoriation and lichenification) scored separately for each of 4 body regions(head and neck, upper limbs, trunk \[including axillae and groin\] and lower limbs \[including buttocks\]) on4-point scale: 0= absent; 1= mild; 2= moderate; 3= severe. EASI area score was based upon % BSA with AD in each 4 body region: 0 (0%), 1 (\>0 to \<10%), 2 (10 to \<30%), 3 (30 to \<50%), 4 (50 to \<70%), 5 (70 to \<90%) and 6 (90 to 100%). Total EASI score =0.1\*Ah\*(Eh+Ih+Exh+Lh) + 0.2\*Au\*(Eu+Iu+ExU+Lu) + 0.3\*At\*(Et+It+Ext+Lt) + 0.4\*Al\*(El+Il+Exl+Ll); A = EASI area score; E = erythema; I = induration/papulation; Ex = excoriation; L = lichenification; h = head and neck; u = upper limbs; t = trunk; l = lower limbs. Total EASI score ranged from 0.0 to 72.0, higher scores = greater severity of AD.
Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationBaseline, Weeks 1, 2, 3, 4 and 6The severity of itch (pruritus) due to AD was assessed using a horizontal NRS. Participants at specified time points were asked the following question: How would you rate your itch due to AD at the worst moment during the previous 24 hours? The scale ranged from 0-10, where 0= no itch and 10= worst itch imaginable. Higher scores indicated worse itch.
Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationBaseline, Weeks 1, 2, 3, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71)The severity of itch (pruritus) due to AD was assessed using a horizontal NRS. Participants at specified time points were asked the following question: How would you rate your itch due to AD at the worst moment during the previous 24 hours? The scale ranged from 0-10, where 0= no itch and 10= worst itch imaginable. Higher scores indicated worse itch.
Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitBaseline, Weeks 1, 2, 3, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71)4 body regions were evaluated: head and neck, upper limbs, trunk (including axillae and groin) and lower limbs (including buttocks). Scalp, palms and soles were excluded. BSA was calculated using handprint method. Number of handprints (size of participant's full palmer hand) fitting in the affected area of a body region was estimated. Maximum number of handprints were 10 for head and neck, 20 for upper limbs, 30 for trunk and 40 for lower limbs. Surface area of body region equivalent to 1 handprint: 1 handprint was equal to 10% for head and neck, 5% for upper limbs, 3.33% for trunk and 2.5% for lower limbs. Percent BSA for a body region was calculated as = total number of handprints in a body region \* % surface area equivalent to 1 handprint. Overall % BSA for an individual: arithmetic mean of % BSA of all 4 body regions, ranged from 0 to 100%, with higher values representing greater severity of AD.
Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationBaseline, Weeks 1, 2, 3, 4 and 6EASI evaluates severity of participant's AD (excluded scalp, palms, soles) based on severity of AD clinical signs and % of body surface area (BSA) affected. Severity of clinical signs of AD (erythema, induration/papulation, excoriation and lichenification) scored separately for each of 4 body regions(head and neck, upper limbs, trunk \[including axillae and groin\] and lower limbs \[including buttocks\]) on4-point scale: 0= absent; 1= mild; 2= moderate; 3= severe. EASI area score was based upon % BSA with AD in each 4 body region: 0 (0%), 1 (\>0 to \<10%), 2 (10 to \<30%), 3 (30 to \<50%), 4 (50 to \<70%), 5 (70 to \<90%) and 6 (90 to 100%). Total EASI score =0.1\*Ah\*(Eh+Ih+Exh+Lh) + 0.2\*Au\*(Eu+Iu+ExU+Lu) + 0.3\*At\*(Et+It+Ext+Lt) + 0.4\*Al\*(El+Il+Exl+Ll); A = EASI area score; E = erythema; I = induration/papulation; Ex = excoriation; L = lichenification; h = head and neck; u = upper limbs; t = trunk; l = lower limbs. Total EASI score ranged from 0.0 to 72.0, higher scores = greater severity of AD.
Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs)Baseline (Day 1) up to at least 28 days after last dose of study drug (approximately up to Week 11)An AE was any untoward medical occurrence in a participant who received investigational product without regard to possibility of causal relationship. SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly; medically important events. Treatment-emergent were events between first dose of investigational product and up to 28 days after the last dose of investigational product that were absent before treatment or that worsened relative to pretreatment state. AEs included both SAEs and all non-SAEs.
Number of Participants With Pre-defined Criteria For Vital SignsBaseline up to Week 6Pre-defined criteria included: 1) Diastolic blood pressure (DBP), a) sitting DBP: change of \>= 20 millimeter of mercury (mmHg) increase, b) sitting DBP: change of \>=20mmHg decrease, c) supine DBP: less than (\<) 50 mmHg, d) supine DBP: change of \>= 20mmHg increase, e) supine DBP: change of \>= 20mmHg decrease; 2) Systolic blood pressure (SBP), a) sitting SBP: \<90 mmHg, b) sitting SBP: change of \>=30mmHg increase, c) sitting SBP: change of \>=30mmHg decrease, d) supine SBP: change of \>=30mmHg increase, e) supine SBP: change of \>=30mmHg decrease and f) Supine SBP: value \<90mmHg.
Number of Participants With Laboratory AbnormalitiesBaseline (Day 1) up to at least 28 days after last dose of study drug (approximately up to Week 11)Hemoglobin (HGB),hematocrit,erythrocytes (ery.),HDL cholesterol (chl.)\<0.8\*lower limit of normal(LLN);reticulocytes (ret.), ret./ery. (%)\<0.5\*LLN,\>1.5\*upper limit of normal (ULN);ery. mean corpuscular (EMC) volume,EMC HGB,EMC HGB concentration,potassium,chloride,calcium,bicarbonate\<0.9\*LLN,\>1.1\*ULN;platelets\<0.5\*LLN,\>1.75\*ULN;leukocytes (leu.),glucose\<0.6\*LLN,\>1.5\*ULN;lymphocytes (lym.), lym./leu.(%), neutrophils (neu.), neu./leu. (%), protein,albumin \<0.8\*LLN,\>1.2\*ULN;basophils (bas.), bas./leu.(%), eosinophils (eos.), eos./leu., monocytes (mon.), mon./leu.(%), urate \>1.2\*ULN;bilirubin (total, direct, indirect)\>1.5\*ULN;aspartate/alanine aminotransferase, gamma glutamyl transferase, lactate dehydrogenase, alkaline phosphatase\>3.0\*ULN;urea nitrogen, creatinine, triglycerides, chl.\>1.3\*ULN; sodium \<0.95\*LLN,\>1.05\*ULN; creatine kinase \>2.0\*ULN;Urine: pH\<4.5,\>8;glucose, ketones, protein, HGB, urobilinogen,bilirubin,nitrite,leukocyte esterase\>=1;ery., leu.\>= 20;hyaline casts\>1;bacteria\>20.
Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsBaseline up to Week 6Clinically significant ECG criteria included PR interval: value greater than (\>) 280 millisecond (msec), percentage change greater than equal to (\>=) 25/50 percentage, QRS interval: value \>120 msec, percentage change \>= 50% and QT interval corrected using the Fridericia's formula (QTCF) value 450 msec and 30\<=change\<60.
Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBaseline, Weeks 1, 2, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71)
Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBaseline, Weeks 1, 2, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71)
Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBaseline, Weeks 1, 2, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71)
Percentage of Participants Achieving Investigator's Global Assessment (IGA) Score Clear (0) or Almost Clear (1) and a Reduction From Baseline of Greater Than or Equal to ( >=2) Points at Week 6: Non-responder ImputationBaseline, Week 6IGA assesses severity of participant's AD on a 5 point scale. 0= clear, no inflammatory signs of AD; 1= almost clear, AD not fully cleared- light pink residual lesions (except post-inflammatory hyperpigmentation), just perceptible erythema, papulation/induration lichenification, excoriation, and no oozing/crusting; 2= mild AD with light red lesions, slight but definite erythema, papulation/induration, lichenification, excoriation and no oozing/crusting; 3= moderate AD with red lesions, moderate erythema, papulation/induration, lichenification, excoriation and slight oozing/crusting and 4= severe AD with deep dark red lesions, severe erythema, papulation/induration, lichenification, excoriation and moderate to severe oozing/crusting. Higher scores indicating more severity of AD. Assessment excluded soles, palms and scalp.
Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBaseline, Weeks 1, 2, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71)
Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBaseline, Weeks 1, 2, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71)
Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBaseline, Weeks 1, 2, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71)
Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBaseline, Weeks 1, 2, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71)
Change From Baseline in Lipids Profile Values at Week 6Baseline, Week 6Lipid parameters that were assessed: high density lipoprotein (HDL) cholesterol, triglycerides, cholesterol, low density lipoprotein (LDL) cholesterol.
Change From Baseline in Ratio of LDL Cholesterol to HDL Cholesterol Lipids Profile at Week 6Baseline, Week 6Mean change in total cholesterol/HDL cholesterol ratio was assessed and reported.
Change From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6Baseline, Weeks 2 and 6
Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6Baseline, Weeks 2 and 6
Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Baseline, Weeks 2 and 6Blood pressure included supine and sitting systolic and diastolic BP.
Change From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6Baseline, Weeks 2 and 6
Change From Baseline in Vital Signs- Temperature at Weeks 2 and 6Baseline, Weeks 2 and 6
Number of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1 and any day on of Week 1, 2, 4, 6: pre dose (before application of IP) and post dose (after application of IP); Follow up visit (28 days after last dose of study drug = maximum up to Day 71) and Early termination (anytime within week 11)Local tolerability skin assessments were performed by the investigator and graded based on severity from grade 0 to 4 as: grade 0=none (no evidence of local intolerance); grade 1=mild (minimal erythema and/or oedema, slight glazed appearance); grade 2= moderate (definite erythema and/or oedema with peeling and/or cracking but needs no adaptation of posology) grade 3=severe (erythema, oedema glazing with fissures, few vesicles or papules consider removing topical agent \[if still in place\]) and grade 4= very severe (strong reaction spreading beyond the treated area, bullous reaction, erosions: removal of topical agent \[if still in place\]). Higher grades indicated worsening of condition. Only those categories in which at least 1 participant had data were reported.
Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBaseline, Weeks 1, 2, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71)

Countries

Australia, Bulgaria, Canada, Denmark, Germany, Hungary, Japan, Latvia, Poland, United States

Participant flow

Participants by arm

ArmCount
Vehicle Cream Once Daily (QD)
Participants or caregivers of participants, topically applied vehicle cream on all eligible AD areas (of participants) once daily for a maximum of 6 weeks. Eligibility of AD areas to be treated were determined on Day 1 by investigator. Participants were followed up for 4 weeks after last dose.
37
PF-06700841 0.1% Cream QD
Participants or caregivers of participants, topically applied PF-06700841 0.1 % cream on all eligible AD areas (of participants) once daily for a maximum of 6 weeks. Eligibility of AD areas to be treated were determined on Day 1 by investigator. Participants were followed up for 4 weeks after last dose.
37
PF-06700841 0.3% Cream QD
Participants or caregivers of participants, topically applied PF-06700841 0.3 % cream on all eligible AD areas (of participants) once daily for a maximum of 6 weeks. Eligibility of AD areas to be treated were determined on Day 1 by investigator. Participants were followed up for 4 weeks after last dose.
36
PF-06700841 1.0% Cream QD
Participants or caregivers of participants, topically applied PF-06700841 1.0 % cream on all eligible AD areas (of participants) once daily for a maximum of 6 weeks. Eligibility of AD areas to be treated were determined on Day 1 by investigator. Participants were followed up for 4 weeks after last dose.
37
PF-06700841 3.0% Cream QD
Participants or caregivers of participants, topically applied PF-06700841 3.0 % cream on all eligible AD areas (of participants) once daily for a maximum of 6 weeks. Eligibility of AD areas to be treated were determined on Day 1 by investigator. Participants were followed up for 4 weeks after last dose.
36
Vehicle Cream Twice Daily (BID)
Participants or caregivers of participants, topically applied vehicle cream on all eligible AD areas (of participants) twice daily for a maximum of 6 weeks. Eligibility of AD areas to be treated were determined on Day 1 by investigator. Participants were followed up for 4 weeks after last dose.
36
PF-06700841 0.3% Cream BID
Participants or caregivers of participants, topically applied PF-06700841 0.3% cream on all eligible AD areas (of participants) twice daily for a maximum of 6 weeks. Eligibility of AD areas to be treated were determined on Day 1 by investigator. Participants were followed up for 4 weeks after last dose.
36
PF-06700841 1.0% Cream BID
Participants or caregivers of participants, topically applied PF-06700841 1.0 % cream on all eligible AD areas (of participants) twice daily for a maximum of 6 weeks. Eligibility of AD areas to be treated were determined on Day 1 by investigator. Participants were followed up for 4 weeks after last dose.
37
Total292

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003FG004FG005FG006FG007
Follow up Phase (4 Weeks)Adverse Event32110510
Follow up Phase (4 Weeks)Lack of Efficacy00001000
Follow up Phase (4 Weeks)Lost to Follow-up20000013
Follow up Phase (4 Weeks)Other11000000
Follow up Phase (4 Weeks)Pregnancy00011000
Follow up Phase (4 Weeks)Refused Further Study Procedures00000100
Follow up Phase (4 Weeks)Withdrawal by Subject25322233
Treatment Phase (6 Weeks)Adverse Event33111610
Treatment Phase (6 Weeks)Lack of Efficacy00001100
Treatment Phase (6 Weeks)Lost to Follow-up00000011
Treatment Phase (6 Weeks)Other21001100
Treatment Phase (6 Weeks)Physician Decision02000000
Treatment Phase (6 Weeks)Pregnancy00011000
Treatment Phase (6 Weeks)Protocol Violation00010000
Treatment Phase (6 Weeks)Refused Further Treatment20000100
Treatment Phase (6 Weeks)Withdrawal by Subject24221233

Baseline characteristics

CharacteristicVehicle Cream Once Daily (QD)PF-06700841 0.1% Cream QDPF-06700841 0.3% Cream QDPF-06700841 1.0% Cream QDPF-06700841 3.0% Cream QDVehicle Cream Twice Daily (BID)PF-06700841 0.3% Cream BIDPF-06700841 1.0% Cream BIDTotal
Age, Continuous39.1 Years
STANDARD_DEVIATION 16.8
40.8 Years
STANDARD_DEVIATION 15.35
43.4 Years
STANDARD_DEVIATION 16.43
38.4 Years
STANDARD_DEVIATION 12.9
40.5 Years
STANDARD_DEVIATION 12.3
42.3 Years
STANDARD_DEVIATION 18.18
39.4 Years
STANDARD_DEVIATION 17.27
38.1 Years
STANDARD_DEVIATION 15.34
40.2 Years
STANDARD_DEVIATION 15.59
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants3 Participants2 Participants1 Participants3 Participants0 Participants4 Participants13 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
37 Participants37 Participants32 Participants35 Participants35 Participants33 Participants35 Participants33 Participants277 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants1 Participants0 Participants0 Participants0 Participants1 Participants0 Participants2 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
4 Participants8 Participants4 Participants8 Participants10 Participants9 Participants9 Participants7 Participants59 Participants
Race (NIH/OMB)
Black or African American
8 Participants7 Participants9 Participants6 Participants4 Participants6 Participants5 Participants6 Participants51 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants2 Participants2 Participants1 Participants0 Participants0 Participants0 Participants5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants1 Participants0 Participants1 Participants0 Participants0 Participants2 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants1 Participants
Race (NIH/OMB)
White
24 Participants22 Participants21 Participants20 Participants21 Participants20 Participants22 Participants24 Participants174 Participants
Sex: Female, Male
Female
20 Participants19 Participants24 Participants23 Participants15 Participants19 Participants16 Participants20 Participants156 Participants
Sex: Female, Male
Male
17 Participants18 Participants12 Participants14 Participants21 Participants17 Participants20 Participants17 Participants136 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
EG004
affected / at risk
EG005
affected / at risk
EG006
affected / at risk
EG007
affected / at risk
deaths
Total, all-cause mortality
0 / 370 / 370 / 360 / 370 / 360 / 360 / 360 / 37
other
Total, other adverse events
18 / 3717 / 3711 / 3612 / 3710 / 3617 / 369 / 3614 / 37
serious
Total, serious adverse events
0 / 370 / 370 / 360 / 370 / 360 / 360 / 360 / 37

Outcome results

Primary

Percent Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation

EASI evaluates severity of participant's AD (excluded scalp, palms, soles) based on severity of AD clinical signs and % of body surface area (BSA) affected. Severity of clinical signs of AD (erythema, induration/papulation, excoriation and lichenification) scored separately for each of 4 body regions(head and neck, upper limbs, trunk \[including axillae and groin\] and lower limbs \[including buttocks\]) on4-point scale: 0= absent; 1= mild; 2= moderate; 3= severe. EASI area score was based upon % BSA with AD in each 4 body region: 0 (0%), 1 (\>0 to \<10%), 2 (10 to \<30%), 3 (30 to \<50%), 4 (50 to \<70%), 5 (70 to \<90%) and 6 (90 to 100%). Total EASI score =0.1\*Ah\*(Eh+Ih+Exh+Lh) + 0.2\*Au\*(Eu+Iu+ExU+Lu) + 0.3\*At\*(Et+It+Ext+Lt) + 0.4\*Al\*(El+Il+Exl+Ll); A = EASI area score; E = erythema; I = induration/papulation; Ex = excoriation; L = lichenification; h = head and neck; u = upper limbs; t = trunk; l = lower limbs. Total EASI score ranged from 0.0 to 72.0, higher scores = greater severity of AD.

Time frame: Baseline, Week 6

Population: Full analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Missing data were imputed with multiple imputation method assuming responses are similar to the corresponding vehicle arm under the MAR assumption

ArmMeasureValue (LEAST_SQUARES_MEAN)
Vehicle Cream Once Daily (QD)Percent Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation-44.4 Percent change
PF-06700841 0.1% Cream QDPercent Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation-58.3 Percent change
PF-06700841 0.3% Cream QDPercent Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation-64.6 Percent change
PF-06700841 1.0% Cream QDPercent Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation-70.1 Percent change
PF-06700841 3.0% Cream QDPercent Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation-67.9 Percent change
Vehicle Cream Twice Daily (BID)Percent Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation-47.6 Percent change
PF-06700841 0.3% Cream BIDPercent Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation-58.6 Percent change
PF-06700841 1.0% Cream BIDPercent Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation-75.0 Percent change
Comparison: Analysis of covariance (ANCOVA) contained fixed factors of treatment and baseline value.p-value: 0.10490% CI: [-32.1, 4.3]ANCOVA
Comparison: ANCOVA contained fixed factors of treatment and baseline value.p-value: 0.033490% CI: [-38.3, -2.1]ANCOVA
Comparison: ANCOVA contained fixed factors of treatment and baseline value.p-value: 0.008690% CI: [-43.3, -8]ANCOVA
Comparison: ANCOVA contained fixed factors of treatment and baseline value.p-value: 0.015890% CI: [-41.5, -5.5]ANCOVA
Comparison: ANCOVA contained fixed factors of treatment and baseline value.p-value: 0.087990% CI: [-24.3, 2.4]ANCOVA
Comparison: ANCOVA contained fixed factors of treatment and baseline value.p-value: 0.000490% CI: [-40.7, -14.1]ANCOVA
Secondary

Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit

Time frame: Baseline, Weeks 1, 2, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71)

Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, Overall Number of Participants Analyzed signifies participants evaluable for this outcome measure and number analyzed signifies participants evaluable for the each specified time point.

ArmMeasureGroupValue (MEAN)Dispersion
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 10.4 Units per literStandard Deviation 25.99
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at follow-up visit-12.3 Units per literStandard Deviation 24.82
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 6-8.8 Units per literStandard Deviation 18.25
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 4-8.6 Units per literStandard Deviation 23.93
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 2-8.8 Units per literStandard Deviation 21.56
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 2-7.8 Units per literStandard Deviation 27.99
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 6-8.1 Units per literStandard Deviation 32.02
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at follow-up visit-12.0 Units per literStandard Deviation 28.83
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 4-5.4 Units per literStandard Deviation 22.87
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 1-7.4 Units per literStandard Deviation 30.2
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 2-1.9 Units per literStandard Deviation 18.18
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at follow-up visit4.0 Units per literStandard Deviation 43.45
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 1-5.3 Units per literStandard Deviation 16.99
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 6-1.5 Units per literStandard Deviation 32.42
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 4-9.3 Units per literStandard Deviation 19.61
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 4-12.1 Units per literStandard Deviation 28.54
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at follow-up visit-2.7 Units per literStandard Deviation 26.27
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 1-9.3 Units per literStandard Deviation 22.65
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 2-8.8 Units per literStandard Deviation 23.7
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 6-6.4 Units per literStandard Deviation 28.53
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 4-16.3 Units per literStandard Deviation 33.97
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 1-18.4 Units per literStandard Deviation 33.42
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 2-15.8 Units per literStandard Deviation 42.19
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 6-18.2 Units per literStandard Deviation 33.86
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at follow-up visit-15.1 Units per literStandard Deviation 38.23
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 4-1.0 Units per literStandard Deviation 29.29
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 6-9.7 Units per literStandard Deviation 20.68
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 2-0.3 Units per literStandard Deviation 22.81
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 1-8.0 Units per literStandard Deviation 34.51
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at follow-up visit-11.3 Units per literStandard Deviation 29.39
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 4-19.5 Units per literStandard Deviation 19.94
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 1-8.0 Units per literStandard Deviation 19.37
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 2-8.0 Units per literStandard Deviation 22.31
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at follow-up visit-13.3 Units per literStandard Deviation 25.37
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 6-11.2 Units per literStandard Deviation 22.34
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at follow-up visit0.2 Units per literStandard Deviation 16.48
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 6-7.0 Units per literStandard Deviation 24.65
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 1-4.3 Units per literStandard Deviation 29.08
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 4-3.7 Units per literStandard Deviation 24.96
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 2-4.9 Units per literStandard Deviation 24.49
Secondary

Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit

Time frame: Baseline, Weeks 1, 2, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71)

Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, Overall Number of Participants Analyzed signifies participants evaluable for this outcome measure and number analyzed signifies participants evaluable for the each specified time point.

ArmMeasureGroupValue (MEAN)Dispersion
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein: change at follow-up visit-0.07 Gram per deciliterStandard Deviation 0.341
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein: change at week 6-0.13 Gram per deciliterStandard Deviation 0.403
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin: change at follow-up visit-0.06 Gram per deciliterStandard Deviation 0.247
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin:change at week 6-0.08 Gram per deciliterStandard Deviation 0.259
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein:change at week 2-0.09 Gram per deciliterStandard Deviation 0.383
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein: change at week 1-0.01 Gram per deciliterStandard Deviation 0.439
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin: change at week 4-0.08 Gram per deciliterStandard Deviation 0.245
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin:change at week 2-0.06 Gram per deciliterStandard Deviation 0.235
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin:change at week 1-0.04 Gram per deciliterStandard Deviation 0.269
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein: change at week 4-0.10 Gram per deciliterStandard Deviation 0.38
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein: change at week 1-0.04 Gram per deciliterStandard Deviation 0.294
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein: change at week 60.13 Gram per deciliterStandard Deviation 0.379
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein: change at follow-up visit0.05 Gram per deciliterStandard Deviation 0.457
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin: change at follow-up visit0.10 Gram per deciliterStandard Deviation 0.26
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin:change at week 20.02 Gram per deciliterStandard Deviation 0.201
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin:change at week 60.08 Gram per deciliterStandard Deviation 0.245
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein: change at week 40.07 Gram per deciliterStandard Deviation 0.315
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin: change at week 40.07 Gram per deciliterStandard Deviation 0.172
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin:change at week 1-0.05 Gram per deciliterStandard Deviation 0.205
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein:change at week 20.03 Gram per deciliterStandard Deviation 0.303
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein:change at week 2-0.18 Gram per deciliterStandard Deviation 0.402
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein: change at week 1-0.14 Gram per deciliterStandard Deviation 0.433
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein: change at week 4-0.08 Gram per deciliterStandard Deviation 0.429
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein: change at week 6-0.19 Gram per deciliterStandard Deviation 0.452
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein: change at follow-up visit-0.15 Gram per deciliterStandard Deviation 0.481
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin:change at week 1-0.10 Gram per deciliterStandard Deviation 0.283
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin:change at week 2-0.10 Gram per deciliterStandard Deviation 0.256
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin: change at week 4-0.08 Gram per deciliterStandard Deviation 0.285
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin:change at week 6-0.14 Gram per deciliterStandard Deviation 0.333
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin: change at follow-up visit-0.09 Gram per deciliterStandard Deviation 0.277
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein: change at follow-up visit-0.04 Gram per deciliterStandard Deviation 0.404
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin:change at week 6-0.02 Gram per deciliterStandard Deviation 0.269
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin: change at follow-up visit-0.04 Gram per deciliterStandard Deviation 0.295
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin:change at week 1-0.02 Gram per deciliterStandard Deviation 0.177
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin:change at week 2-0.02 Gram per deciliterStandard Deviation 0.204
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein: change at week 60.01 Gram per deciliterStandard Deviation 0.368
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein: change at week 1-0.04 Gram per deciliterStandard Deviation 0.264
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin: change at week 40.01 Gram per deciliterStandard Deviation 0.239
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein: change at week 4-0.03 Gram per deciliterStandard Deviation 0.341
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein:change at week 2-0.01 Gram per deciliterStandard Deviation 0.275
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein:change at week 20.01 Gram per deciliterStandard Deviation 0.561
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin:change at week 2-0.01 Gram per deciliterStandard Deviation 0.283
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein: change at follow-up visit0.03 Gram per deciliterStandard Deviation 0.481
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein: change at week 6-0.03 Gram per deciliterStandard Deviation 0.405
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein: change at week 1-0.03 Gram per deciliterStandard Deviation 0.421
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin:change at week 6-0.00 Gram per deciliterStandard Deviation 0.218
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin:change at week 10.00 Gram per deciliterStandard Deviation 0.256
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein: change at week 4-0.04 Gram per deciliterStandard Deviation 0.465
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin: change at week 40.04 Gram per deciliterStandard Deviation 0.292
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin: change at follow-up visit-0.01 Gram per deciliterStandard Deviation 0.346
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein: change at week 6-0.10 Gram per deciliterStandard Deviation 0.424
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein: change at follow-up visit-0.18 Gram per deciliterStandard Deviation 0.471
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin:change at week 1-0.05 Gram per deciliterStandard Deviation 0.218
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein:change at week 20.02 Gram per deciliterStandard Deviation 0.503
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin:change at week 20.02 Gram per deciliterStandard Deviation 0.266
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin: change at follow-up visit-0.09 Gram per deciliterStandard Deviation 0.262
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin: change at week 4-0.10 Gram per deciliterStandard Deviation 0.232
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein: change at week 1-0.10 Gram per deciliterStandard Deviation 0.36
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin:change at week 6-0.03 Gram per deciliterStandard Deviation 0.252
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein: change at week 4-0.18 Gram per deciliterStandard Deviation 0.292
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin:change at week 1-0.03 Gram per deciliterStandard Deviation 0.246
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein: change at follow-up visit-0.09 Gram per deciliterStandard Deviation 0.398
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin: change at week 4-0.08 Gram per deciliterStandard Deviation 0.18
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein: change at week 1-0.01 Gram per deciliterStandard Deviation 0.344
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin: change at follow-up visit-0.02 Gram per deciliterStandard Deviation 0.211
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein:change at week 2-0.04 Gram per deciliterStandard Deviation 0.286
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin:change at week 6-0.07 Gram per deciliterStandard Deviation 0.244
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein: change at week 4-0.15 Gram per deciliterStandard Deviation 0.242
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin:change at week 2-0.03 Gram per deciliterStandard Deviation 0.174
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein: change at week 6-0.09 Gram per deciliterStandard Deviation 0.368
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin:change at week 10.00 Gram per deciliterStandard Deviation 0.169
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin:change at week 6-0.05 Gram per deciliterStandard Deviation 0.227
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein: change at follow-up visit0.02 Gram per deciliterStandard Deviation 0.299
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin: change at week 40.03 Gram per deciliterStandard Deviation 0.224
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein: change at week 40.03 Gram per deciliterStandard Deviation 0.28
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin: change at follow-up visit0.06 Gram per deciliterStandard Deviation 0.181
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein: change at week 1-0.02 Gram per deciliterStandard Deviation 0.301
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitAlbumin:change at week 2-0.06 Gram per deciliterStandard Deviation 0.202
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein:change at week 2-0.10 Gram per deciliterStandard Deviation 0.299
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitProtein: change at week 6-0.09 Gram per deciliterStandard Deviation 0.31
Secondary

Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit

Time frame: Baseline, Weeks 1, 2, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71)

Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, Overall Number of Participants Analyzed signifies participants evaluable for this outcome measure and number analyzed signifies participants evaluable for the each specified time point.

ArmMeasureGroupValue (MEAN)Dispersion
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium: change at week 40.01 Milliequivalents per literStandard Deviation 0.389
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at week 10.13 Milliequivalents per literStandard Deviation 2.548
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium: change at week 1-0.00 Milliequivalents per literStandard Deviation 0.363
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride: change at follow-up visit0.6 Milliequivalents per literStandard Deviation 2.97
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at week 60.52 Milliequivalents per literStandard Deviation 2.56
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium:change at week 6-0.8 Milliequivalents per literStandard Deviation 2.31
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium:change at week 2-0.14 Milliequivalents per literStandard Deviation 0.367
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at follow-up visit-0.02 Milliequivalents per literStandard Deviation 2.916
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium: change at week 6-0.09 Milliequivalents per literStandard Deviation 0.373
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at week 40.21 Milliequivalents per literStandard Deviation 2.739
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride:change at week 6-0.6 Milliequivalents per literStandard Deviation 1.98
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium: change at week 10.1 Milliequivalents per literStandard Deviation 2.34
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride: change at week 40.3 Milliequivalents per literStandard Deviation 2.05
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium: change at follow up-0.4 Milliequivalents per literStandard Deviation 3.26
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at week 20.08 Milliequivalents per literStandard Deviation 2.229
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium:change at week 4-0.3 Milliequivalents per literStandard Deviation 2.7
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium: change at week 2-0.5 Milliequivalents per literStandard Deviation 2.23
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride: change at week 2-0.2 Milliequivalents per literStandard Deviation 2.52
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium: change at follow-up visit-0.11 Milliequivalents per literStandard Deviation 0.379
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride: change at week 10.1 Milliequivalents per literStandard Deviation 2.11
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at week 1-0.38 Milliequivalents per literStandard Deviation 1.759
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium: change at week 10.08 Milliequivalents per literStandard Deviation 0.282
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium:change at week 20.04 Milliequivalents per literStandard Deviation 0.298
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium: change at week 2-0.3 Milliequivalents per literStandard Deviation 1.89
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium: change at week 1-0.0 Milliequivalents per literStandard Deviation 1.77
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at week 6-0.44 Milliequivalents per literStandard Deviation 2.598
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at week 40.05 Milliequivalents per literStandard Deviation 2.128
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at week 2-0.40 Milliequivalents per literStandard Deviation 2.151
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium:change at week 40.6 Milliequivalents per literStandard Deviation 1.83
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at follow-up visit0.66 Milliequivalents per literStandard Deviation 2.209
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium: change at week 4-0.06 Milliequivalents per literStandard Deviation 0.285
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride: change at follow-up visit-0.3 Milliequivalents per literStandard Deviation 2.16
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium: change at week 60.03 Milliequivalents per literStandard Deviation 0.295
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium:change at week 60.0 Milliequivalents per literStandard Deviation 2.39
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride:change at week 60.1 Milliequivalents per literStandard Deviation 2.27
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride: change at week 40.6 Milliequivalents per literStandard Deviation 1.89
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium: change at follow up0.5 Milliequivalents per literStandard Deviation 2.5
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium: change at follow-up visit0.10 Milliequivalents per literStandard Deviation 0.375
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride: change at week 2-0.2 Milliequivalents per literStandard Deviation 2.08
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride: change at week 10.3 Milliequivalents per literStandard Deviation 1.86
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at week 60.66 Milliequivalents per literStandard Deviation 2.132
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium: change at week 1-0.7 Milliequivalents per literStandard Deviation 2.04
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium: change at week 2-0.1 Milliequivalents per literStandard Deviation 2.39
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium:change at week 4-0.2 Milliequivalents per literStandard Deviation 2.44
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium:change at week 6-0.2 Milliequivalents per literStandard Deviation 2.23
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium: change at follow up-0.1 Milliequivalents per literStandard Deviation 2.45
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium: change at week 10.03 Milliequivalents per literStandard Deviation 0.372
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium:change at week 2-0.07 Milliequivalents per literStandard Deviation 0.338
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride: change at week 10.3 Milliequivalents per literStandard Deviation 1.57
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride: change at week 20.7 Milliequivalents per literStandard Deviation 2.03
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride: change at week 40.2 Milliequivalents per literStandard Deviation 2.68
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium: change at week 4-0.02 Milliequivalents per literStandard Deviation 0.35
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride:change at week 60.0 Milliequivalents per literStandard Deviation 2.34
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at week 1-0.20 Milliequivalents per literStandard Deviation 1.965
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium: change at week 6-0.06 Milliequivalents per literStandard Deviation 0.332
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride: change at follow-up visit0.8 Milliequivalents per literStandard Deviation 2.64
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at week 2-0.51 Milliequivalents per literStandard Deviation 1.956
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at week 4-0.24 Milliequivalents per literStandard Deviation 2.484
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium: change at follow-up visit0.03 Milliequivalents per literStandard Deviation 0.394
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at follow-up visit0.41 Milliequivalents per literStandard Deviation 2.056
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride: change at follow-up visit0.1 Milliequivalents per literStandard Deviation 2.41
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium: change at week 2-0.2 Milliequivalents per literStandard Deviation 2.18
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride: change at week 20.2 Milliequivalents per literStandard Deviation 2.5
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium: change at week 10.02 Milliequivalents per literStandard Deviation 0.347
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at week 1-0.18 Milliequivalents per literStandard Deviation 1.768
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium: change at week 4-0.01 Milliequivalents per literStandard Deviation 0.327
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium: change at follow up-0.3 Milliequivalents per literStandard Deviation 2.41
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium:change at week 20.04 Milliequivalents per literStandard Deviation 0.359
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride:change at week 6-0.5 Milliequivalents per literStandard Deviation 2.44
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at week 60.27 Milliequivalents per literStandard Deviation 2.204
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium: change at week 1-0.6 Milliequivalents per literStandard Deviation 2.17
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium: change at week 60.03 Milliequivalents per literStandard Deviation 0.407
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at follow-up visit0.75 Milliequivalents per literStandard Deviation 2.386
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at week 40.34 Milliequivalents per literStandard Deviation 1.868
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium: change at follow-up visit0.04 Milliequivalents per literStandard Deviation 0.351
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium:change at week 6-0.9 Milliequivalents per literStandard Deviation 2.4
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride: change at week 4-0.4 Milliequivalents per literStandard Deviation 2.23
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at week 20.10 Milliequivalents per literStandard Deviation 2.129
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride: change at week 10.0 Milliequivalents per literStandard Deviation 2.54
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium:change at week 4-0.7 Milliequivalents per literStandard Deviation 2.71
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at week 60.12 Milliequivalents per literStandard Deviation 2.407
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride: change at follow-up visit-0.4 Milliequivalents per literStandard Deviation 2.9
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at week 10.28 Milliequivalents per literStandard Deviation 1.638
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium: change at week 6-0.06 Milliequivalents per literStandard Deviation 0.262
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride: change at week 2-0.2 Milliequivalents per literStandard Deviation 2.87
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride: change at week 10.0 Milliequivalents per literStandard Deviation 2.66
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium: change at week 10.07 Milliequivalents per literStandard Deviation 0.343
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium: change at follow-up visit0.12 Milliequivalents per literStandard Deviation 0.358
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride: change at week 4-0.3 Milliequivalents per literStandard Deviation 2.16
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium:change at week 4-0.4 Milliequivalents per literStandard Deviation 3.08
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium: change at week 2-0.4 Milliequivalents per literStandard Deviation 3.61
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at week 40.02 Milliequivalents per literStandard Deviation 2.011
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium:change at week 6-0.9 Milliequivalents per literStandard Deviation 3.55
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium: change at week 1-0.4 Milliequivalents per literStandard Deviation 3.5
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride:change at week 6-0.4 Milliequivalents per literStandard Deviation 3.05
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium: change at week 40.05 Milliequivalents per literStandard Deviation 0.375
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium:change at week 20.07 Milliequivalents per literStandard Deviation 0.346
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at week 2-0.13 Milliequivalents per literStandard Deviation 1.931
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium: change at follow up-0.8 Milliequivalents per literStandard Deviation 3.59
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at follow-up visit0.43 Milliequivalents per literStandard Deviation 2.162
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium: change at follow up0.7 Milliequivalents per literStandard Deviation 1.94
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride: change at week 10.6 Milliequivalents per literStandard Deviation 2.11
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at week 60.63 Milliequivalents per literStandard Deviation 2.096
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride: change at week 20.4 Milliequivalents per literStandard Deviation 2.7
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride: change at week 40.3 Milliequivalents per literStandard Deviation 3.28
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium:change at week 60.9 Milliequivalents per literStandard Deviation 2.5
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium: change at week 4-0.09 Milliequivalents per literStandard Deviation 0.3
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride:change at week 60.5 Milliequivalents per literStandard Deviation 2.93
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium:change at week 4-0.4 Milliequivalents per literStandard Deviation 2.72
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at week 10.09 Milliequivalents per literStandard Deviation 2.209
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium: change at week 6-0.06 Milliequivalents per literStandard Deviation 0.309
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride: change at follow-up visit1.3 Milliequivalents per literStandard Deviation 2.11
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium: change at week 10.01 Milliequivalents per literStandard Deviation 0.337
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at week 2-0.15 Milliequivalents per literStandard Deviation 2.341
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium: change at week 2-0.2 Milliequivalents per literStandard Deviation 2.61
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at follow-up visit0.08 Milliequivalents per literStandard Deviation 1.643
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at week 40.14 Milliequivalents per literStandard Deviation 1.286
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium: change at week 10.4 Milliequivalents per literStandard Deviation 1.97
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium: change at follow-up visit0.05 Milliequivalents per literStandard Deviation 0.293
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium:change at week 20.00 Milliequivalents per literStandard Deviation 0.245
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium: change at week 10.0 Milliequivalents per literStandard Deviation 2.08
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium: change at follow up-0.1 Milliequivalents per literStandard Deviation 2.46
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at follow-up visit0.18 Milliequivalents per literStandard Deviation 2.3
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at week 6-0.19 Milliequivalents per literStandard Deviation 2.038
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium:change at week 6-0.1 Milliequivalents per literStandard Deviation 2.23
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium: change at week 4-0.03 Milliequivalents per literStandard Deviation 0.415
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium: change at follow-up visit-0.09 Milliequivalents per literStandard Deviation 0.475
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at week 2-0.60 Milliequivalents per literStandard Deviation 2.354
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium: change at week 10.00 Milliequivalents per literStandard Deviation 0.429
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride: change at week 10.5 Milliequivalents per literStandard Deviation 2.02
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at week 4-0.00 Milliequivalents per literStandard Deviation 2.695
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at week 1-0.21 Milliequivalents per literStandard Deviation 2.388
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium: change at week 6-0.10 Milliequivalents per literStandard Deviation 0.355
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride:change at week 60.9 Milliequivalents per literStandard Deviation 2.73
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium:change at week 4-0.1 Milliequivalents per literStandard Deviation 1.77
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium: change at week 2-0.5 Milliequivalents per literStandard Deviation 2.2
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride: change at week 20.4 Milliequivalents per literStandard Deviation 2.15
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride: change at follow-up visit0.3 Milliequivalents per literStandard Deviation 2.35
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride: change at week 41.0 Milliequivalents per literStandard Deviation 2.21
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium:change at week 2-0.16 Milliequivalents per literStandard Deviation 0.438
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at follow-up visit1.09 Milliequivalents per literStandard Deviation 2.049
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium: change at week 2-0.3 Milliequivalents per literStandard Deviation 3.45
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride: change at week 10.5 Milliequivalents per literStandard Deviation 2.83
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium:change at week 4-0.3 Milliequivalents per literStandard Deviation 3.28
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium: change at week 40.26 Milliequivalents per literStandard Deviation 0.35
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at week 2-0.07 Milliequivalents per literStandard Deviation 1.828
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium:change at week 2-0.02 Milliequivalents per literStandard Deviation 0.322
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at week 6-0.20 Milliequivalents per literStandard Deviation 2.217
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at week 40.02 Milliequivalents per literStandard Deviation 1.704
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride: change at week 4-0.2 Milliequivalents per literStandard Deviation 2.57
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium: change at week 1-0.1 Milliequivalents per literStandard Deviation 3.39
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium: change at follow up0.1 Milliequivalents per literStandard Deviation 3.32
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium: change at follow-up visit0.26 Milliequivalents per literStandard Deviation 0.46
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium: change at week 10.20 Milliequivalents per literStandard Deviation 0.464
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitSodium:change at week 6-0.5 Milliequivalents per literStandard Deviation 2.49
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride: change at week 20.2 Milliequivalents per literStandard Deviation 2.99
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBicarbonate: change at week 1-0.02 Milliequivalents per literStandard Deviation 1.651
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPotassium: change at week 60.09 Milliequivalents per literStandard Deviation 0.388
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride: change at follow-up visit0.4 Milliequivalents per literStandard Deviation 3.16
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChloride:change at week 60.0 Milliequivalents per literStandard Deviation 2.32
Secondary

Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit

Time frame: Baseline, Weeks 1, 2, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71)

Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, Overall Number of Participants Analyzed signifies participants evaluable for this outcome measure and number analyzed signifies participants evaluable for the each specified time point.

ArmMeasureGroupValue (MEAN)Dispersion
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium: change at week 2-0.08 Microgram per deciliterStandard Deviation 0.417
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium:change at week 10.01 Microgram per deciliterStandard Deviation 0.419
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate:change at week 10.16 Microgram per deciliterStandard Deviation 0.807
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at follow-up visit0.0 Microgram per deciliterStandard Deviation 3.17
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose: change at follow -up visit4.5 Microgram per deciliterStandard Deviation 11.58
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at week 20.8 Microgram per deciliterStandard Deviation 3.89
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium: change at follow-up visit0.00 Microgram per deciliterStandard Deviation 0.317
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium: change at week 6-0.04 Microgram per deciliterStandard Deviation 0.355
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at week 40.6 Microgram per deciliterStandard Deviation 3.39
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose: change at week 47.3 Microgram per deciliterStandard Deviation 15.6
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate: change at week 60.13 Microgram per deciliterStandard Deviation 0.728
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at week 10.9 Microgram per deciliterStandard Deviation 4.57
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose: change at week 29.7 Microgram per deciliterStandard Deviation 23.71
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium: change at week 4-0.04 Microgram per deciliterStandard Deviation 0.354
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate: change at follow- up visit-0.11 Microgram per deciliterStandard Deviation 0.721
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose:change at week 14.9 Microgram per deciliterStandard Deviation 8.73
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate: change at week 40.21 Microgram per deciliterStandard Deviation 0.497
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate: change at week 20.30 Microgram per deciliterStandard Deviation 0.99
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at week 60.7 Microgram per deciliterStandard Deviation 2.84
Vehicle Cream Once Daily (QD)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose: change at week 63.5 Microgram per deciliterStandard Deviation 9.19
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate: change at week 40.14 Microgram per deciliterStandard Deviation 0.731
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium:change at week 10.01 Microgram per deciliterStandard Deviation 0.259
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate: change at week 60.07 Microgram per deciliterStandard Deviation 0.984
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate:change at week 10.01 Microgram per deciliterStandard Deviation 0.606
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate: change at follow- up visit-0.33 Microgram per deciliterStandard Deviation 0.753
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose: change at week 21.2 Microgram per deciliterStandard Deviation 17.34
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at follow-up visit-0.3 Microgram per deciliterStandard Deviation 3.13
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate: change at week 2-0.11 Microgram per deciliterStandard Deviation 0.655
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose: change at follow -up visit2.2 Microgram per deciliterStandard Deviation 11.45
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at week 20.0 Microgram per deciliterStandard Deviation 2.71
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at week 10.6 Microgram per deciliterStandard Deviation 3.04
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium: change at follow-up visit-0.01 Microgram per deciliterStandard Deviation 0.345
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose:change at week 15.7 Microgram per deciliterStandard Deviation 13.97
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium: change at week 60.10 Microgram per deciliterStandard Deviation 0.303
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose: change at week 62.4 Microgram per deciliterStandard Deviation 17.55
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium: change at week 40.11 Microgram per deciliterStandard Deviation 0.329
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose: change at week 40.5 Microgram per deciliterStandard Deviation 12.5
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium: change at week 20.00 Microgram per deciliterStandard Deviation 0.268
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at week 40.0 Microgram per deciliterStandard Deviation 3.04
PF-06700841 0.1% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at week 6-0.2 Microgram per deciliterStandard Deviation 3.11
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose: change at week 6-1.7 Microgram per deciliterStandard Deviation 10.62
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at week 10.1 Microgram per deciliterStandard Deviation 3.12
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at week 20.6 Microgram per deciliterStandard Deviation 3.54
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate: change at week 6-0.02 Microgram per deciliterStandard Deviation 0.831
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at week 4-0.0 Microgram per deciliterStandard Deviation 2.67
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at week 6-0.6 Microgram per deciliterStandard Deviation 3.61
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate: change at follow- up visit0.05 Microgram per deciliterStandard Deviation 0.763
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at follow-up visit0.4 Microgram per deciliterStandard Deviation 2.6
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium:change at week 1-0.06 Microgram per deciliterStandard Deviation 0.377
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate:change at week 10.16 Microgram per deciliterStandard Deviation 0.678
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium: change at week 2-0.10 Microgram per deciliterStandard Deviation 0.362
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate: change at week 20.12 Microgram per deciliterStandard Deviation 0.617
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate: change at week 40.06 Microgram per deciliterStandard Deviation 0.756
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium: change at follow-up visit-0.08 Microgram per deciliterStandard Deviation 0.409
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose:change at week 13.4 Microgram per deciliterStandard Deviation 14.62
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose: change at week 20.6 Microgram per deciliterStandard Deviation 10.97
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose: change at week 4-1.2 Microgram per deciliterStandard Deviation 15.86
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium: change at week 4-0.07 Microgram per deciliterStandard Deviation 0.345
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium: change at week 6-0.21 Microgram per deciliterStandard Deviation 0.393
PF-06700841 0.3% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose: change at follow -up visit4.8 Microgram per deciliterStandard Deviation 13.28
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate: change at week 2-0.03 Microgram per deciliterStandard Deviation 0.649
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose: change at week 62.1 Microgram per deciliterStandard Deviation 13.8
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at week 41.4 Microgram per deciliterStandard Deviation 3.06
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium: change at follow-up visit0.00 Microgram per deciliterStandard Deviation 0.323
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate: change at week 4-0.06 Microgram per deciliterStandard Deviation 0.621
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at week 20.9 Microgram per deciliterStandard Deviation 3.18
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at week 11.0 Microgram per deciliterStandard Deviation 3.19
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate:change at week 1-0.01 Microgram per deciliterStandard Deviation 0.561
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium: change at week 60.03 Microgram per deciliterStandard Deviation 0.315
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium:change at week 1-0.02 Microgram per deciliterStandard Deviation 0.248
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate: change at follow- up visit-0.21 Microgram per deciliterStandard Deviation 0.554
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose: change at week 44.5 Microgram per deciliterStandard Deviation 13.99
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at week 60.9 Microgram per deciliterStandard Deviation 3.27
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose: change at follow -up visit4.6 Microgram per deciliterStandard Deviation 14.77
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium: change at week 20.05 Microgram per deciliterStandard Deviation 0.296
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium: change at week 40.05 Microgram per deciliterStandard Deviation 0.272
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose: change at week 23.2 Microgram per deciliterStandard Deviation 12.63
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate: change at week 60.06 Microgram per deciliterStandard Deviation 0.63
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose:change at week 14.5 Microgram per deciliterStandard Deviation 8.6
PF-06700841 1.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at follow-up visit1.2 Microgram per deciliterStandard Deviation 4.22
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at week 60.3 Microgram per deciliterStandard Deviation 3.82
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium:change at week 10.07 Microgram per deciliterStandard Deviation 0.386
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate:change at week 10.00 Microgram per deciliterStandard Deviation 0.739
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose: change at follow -up visit6.0 Microgram per deciliterStandard Deviation 13.79
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate: change at week 2-0.15 Microgram per deciliterStandard Deviation 0.842
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at week 40.5 Microgram per deciliterStandard Deviation 3.84
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate: change at week 4-0.14 Microgram per deciliterStandard Deviation 0.856
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium: change at follow-up visit0.10 Microgram per deciliterStandard Deviation 0.441
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose:change at week 14.4 Microgram per deciliterStandard Deviation 16.14
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium: change at week 20.07 Microgram per deciliterStandard Deviation 0.423
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose: change at week 23.1 Microgram per deciliterStandard Deviation 10
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate: change at week 6-0.02 Microgram per deciliterStandard Deviation 0.649
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium: change at week 40.00 Microgram per deciliterStandard Deviation 0.376
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose: change at week 42.8 Microgram per deciliterStandard Deviation 20.2
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at week 11.0 Microgram per deciliterStandard Deviation 3.05
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium: change at week 60.00 Microgram per deciliterStandard Deviation 0.397
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at week 20.5 Microgram per deciliterStandard Deviation 3.63
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose: change at week 6-0.5 Microgram per deciliterStandard Deviation 9.77
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate: change at follow- up visit-0.02 Microgram per deciliterStandard Deviation 0.81
PF-06700841 3.0% Cream QDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at follow-up visit0.2 Microgram per deciliterStandard Deviation 2.87
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at follow-up visit0.8 Microgram per deciliterStandard Deviation 3.78
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose: change at week 41.3 Microgram per deciliterStandard Deviation 24.01
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at week 20.6 Microgram per deciliterStandard Deviation 4.19
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at week 10.2 Microgram per deciliterStandard Deviation 2.19
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium: change at follow-up visit-0.05 Microgram per deciliterStandard Deviation 0.419
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate: change at week 20.27 Microgram per deciliterStandard Deviation 1.025
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium: change at week 4-0.08 Microgram per deciliterStandard Deviation 0.309
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate: change at week 40.22 Microgram per deciliterStandard Deviation 0.806
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate: change at follow- up visit0.02 Microgram per deciliterStandard Deviation 0.59
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate:change at week 10.05 Microgram per deciliterStandard Deviation 0.661
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose:change at week 14.5 Microgram per deciliterStandard Deviation 29.9
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate: change at week 60.06 Microgram per deciliterStandard Deviation 0.534
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose: change at follow -up visit6.2 Microgram per deciliterStandard Deviation 16.75
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at week 4-0.7 Microgram per deciliterStandard Deviation 2.96
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose: change at week 6-3.4 Microgram per deciliterStandard Deviation 16.37
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at week 6-0.8 Microgram per deciliterStandard Deviation 3.24
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose: change at week 2-1.9 Microgram per deciliterStandard Deviation 13.51
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium: change at week 20.03 Microgram per deciliterStandard Deviation 0.389
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium:change at week 1-0.02 Microgram per deciliterStandard Deviation 0.303
Vehicle Cream Twice Daily (BID)Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium: change at week 6-0.05 Microgram per deciliterStandard Deviation 0.335
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose: change at follow -up visit9.1 Microgram per deciliterStandard Deviation 17.21
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at week 41.3 Microgram per deciliterStandard Deviation 2.81
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose:change at week 15.6 Microgram per deciliterStandard Deviation 13.14
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at week 10.4 Microgram per deciliterStandard Deviation 3.38
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium: change at week 2-0.10 Microgram per deciliterStandard Deviation 0.293
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate: change at week 6-0.11 Microgram per deciliterStandard Deviation 0.827
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose: change at week 27.9 Microgram per deciliterStandard Deviation 16.67
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate:change at week 1-0.02 Microgram per deciliterStandard Deviation 0.704
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at follow-up visit0.5 Microgram per deciliterStandard Deviation 3.42
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium: change at week 4-0.03 Microgram per deciliterStandard Deviation 0.257
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at week 20.8 Microgram per deciliterStandard Deviation 2.99
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate: change at follow- up visit-0.08 Microgram per deciliterStandard Deviation 0.677
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium: change at week 6-0.05 Microgram per deciliterStandard Deviation 0.464
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium:change at week 1-0.01 Microgram per deciliterStandard Deviation 0.295
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at week 60.2 Microgram per deciliterStandard Deviation 3.52
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose: change at week 64.3 Microgram per deciliterStandard Deviation 12.23
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate: change at week 4-0.21 Microgram per deciliterStandard Deviation 0.663
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose: change at week 410.7 Microgram per deciliterStandard Deviation 26.13
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate: change at week 2-0.03 Microgram per deciliterStandard Deviation 0.718
PF-06700841 0.3% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium: change at follow-up visit0.01 Microgram per deciliterStandard Deviation 0.378
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at week 6-0.4 Microgram per deciliterStandard Deviation 3.69
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at week 1-0.1 Microgram per deciliterStandard Deviation 2.65
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose: change at week 22.7 Microgram per deciliterStandard Deviation 18.07
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate: change at follow- up visit-0.20 Microgram per deciliterStandard Deviation 0.989
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate:change at week 1-0.14 Microgram per deciliterStandard Deviation 0.89
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose: change at week 43.4 Microgram per deciliterStandard Deviation 18.33
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose:change at week 13.3 Microgram per deciliterStandard Deviation 13.58
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at week 4-0.2 Microgram per deciliterStandard Deviation 3.61
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate: change at week 2-0.37 Microgram per deciliterStandard Deviation 1.059
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose: change at week 61.5 Microgram per deciliterStandard Deviation 12.62
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium: change at week 2-0.01 Microgram per deciliterStandard Deviation 0.244
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium: change at week 40.10 Microgram per deciliterStandard Deviation 0.341
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitGlucose: change at follow -up visit2.0 Microgram per deciliterStandard Deviation 22.43
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at week 20.4 Microgram per deciliterStandard Deviation 3.28
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrea nitrogen: change at follow-up visit0.1 Microgram per deciliterStandard Deviation 3.78
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium:change at week 10.09 Microgram per deciliterStandard Deviation 0.318
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate: change at week 6-0.21 Microgram per deciliterStandard Deviation 1.084
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitUrate: change at week 4-0.16 Microgram per deciliterStandard Deviation 0.713
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium: change at follow-up visit0.05 Microgram per deciliterStandard Deviation 0.356
PF-06700841 1.0% Cream BIDChange From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitCalcium: change at week 6-0.04 Microgram per deciliterStandard Deviation 0.337
Secondary

Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation

EASI evaluates severity of participant's AD (excluded scalp, palms, soles) based on severity of AD clinical signs and % of body surface area (BSA) affected. Severity of clinical signs of AD (erythema, induration/papulation, excoriation and lichenification) scored separately for each of 4 body regions(head and neck, upper limbs, trunk \[including axillae and groin\] and lower limbs \[including buttocks\]) on4-point scale: 0= absent; 1= mild; 2= moderate; 3= severe. EASI area score was based upon % BSA with AD in each 4 body region: 0 (0%), 1 (\>0 to \<10%), 2 (10 to \<30%), 3 (30 to \<50%), 4 (50 to \<70%), 5 (70 to \<90%) and 6 (90 to 100%). Total EASI score =0.1\*Ah\*(Eh+Ih+Exh+Lh) + 0.2\*Au\*(Eu+Iu+ExU+Lu) + 0.3\*At\*(Et+It+Ext+Lt) + 0.4\*Al\*(El+Il+Exl+Ll); A = EASI area score; E = erythema; I = induration/papulation; Ex = excoriation; L = lichenification; h = head and neck; u = upper limbs; t = trunk; l = lower limbs. Total EASI score ranged from 0.0 to 72.0, higher scores = greater severity of AD.

Time frame: Baseline, Week 6

Population: Full analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Missing data were imputed with multiple imputation method assuming responses are similar to the corresponding vehicle arm under the MAR assumption

ArmMeasureValue (LEAST_SQUARES_MEAN)
Vehicle Cream Once Daily (QD)Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation-3.2 Units on a scale
PF-06700841 0.1% Cream QDChange From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation-4.5 Units on a scale
PF-06700841 0.3% Cream QDChange From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation-4.6 Units on a scale
PF-06700841 1.0% Cream QDChange From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation-4.8 Units on a scale
PF-06700841 3.0% Cream QDChange From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation-5.5 Units on a scale
Vehicle Cream Twice Daily (BID)Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation-3.6 Units on a scale
PF-06700841 0.3% Cream BIDChange From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation-4.4 Units on a scale
PF-06700841 1.0% Cream BIDChange From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation-5.3 Units on a scale
Comparison: ANCOVA contained fixed factors of treatment and baseline value.p-value: 0.048890% CI: [-2.61, -0.01]ANCOVA
Comparison: ANCOVA contained fixed factors of treatment and baseline value.p-value: 0.041390% CI: [-2.66, -0.07]ANCOVA
Comparison: ANCOVA contained fixed factors of treatment and baseline value.p-value: 0.0290% CI: [-2.86, -0.32]ANCOVA
Comparison: ANCOVA contained fixed factors of treatment and baseline value.p-value: 0.001190% CI: [-3.58, -1.08]ANCOVA
Comparison: ANCOVA contained fixed factors of treatment and baseline value.p-value: 0.072790% CI: [-1.66, 0.1]ANCOVA
Comparison: ANCOVA contained fixed factors of treatment and baseline value.p-value: 0.00190% CI: [-2.52, -0.77]ANCOVA
Secondary

Change From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6

Time frame: Baseline, Weeks 2 and 6

Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, number analyzed signifies participants evaluable for the each specified time point.

ArmMeasureGroupValue (MEAN)Dispersion
Vehicle Cream Once Daily (QD)Change From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6Change at week 60.3 Beats per minuteStandard Deviation 6.19
Vehicle Cream Once Daily (QD)Change From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6Baseline66.8 Beats per minuteStandard Deviation 11.45
Vehicle Cream Once Daily (QD)Change From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6Change at week 20.7 Beats per minuteStandard Deviation 10.05
PF-06700841 0.1% Cream QDChange From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6Change at week 6-1.1 Beats per minuteStandard Deviation 7.65
PF-06700841 0.1% Cream QDChange From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6Baseline66.9 Beats per minuteStandard Deviation 9.33
PF-06700841 0.1% Cream QDChange From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6Change at week 2-0.5 Beats per minuteStandard Deviation 8.03
PF-06700841 0.3% Cream QDChange From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6Baseline68.4 Beats per minuteStandard Deviation 14.66
PF-06700841 0.3% Cream QDChange From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6Change at week 6-1.7 Beats per minuteStandard Deviation 9.06
PF-06700841 0.3% Cream QDChange From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6Change at week 2-1.8 Beats per minuteStandard Deviation 11.53
PF-06700841 1.0% Cream QDChange From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6Baseline64.9 Beats per minuteStandard Deviation 9.05
PF-06700841 1.0% Cream QDChange From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6Change at week 2-0.6 Beats per minuteStandard Deviation 7.88
PF-06700841 1.0% Cream QDChange From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6Change at week 60.8 Beats per minuteStandard Deviation 8.53
PF-06700841 3.0% Cream QDChange From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6Change at week 21.9 Beats per minuteStandard Deviation 8.01
PF-06700841 3.0% Cream QDChange From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6Baseline64.9 Beats per minuteStandard Deviation 12.26
PF-06700841 3.0% Cream QDChange From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6Change at week 6-0.3 Beats per minuteStandard Deviation 8.46
Vehicle Cream Twice Daily (BID)Change From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6Change at week 22.2 Beats per minuteStandard Deviation 8.76
Vehicle Cream Twice Daily (BID)Change From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6Baseline66.9 Beats per minuteStandard Deviation 12.03
Vehicle Cream Twice Daily (BID)Change From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6Change at week 6-0.8 Beats per minuteStandard Deviation 8.23
PF-06700841 0.3% Cream BIDChange From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6Change at week 21.7 Beats per minuteStandard Deviation 9.13
PF-06700841 0.3% Cream BIDChange From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6Baseline68.2 Beats per minuteStandard Deviation 12.11
PF-06700841 0.3% Cream BIDChange From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6Change at week 60.5 Beats per minuteStandard Deviation 8.76
PF-06700841 1.0% Cream BIDChange From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6Baseline68.1 Beats per minuteStandard Deviation 12.48
PF-06700841 1.0% Cream BIDChange From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6Change at week 21.7 Beats per minuteStandard Deviation 12.52
PF-06700841 1.0% Cream BIDChange From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6Change at week 6-0.4 Beats per minuteStandard Deviation 12.06
Secondary

Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit

Time frame: Baseline, Weeks 1, 2, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71)

Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, Overall Number of Participants Analyzed signifies participants evaluable for this outcome measure and number analyzed signifies participants evaluable for the each specified time point.

ArmMeasureGroupValue (MEAN)Dispersion
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at week 10.0 10^12*cells per literStandard Deviation 0.02
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at follow-up visit0.03 10^12*cells per literStandard Deviation 0.22
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at week 6-0.04 10^12*cells per literStandard Deviation 0.247
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at week 10.03 10^12*cells per literStandard Deviation 0.261
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at follow-up visit-0.0 10^12*cells per literStandard Deviation 0.02
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at week 6-0.0 10^12*cells per literStandard Deviation 0.02
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at week 2-0.05 10^12*cells per literStandard Deviation 0.234
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at week 40.0 10^12*cells per literStandard Deviation 0.03
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at week 2-0.0 10^12*cells per literStandard Deviation 0.02
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at week 4-0.01 10^12*cells per literStandard Deviation 0.216
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at follow-up visit0.02 10^12*cells per literStandard Deviation 0.244
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at week 4-0.05 10^12*cells per literStandard Deviation 0.221
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at week 6-0.01 10^12*cells per literStandard Deviation 0.18
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at week 2-0.03 10^12*cells per literStandard Deviation 0.212
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at week 20.0 10^12*cells per literStandard Deviation 0.02
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at follow-up visit-0.0 10^12*cells per literStandard Deviation 0.02
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at week 1-0.07 10^12*cells per literStandard Deviation 0.232
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at week 60.0 10^12*cells per literStandard Deviation 0.02
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at week 10.0 10^12*cells per literStandard Deviation 0.02
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at week 4-0.0 10^12*cells per literStandard Deviation 0.02
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at week 20.0 10^12*cells per literStandard Deviation 0.02
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at week 2-0.18 10^12*cells per literStandard Deviation 0.251
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at week 1-0.12 10^12*cells per literStandard Deviation 0.264
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at week 4-0.16 10^12*cells per literStandard Deviation 0.251
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at week 6-0.17 10^12*cells per literStandard Deviation 0.265
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at follow-up visit-0.15 10^12*cells per literStandard Deviation 0.266
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at week 1-0.0 10^12*cells per literStandard Deviation 0.02
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at week 4-0.0 10^12*cells per literStandard Deviation 0.02
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at week 60.0 10^12*cells per literStandard Deviation 0.02
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at follow-up visit0.0 10^12*cells per literStandard Deviation 0.02
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at week 4-0.10 10^12*cells per literStandard Deviation 0.233
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at week 2-0.0 10^12*cells per literStandard Deviation 0.02
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at week 10.0 10^12*cells per literStandard Deviation 0.02
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at week 6-0.04 10^12*cells per literStandard Deviation 0.238
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at follow-up visit-0.0 10^12*cells per literStandard Deviation 0.02
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at follow-up visit-0.03 10^12*cells per literStandard Deviation 0.254
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at week 1-0.04 10^12*cells per literStandard Deviation 0.252
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at week 6-0.0 10^12*cells per literStandard Deviation 0.02
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at week 40.0 10^12*cells per literStandard Deviation 0.02
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at week 2-0.10 10^12*cells per literStandard Deviation 0.208
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at follow-up visit-0.0 10^12*cells per literStandard Deviation 0.01
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at week 40.01 10^12*cells per literStandard Deviation 0.275
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at follow-up visit0.04 10^12*cells per literStandard Deviation 0.3
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at week 10.0 10^12*cells per literStandard Deviation 0.02
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at week 2-0.07 10^12*cells per literStandard Deviation 0.242
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at week 20.0 10^12*cells per literStandard Deviation 0.02
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at week 40.0 10^12*cells per literStandard Deviation 0.02
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at week 60.0 10^12*cells per literStandard Deviation 0.02
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at week 1-0.08 10^12*cells per literStandard Deviation 0.254
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at week 6-0.02 10^12*cells per literStandard Deviation 0.262
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at week 2-0.10 10^12*cells per literStandard Deviation 0.366
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at week 2-0.0 10^12*cells per literStandard Deviation 0.02
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at follow-up visit-0.0 10^12*cells per literStandard Deviation 0.02
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at week 4-0.0 10^12*cells per literStandard Deviation 0.01
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at week 1-0.08 10^12*cells per literStandard Deviation 0.298
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at follow-up visit-0.08 10^12*cells per literStandard Deviation 0.28
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at week 6-0.0 10^12*cells per literStandard Deviation 0.01
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at week 6-0.10 10^12*cells per literStandard Deviation 0.256
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at week 4-0.12 10^12*cells per literStandard Deviation 0.271
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at week 10.0 10^12*cells per literStandard Deviation 0.01
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at follow-up visit-0.03 10^12*cells per literStandard Deviation 0.308
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at week 6-0.07 10^12*cells per literStandard Deviation 0.303
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at week 4-0.0 10^12*cells per literStandard Deviation 0.02
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at week 1-0.08 10^12*cells per literStandard Deviation 0.192
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at week 2-0.06 10^12*cells per literStandard Deviation 0.229
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at follow-up visit-0.0 10^12*cells per literStandard Deviation 0.02
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at week 10.0 10^12*cells per literStandard Deviation 0.02
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at week 6-0.0 10^12*cells per literStandard Deviation 0.02
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at week 4-0.08 10^12*cells per literStandard Deviation 0.248
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at week 20.0 10^12*cells per literStandard Deviation 0.02
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at week 1-0.09 10^12*cells per literStandard Deviation 0.24
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at week 2-0.11 10^12*cells per literStandard Deviation 0.232
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at week 1-0.0 10^12*cells per literStandard Deviation 0.02
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at week 40.0 10^12*cells per literStandard Deviation 0.02
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at week 60.0 10^12*cells per literStandard Deviation 0.02
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at follow-up visit0.0 10^12*cells per literStandard Deviation 0.02
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes: change at week 2-0.0 10^12*cells per literStandard Deviation 0.02
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at week 4-0.06 10^12*cells per literStandard Deviation 0.219
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at week 6-0.08 10^12*cells per literStandard Deviation 0.239
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitErythrocytes: change at follow-up visit-0.05 10^12*cells per literStandard Deviation 0.262
Secondary

Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit

Time frame: Baseline, Weeks 1, 2, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71)

Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, Overall Number of Participants Analyzed signifies participants evaluable for this outcome measure and number analyzed signifies participants evaluable for the each specified time point.

ArmMeasureGroupValue (MEAN)Dispersion
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at week 2-0.11 Percentage of cellsStandard Deviation 1.801
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at week 1-0.09 Percentage of cellsStandard Deviation 1.39
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at follow-up visit-0.04 Percentage of cellsStandard Deviation 0.36
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at week 1-0.06 Percentage of cellsStandard Deviation 0.431
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at week 6-0.07 Percentage of cellsStandard Deviation 0.272
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at week 4-0.07 Percentage of cellsStandard Deviation 0.485
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at week 2-0.02 Percentage of cellsStandard Deviation 0.304
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes: change at week 2-0.03 Percentage of cellsStandard Deviation 0.382
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at week 2-0.12 Percentage of cellsStandard Deviation 7.827
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at week 10.57 Percentage of cellsStandard Deviation 7.515
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at follow-up visit1.53 Percentage of cellsStandard Deviation 6.219
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at week 10.2 Percentage of cellsStandard Deviation 2.51
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at week 6-0.92 Percentage of cellsStandard Deviation 6.701
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at week 41.58 Percentage of cellsStandard Deviation 7.591
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at week 2-0.5 Percentage of cellsStandard Deviation 2.19
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at follow-up visit-1.71 Percentage of cellsStandard Deviation 7.046
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at week 20.20 Percentage of cellsStandard Deviation 6.175
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at week 1-0.43 Percentage of cellsStandard Deviation 6.772
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes:change at FU visit-0.11 Percentage of cellsStandard Deviation 0.396
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at week 40.0 Percentage of cellsStandard Deviation 2.45
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes: change at week 6-0.06 Percentage of cellsStandard Deviation 0.382
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes : change at follow-up visit0.06 Percentage of cellsStandard Deviation 2.105
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at week 6-0.6 Percentage of cellsStandard Deviation 2.47
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at week 60.95 Percentage of cellsStandard Deviation 8.648
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes : change at week 60.06 Percentage of cellsStandard Deviation 2.488
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes : change at week 4-0.51 Percentage of cellsStandard Deviation 2.509
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes: change at week 20.04 Percentage of cellsStandard Deviation 2.055
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at follow-up (FU) visit0.3 Percentage of cellsStandard Deviation 2.49
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes: change at week 10.02 Percentage of cellsStandard Deviation 1.913
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at follow-up visit0.16 Percentage of cellsStandard Deviation 1.754
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes change at week 10.03 Percentage of cellsStandard Deviation 0.317
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at week 4-1.42 Percentage of cellsStandard Deviation 8.812
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at week 6-0.03 Percentage of cellsStandard Deviation 1.522
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at week 40.42 Percentage of cellsStandard Deviation 1.982
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes: change at week 40.16 Percentage of cellsStandard Deviation 0.596
PF-06700841 0.1% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes: change at week 10.12 Percentage of cellsStandard Deviation 1.391
PF-06700841 0.1% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at week 4-0.8 Percentage of cellsStandard Deviation 1.96
PF-06700841 0.1% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at follow-up visit-0.15 Percentage of cellsStandard Deviation 0.476
PF-06700841 0.1% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at week 6-0.58 Percentage of cellsStandard Deviation 7.009
PF-06700841 0.1% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes: change at week 60.02 Percentage of cellsStandard Deviation 0.361
PF-06700841 0.1% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at week 60.11 Percentage of cellsStandard Deviation 0.809
PF-06700841 0.1% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at week 4-0.12 Percentage of cellsStandard Deviation 1.725
PF-06700841 0.1% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at week 40.06 Percentage of cellsStandard Deviation 0.651
PF-06700841 0.1% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes : change at follow-up visit-0.22 Percentage of cellsStandard Deviation 1.304
PF-06700841 0.1% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at follow-up visit-0.24 Percentage of cellsStandard Deviation 1.86
PF-06700841 0.1% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at week 20.01 Percentage of cellsStandard Deviation 0.493
PF-06700841 0.1% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes: change at week 4-0.08 Percentage of cellsStandard Deviation 0.359
PF-06700841 0.1% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes : change at week 60.33 Percentage of cellsStandard Deviation 2.257
PF-06700841 0.1% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at week 10.17 Percentage of cellsStandard Deviation 1.84
PF-06700841 0.1% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at week 1-0.95 Percentage of cellsStandard Deviation 6.957
PF-06700841 0.1% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at week 6-0.9 Percentage of cellsStandard Deviation 1.93
PF-06700841 0.1% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at follow-up visit1.25 Percentage of cellsStandard Deviation 4.974
PF-06700841 0.1% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at week 60.22 Percentage of cellsStandard Deviation 1.57
PF-06700841 0.1% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at follow-up visit-0.65 Percentage of cellsStandard Deviation 6.057
PF-06700841 0.1% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at week 1-0.02 Percentage of cellsStandard Deviation 0.69
PF-06700841 0.1% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at week 1-0.8 Percentage of cellsStandard Deviation 2.11
PF-06700841 0.1% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes: change at week 20.17 Percentage of cellsStandard Deviation 0.325
PF-06700841 0.1% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at week 6-0.06 Percentage of cellsStandard Deviation 5.461
PF-06700841 0.1% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes : change at week 4-0.17 Percentage of cellsStandard Deviation 1.966
PF-06700841 0.1% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at week 40.51 Percentage of cellsStandard Deviation 7.297
PF-06700841 0.1% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes change at week 10.14 Percentage of cellsStandard Deviation 0.378
PF-06700841 0.1% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at week 20.84 Percentage of cellsStandard Deviation 7.544
PF-06700841 0.1% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes: change at week 2-0.31 Percentage of cellsStandard Deviation 1.502
PF-06700841 0.1% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at week 2-0.8 Percentage of cellsStandard Deviation 2.12
PF-06700841 0.1% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at week 2-0.34 Percentage of cellsStandard Deviation 8.219
PF-06700841 0.1% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at week 2-0.20 Percentage of cellsStandard Deviation 1.298
PF-06700841 0.1% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at week 10.68 Percentage of cellsStandard Deviation 5.814
PF-06700841 0.1% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at follow-up (FU) visit-0.7 Percentage of cellsStandard Deviation 2.24
PF-06700841 0.1% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes:change at FU visit-0.02 Percentage of cellsStandard Deviation 0.384
PF-06700841 0.1% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at week 4-0.30 Percentage of cellsStandard Deviation 7.754
PF-06700841 0.3% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at week 12.33 Percentage of cellsStandard Deviation 5.616
PF-06700841 0.3% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes: change at week 20.09 Percentage of cellsStandard Deviation 0.413
PF-06700841 0.3% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes: change at week 40.01 Percentage of cellsStandard Deviation 0.46
PF-06700841 0.3% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at week 1-1.3 Percentage of cellsStandard Deviation 2.61
PF-06700841 0.3% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at week 2-1.8 Percentage of cellsStandard Deviation 2.42
PF-06700841 0.3% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at week 4-1.8 Percentage of cellsStandard Deviation 2.06
PF-06700841 0.3% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at week 6-1.6 Percentage of cellsStandard Deviation 2.64
PF-06700841 0.3% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at follow-up (FU) visit-1.4 Percentage of cellsStandard Deviation 3.05
PF-06700841 0.3% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes change at week 10.02 Percentage of cellsStandard Deviation 0.483
PF-06700841 0.3% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at week 1-0.06 Percentage of cellsStandard Deviation 0.524
PF-06700841 0.3% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at follow-up visit-1.86 Percentage of cellsStandard Deviation 6.892
PF-06700841 0.3% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at week 2-0.09 Percentage of cellsStandard Deviation 0.342
PF-06700841 0.3% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at week 4-0.03 Percentage of cellsStandard Deviation 0.42
PF-06700841 0.3% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at week 6-0.12 Percentage of cellsStandard Deviation 0.48
PF-06700841 0.3% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at follow-up visit-0.13 Percentage of cellsStandard Deviation 0.443
PF-06700841 0.3% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at week 10.17 Percentage of cellsStandard Deviation 0.934
PF-06700841 0.3% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at week 2-0.16 Percentage of cellsStandard Deviation 1.284
PF-06700841 0.3% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at week 40.15 Percentage of cellsStandard Deviation 1.884
PF-06700841 0.3% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at week 6-0.04 Percentage of cellsStandard Deviation 1.213
PF-06700841 0.3% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at follow-up visit-0.09 Percentage of cellsStandard Deviation 1.155
PF-06700841 0.3% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes: change at week 10.50 Percentage of cellsStandard Deviation 1.428
PF-06700841 0.3% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes: change at week 20.30 Percentage of cellsStandard Deviation 1.522
PF-06700841 0.3% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes : change at week 4-0.02 Percentage of cellsStandard Deviation 2.072
PF-06700841 0.3% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes : change at week 6-0.00 Percentage of cellsStandard Deviation 1.813
PF-06700841 0.3% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes : change at follow-up visit0.50 Percentage of cellsStandard Deviation 1.463
PF-06700841 0.3% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes: change at week 60.02 Percentage of cellsStandard Deviation 0.473
PF-06700841 0.3% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes:change at FU visit0.10 Percentage of cellsStandard Deviation 0.435
PF-06700841 0.3% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at week 21.68 Percentage of cellsStandard Deviation 5.208
PF-06700841 0.3% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at week 41.43 Percentage of cellsStandard Deviation 5.298
PF-06700841 0.3% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at week 60.82 Percentage of cellsStandard Deviation 6.685
PF-06700841 0.3% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at follow-up visit1.61 Percentage of cellsStandard Deviation 6.597
PF-06700841 0.3% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at week 1-2.93 Percentage of cellsStandard Deviation 6.191
PF-06700841 0.3% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at week 2-1.70 Percentage of cellsStandard Deviation 6.037
PF-06700841 0.3% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at week 4-1.52 Percentage of cellsStandard Deviation 6.661
PF-06700841 0.3% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at week 6-0.64 Percentage of cellsStandard Deviation 6.833
PF-06700841 1.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes : change at week 6-0.24 Percentage of cellsStandard Deviation 1.217
PF-06700841 1.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at week 6-0.7 Percentage of cellsStandard Deviation 2.23
PF-06700841 1.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes : change at week 4-0.10 Percentage of cellsStandard Deviation 1.582
PF-06700841 1.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes: change at week 2-0.13 Percentage of cellsStandard Deviation 1.267
PF-06700841 1.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at week 40.06 Percentage of cellsStandard Deviation 8.536
PF-06700841 1.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes: change at week 1-0.06 Percentage of cellsStandard Deviation 1.409
PF-06700841 1.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at follow-up visit-0.41 Percentage of cellsStandard Deviation 2.188
PF-06700841 1.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes: change at week 40.19 Percentage of cellsStandard Deviation 0.429
PF-06700841 1.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at follow-up (FU) visit-0.7 Percentage of cellsStandard Deviation 2.39
PF-06700841 1.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at week 1-0.37 Percentage of cellsStandard Deviation 1.549
PF-06700841 1.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at week 60.08 Percentage of cellsStandard Deviation 0.458
PF-06700841 1.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at week 10.30 Percentage of cellsStandard Deviation 5.755
PF-06700841 1.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at follow-up visit-0.85 Percentage of cellsStandard Deviation 6.367
PF-06700841 1.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at week 61.28 Percentage of cellsStandard Deviation 5.881
PF-06700841 1.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at follow-up visit1.32 Percentage of cellsStandard Deviation 7.355
PF-06700841 1.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at week 10.08 Percentage of cellsStandard Deviation 0.319
PF-06700841 1.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at week 6-1.14 Percentage of cellsStandard Deviation 6.872
PF-06700841 1.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at week 20.11 Percentage of cellsStandard Deviation 1.46
PF-06700841 1.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at week 2-1.50 Percentage of cellsStandard Deviation 6.578
PF-06700841 1.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at week 1-0.4 Percentage of cellsStandard Deviation 2.27
PF-06700841 1.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at week 40.43 Percentage of cellsStandard Deviation 7.586
PF-06700841 1.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at week 21.50 Percentage of cellsStandard Deviation 5.639
PF-06700841 1.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes: change at week 2-0.02 Percentage of cellsStandard Deviation 0.473
PF-06700841 1.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at week 40.01 Percentage of cellsStandard Deviation 0.402
PF-06700841 1.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at week 2-0.9 Percentage of cellsStandard Deviation 2.32
PF-06700841 1.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at week 4-0.37 Percentage of cellsStandard Deviation 1.729
PF-06700841 1.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at week 20.02 Percentage of cellsStandard Deviation 0.323
PF-06700841 1.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at week 10.06 Percentage of cellsStandard Deviation 4.765
PF-06700841 1.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes:change at FU visit-0.10 Percentage of cellsStandard Deviation 0.398
PF-06700841 1.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes: change at week 60.01 Percentage of cellsStandard Deviation 0.486
PF-06700841 1.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes change at week 10.06 Percentage of cellsStandard Deviation 0.364
PF-06700841 1.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at week 4-0.8 Percentage of cellsStandard Deviation 2.34
PF-06700841 1.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes : change at follow-up visit-0.07 Percentage of cellsStandard Deviation 1.226
PF-06700841 1.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at week 60.02 Percentage of cellsStandard Deviation 2.126
PF-06700841 1.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at follow-up visit0.02 Percentage of cellsStandard Deviation 0.512
PF-06700841 3.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at week 2-0.24 Percentage of cellsStandard Deviation 6.146
PF-06700841 3.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at follow-up visit-0.25 Percentage of cellsStandard Deviation 0.541
PF-06700841 3.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at follow-up visit-1.32 Percentage of cellsStandard Deviation 6.559
PF-06700841 3.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at week 1-0.31 Percentage of cellsStandard Deviation 1.607
PF-06700841 3.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at week 2-0.27 Percentage of cellsStandard Deviation 1.131
PF-06700841 3.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes change at week 10.11 Percentage of cellsStandard Deviation 0.318
PF-06700841 3.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at week 4-0.35 Percentage of cellsStandard Deviation 1.431
PF-06700841 3.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at week 6-0.15 Percentage of cellsStandard Deviation 1.714
PF-06700841 3.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at follow-up visit0.12 Percentage of cellsStandard Deviation 1.954
PF-06700841 3.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at follow-up (FU) visit-0.2 Percentage of cellsStandard Deviation 2.5
PF-06700841 3.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes: change at week 1-0.01 Percentage of cellsStandard Deviation 1.593
PF-06700841 3.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes: change at week 20.38 Percentage of cellsStandard Deviation 1.362
PF-06700841 3.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at week 6-0.6 Percentage of cellsStandard Deviation 2.51
PF-06700841 3.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at week 4-2.25 Percentage of cellsStandard Deviation 7.468
PF-06700841 3.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes : change at week 40.22 Percentage of cellsStandard Deviation 1.323
PF-06700841 3.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes : change at week 6-0.12 Percentage of cellsStandard Deviation 1.03
PF-06700841 3.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes : change at follow-up visit0.13 Percentage of cellsStandard Deviation 1.205
PF-06700841 3.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at week 40.0 Percentage of cellsStandard Deviation 2.73
PF-06700841 3.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes: change at week 60.15 Percentage of cellsStandard Deviation 0.399
PF-06700841 3.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes: change at week 20.19 Percentage of cellsStandard Deviation 0.443
PF-06700841 3.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes:change at FU visit-0.03 Percentage of cellsStandard Deviation 0.298
PF-06700841 3.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at week 2-0.7 Percentage of cellsStandard Deviation 2.58
PF-06700841 3.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at week 11.31 Percentage of cellsStandard Deviation 6.259
PF-06700841 3.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at week 20.23 Percentage of cellsStandard Deviation 6.175
PF-06700841 3.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at week 42.41 Percentage of cellsStandard Deviation 6.577
PF-06700841 3.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at week 1-0.8 Percentage of cellsStandard Deviation 2.41
PF-06700841 3.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at week 61.65 Percentage of cellsStandard Deviation 5.818
PF-06700841 3.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at week 6-1.15 Percentage of cellsStandard Deviation 6.969
PF-06700841 3.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at follow-up visit1.34 Percentage of cellsStandard Deviation 6.165
PF-06700841 3.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes: change at week 40.10 Percentage of cellsStandard Deviation 0.409
PF-06700841 3.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at week 1-0.96 Percentage of cellsStandard Deviation 7.843
PF-06700841 3.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at week 2-0.03 Percentage of cellsStandard Deviation 0.532
PF-06700841 3.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at week 4-0.08 Percentage of cellsStandard Deviation 0.712
PF-06700841 3.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at week 10.03 Percentage of cellsStandard Deviation 0.515
PF-06700841 3.0% Cream QDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at week 6-0.16 Percentage of cellsStandard Deviation 0.557
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at week 4-0.34 Percentage of cellsStandard Deviation 1.258
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at week 4-0.05 Percentage of cellsStandard Deviation 0.362
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at week 10.59 Percentage of cellsStandard Deviation 5.179
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at week 41.65 Percentage of cellsStandard Deviation 6.622
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at week 6-0.56 Percentage of cellsStandard Deviation 5.699
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes: change at week 40.03 Percentage of cellsStandard Deviation 0.29
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at follow-up visit0.22 Percentage of cellsStandard Deviation 6.315
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes change at week 10.01 Percentage of cellsStandard Deviation 0.32
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at follow-up visit-0.05 Percentage of cellsStandard Deviation 0.449
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at week 6-1.1 Percentage of cellsStandard Deviation 1.98
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at week 20.50 Percentage of cellsStandard Deviation 5.405
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes: change at week 20.11 Percentage of cellsStandard Deviation 1.318
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at week 60.50 Percentage of cellsStandard Deviation 4.452
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at follow-up (FU) visit-0.6 Percentage of cellsStandard Deviation 2.2
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at week 1-0.5 Percentage of cellsStandard Deviation 1.97
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at week 2-0.14 Percentage of cellsStandard Deviation 1.199
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes: change at week 1-0.19 Percentage of cellsStandard Deviation 1.043
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at week 1-0.03 Percentage of cellsStandard Deviation 0.291
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at week 4-1.38 Percentage of cellsStandard Deviation 5.415
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at week 2-0.49 Percentage of cellsStandard Deviation 6.665
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at week 20.03 Percentage of cellsStandard Deviation 0.355
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes: change at week 6-0.15 Percentage of cellsStandard Deviation 0.31
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at week 6-0.01 Percentage of cellsStandard Deviation 1.767
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes: change at week 2-0.10 Percentage of cellsStandard Deviation 0.318
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at follow-up visit-0.05 Percentage of cellsStandard Deviation 2.805
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at week 4-1.0 Percentage of cellsStandard Deviation 2.34
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes : change at week 40.14 Percentage of cellsStandard Deviation 1.323
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes : change at week 60.13 Percentage of cellsStandard Deviation 0.807
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at week 1-0.17 Percentage of cellsStandard Deviation 5.769
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes:change at FU visit-0.09 Percentage of cellsStandard Deviation 0.331
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at follow-up visit-0.41 Percentage of cellsStandard Deviation 6.961
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at week 6-0.05 Percentage of cellsStandard Deviation 0.296
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at week 2-0.9 Percentage of cellsStandard Deviation 2.55
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at week 1-0.19 Percentage of cellsStandard Deviation 1.41
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes : change at follow-up visit0.26 Percentage of cellsStandard Deviation 1.543
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at week 60.13 Percentage of cellsStandard Deviation 6.029
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at week 2-0.06 Percentage of cellsStandard Deviation 0.624
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes : change at week 6-0.02 Percentage of cellsStandard Deviation 1.324
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at week 4-0.9 Percentage of cellsStandard Deviation 2.29
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at week 4-1.42 Percentage of cellsStandard Deviation 6.498
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes: change at week 20.06 Percentage of cellsStandard Deviation 0.315
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes : change at follow-up visit0.15 Percentage of cellsStandard Deviation 1.599
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at week 1-0.01 Percentage of cellsStandard Deviation 0.411
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes: change at week 6-0.01 Percentage of cellsStandard Deviation 0.355
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at week 2-0.7 Percentage of cellsStandard Deviation 2.24
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at week 60.05 Percentage of cellsStandard Deviation 1.229
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at week 40.40 Percentage of cellsStandard Deviation 1.468
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes:change at FU visit-0.19 Percentage of cellsStandard Deviation 0.395
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes change at week 10.04 Percentage of cellsStandard Deviation 0.355
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at week 10.49 Percentage of cellsStandard Deviation 5.509
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at week 4-0.01 Percentage of cellsStandard Deviation 0.465
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at week 20.72 Percentage of cellsStandard Deviation 6.638
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at week 1-0.9 Percentage of cellsStandard Deviation 2.04
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at week 20.16 Percentage of cellsStandard Deviation 1.304
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at week 41.07 Percentage of cellsStandard Deviation 5.739
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at week 2-1.04 Percentage of cellsStandard Deviation 7.376
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at week 6-0.04 Percentage of cellsStandard Deviation 5.3
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes: change at week 40.04 Percentage of cellsStandard Deviation 0.446
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at follow-up visit0.01 Percentage of cellsStandard Deviation 0.472
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at week 10.89 Percentage of cellsStandard Deviation 1.85
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at follow-up visit0.07 Percentage of cellsStandard Deviation 5.103
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at follow-up visit-0.71 Percentage of cellsStandard Deviation 6.59
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at week 1-1.87 Percentage of cellsStandard Deviation 6.873
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at follow-up visit0.50 Percentage of cellsStandard Deviation 1.986
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes: change at week 10.51 Percentage of cellsStandard Deviation 1.275
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at week 6-1.1 Percentage of cellsStandard Deviation 2.84
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at follow-up (FU) visit-0.6 Percentage of cellsStandard Deviation 2.73
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes: change at week 20.22 Percentage of cellsStandard Deviation 1.414
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at week 6-0.12 Percentage of cellsStandard Deviation 0.576
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes : change at week 4-0.03 Percentage of cellsStandard Deviation 1.039
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at week 4-0.5 Percentage of cellsStandard Deviation 2.56
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at follow-up visit2.48 Percentage of cellsStandard Deviation 6.914
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at week 2-0.56 Percentage of cellsStandard Deviation 8.017
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes: change at week 2-0.01 Percentage of cellsStandard Deviation 1.755
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at week 11.79 Percentage of cellsStandard Deviation 6.269
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at week 6-0.17 Percentage of cellsStandard Deviation 0.75
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes:change at FU visit0.11 Percentage of cellsStandard Deviation 0.448
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at follow-up visit-0.25 Percentage of cellsStandard Deviation 0.572
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes : change at follow-up visit-0.04 Percentage of cellsStandard Deviation 1.047
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at week 2-0.24 Percentage of cellsStandard Deviation 0.709
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at follow-up visit-0.13 Percentage of cellsStandard Deviation 2.021
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at week 1-1.44 Percentage of cellsStandard Deviation 6.58
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at week 2-1.0 Percentage of cellsStandard Deviation 2.61
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at week 6-1.01 Percentage of cellsStandard Deviation 8.445
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes: change at week 60.01 Percentage of cellsStandard Deviation 0.463
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at week 4-0.37 Percentage of cellsStandard Deviation 1.747
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at week 4-0.45 Percentage of cellsStandard Deviation 7.362
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes : change at week 40.33 Percentage of cellsStandard Deviation 1.695
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes: change at week 1-0.11 Percentage of cellsStandard Deviation 1.251
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at week 6-0.8 Percentage of cellsStandard Deviation 2.6
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at week 40.56 Percentage of cellsStandard Deviation 7.264
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at week 4-0.10 Percentage of cellsStandard Deviation 0.464
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes change at week 10.01 Percentage of cellsStandard Deviation 0.329
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at week 6-0.19 Percentage of cellsStandard Deviation 1.84
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at week 1-0.23 Percentage of cellsStandard Deviation 1.339
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils/Leukocytes: change at follow-up visit-2.04 Percentage of cellsStandard Deviation 7.7
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at week 20.86 Percentage of cellsStandard Deviation 7.264
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at follow-up (FU) visit-0.3 Percentage of cellsStandard Deviation 2.78
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes/Leukocytes: change at week 61.52 Percentage of cellsStandard Deviation 7.266
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes: change at week 40.05 Percentage of cellsStandard Deviation 0.374
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes/Leukocytes : change at week 6-0.16 Percentage of cellsStandard Deviation 1.516
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitReticulocytes/Erythrocytes: change at week 2-0.01 Percentage of cellsStandard Deviation 0.389
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils/Leukocytes: change at week 1-0.01 Percentage of cellsStandard Deviation 0.57
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils/Leukocytes: change at week 2-0.05 Percentage of cellsStandard Deviation 1.531
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitHematocrit: change at week 1-0.9 Percentage of cellsStandard Deviation 2.3
Secondary

Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit

Time frame: Baseline, Weeks 1, 2, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71)

Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, Overall Number of Participants Analyzed signifies participants evaluable for this outcome measure and number analyzed signifies participants evaluable for the each specified time point.

ArmMeasureGroupValue (MEAN)Dispersion
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 1-0.01 Gram per deciliterStandard Deviation 0.79
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at follow-up visit0.05 Gram per deciliterStandard Deviation 0.613
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 6-0.13 Gram per deciliterStandard Deviation 0.832
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 2-0.16 Gram per deciliterStandard Deviation 0.636
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 40.03 Gram per deciliterStandard Deviation 0.725
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at follow-up visit-0.04 Gram per deciliterStandard Deviation 0.717
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 4-0.17 Gram per deciliterStandard Deviation 0.63
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 1-0.22 Gram per deciliterStandard Deviation 0.62
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 6-0.06 Gram per deciliterStandard Deviation 0.614
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 2-0.09 Gram per deciliterStandard Deviation 0.566
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 2-0.64 Gram per deciliterStandard Deviation 0.715
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 6-0.48 Gram per deciliterStandard Deviation 0.767
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 1-0.36 Gram per deciliterStandard Deviation 0.775
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at follow-up visit-0.49 Gram per deciliterStandard Deviation 0.777
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 4-0.48 Gram per deciliterStandard Deviation 0.659
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 4-0.25 Gram per deciliterStandard Deviation 0.628
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at follow-up visit-0.09 Gram per deciliterStandard Deviation 0.784
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 2-0.24 Gram per deciliterStandard Deviation 0.657
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 6-0.03 Gram per deciliterStandard Deviation 0.617
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 1-0.12 Gram per deciliterStandard Deviation 0.678
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 4-0.06 Gram per deciliterStandard Deviation 0.821
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 1-0.26 Gram per deciliterStandard Deviation 0.726
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 2-0.22 Gram per deciliterStandard Deviation 0.798
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 6-0.11 Gram per deciliterStandard Deviation 0.775
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at follow-up visit0.00 Gram per deciliterStandard Deviation 0.773
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 4-0.27 Gram per deciliterStandard Deviation 0.789
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 6-0.22 Gram per deciliterStandard Deviation 0.724
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 2-0.16 Gram per deciliterStandard Deviation 0.83
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 1-0.19 Gram per deciliterStandard Deviation 0.698
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at follow-up visit-0.27 Gram per deciliterStandard Deviation 0.756
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 4-0.32 Gram per deciliterStandard Deviation 0.701
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 1-0.21 Gram per deciliterStandard Deviation 0.584
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 2-0.25 Gram per deciliterStandard Deviation 0.625
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at follow-up visit-0.12 Gram per deciliterStandard Deviation 0.826
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 6-0.21 Gram per deciliterStandard Deviation 0.833
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at follow-up visit-0.18 Gram per deciliterStandard Deviation 0.74
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 6-0.28 Gram per deciliterStandard Deviation 0.683
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 1-0.27 Gram per deciliterStandard Deviation 0.679
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 4-0.20 Gram per deciliterStandard Deviation 0.658
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitChange at week 2-0.32 Gram per deciliterStandard Deviation 0.793
Secondary

Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit

Time frame: Baseline, Weeks 1, 2, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71)

Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, Overall Number of Participants Analyzed signifies participants evaluable for this outcome measure and number analyzed signifies participants evaluable for the each specified time point.

ArmMeasureGroupValue (MEAN)Dispersion
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at week 60.033 10^9 *cells per literStandard Deviation 0.3375
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at follow-up visit-0.066 10^9 *cells per literStandard Deviation 1.5744
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at week 2-0.119 10^9 *cells per literStandard Deviation 1.5672
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at week 2-0.019 10^9 *cells per literStandard Deviation 0.1087
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at week 60.112 10^9 *cells per literStandard Deviation 1.6282
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at week 60.002 10^9 *cells per literStandard Deviation 0.0935
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at follow-up visit0.011 10^9 *cells per literStandard Deviation 0.1806
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at week 1-0.008 10^9 *cells per literStandard Deviation 0.5539
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at week 40.107 10^9 *cells per literStandard Deviation 0.4302
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at week 1-0.006 10^9 *cells per literStandard Deviation 0.0319
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at week 40.032 10^9 *cells per literStandard Deviation 0.1813
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at week 2-0.061 10^9 *cells per literStandard Deviation 0.5558
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at week 60.017 10^9 *cells per literStandard Deviation 0.1777
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at week 64.9 10^9 *cells per literStandard Deviation 35.17
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at week 410.5 10^9 *cells per literStandard Deviation 36.42
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at week 4-0.035 10^9 *cells per literStandard Deviation 0.1904
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at follow-up visit1.3 10^9 *cells per literStandard Deviation 30.48
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at week 4-0.304 10^9 *cells per literStandard Deviation 1.6117
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at week 10.027 10^9 *cells per literStandard Deviation 1.6137
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at follow-up visit-0.004 10^9 *cells per literStandard Deviation 0.0265
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at week 6-0.005 10^9 *cells per literStandard Deviation 0.0186
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at week 10.027 10^9 *cells per literStandard Deviation 1.874
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at week 4-0.006 10^9 *cells per literStandard Deviation 0.0328
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at week 2-0.006 10^9 *cells per literStandard Deviation 0.1509
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at week 10.9 10^9 *cells per literStandard Deviation 60.03
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at week 2-0.206 10^9 *cells per literStandard Deviation 1.8886
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at week 2-0.002 10^9 *cells per literStandard Deviation 0.0179
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at follow-up visit0.134 10^9 *cells per literStandard Deviation 0.3256
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at follow-up visit-0.229 10^9 *cells per literStandard Deviation 1.3379
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at week 10.006 10^9 *cells per literStandard Deviation 0.1796
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at week 4-0.203 10^9 *cells per literStandard Deviation 1.739
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at week 10.007 10^9 *cells per literStandard Deviation 0.0964
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at week 2-4.9 10^9 *cells per literStandard Deviation 58.16
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at week 60.160 10^9 *cells per literStandard Deviation 1.7059
Vehicle Cream Once Daily (QD)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at follow-up visit0.022 10^9 *cells per literStandard Deviation 0.1461
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at week 10.205 10^9 *cells per literStandard Deviation 0.9185
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at week 20.293 10^9 *cells per literStandard Deviation 1.5459
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at follow-up visit0.006 10^9 *cells per literStandard Deviation 0.0931
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at follow-up visit0.479 10^9 *cells per literStandard Deviation 1.0939
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at week 10.030 10^9 *cells per literStandard Deviation 0.0855
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at week 27.1 10^9 *cells per literStandard Deviation 43.34
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at week 20.016 10^9 *cells per literStandard Deviation 0.1343
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at week 60.029 10^9 *cells per literStandard Deviation 0.109
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at week 60.066 10^9 *cells per literStandard Deviation 1.0672
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at week 10.395 10^9 *cells per literStandard Deviation 1.094
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at week 40.729 10^9 *cells per literStandard Deviation 1.3199
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at week 10.124 10^9 *cells per literStandard Deviation 0.3659
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at week 10.004 10^9 *cells per literStandard Deviation 0.0445
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at week 40.229 10^9 *cells per literStandard Deviation 0.3998
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at follow-up visit-0.003 10^9 *cells per literStandard Deviation 0.0259
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at week 20.004 10^9 *cells per literStandard Deviation 0.0261
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at week 40.018 10^9 *cells per literStandard Deviation 0.112
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at follow-up visit0.261 10^9 *cells per literStandard Deviation 0.8874
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at week 410.1 10^9 *cells per literStandard Deviation 37.55
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at week 20.145 10^9 *cells per literStandard Deviation 0.3735
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at week 60.017 10^9 *cells per literStandard Deviation 0.1069
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at week 2-0.000 10^9 *cells per literStandard Deviation 0.0734
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at follow-up visit0.194 10^9 *cells per literStandard Deviation 0.3533
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at week 60.009 10^9 *cells per literStandard Deviation 0.0489
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at week 60.016 10^9 *cells per literStandard Deviation 0.3437
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at week 6-3.3 10^9 *cells per literStandard Deviation 32.76
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at week 6-0.001 10^9 *cells per literStandard Deviation 0.8996
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at week 20.459 10^9 *cells per literStandard Deviation 1.5567
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at week 16.8 10^9 *cells per literStandard Deviation 34.08
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at week 40.011 10^9 *cells per literStandard Deviation 0.0404
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at week 40.030 10^9 *cells per literStandard Deviation 0.1212
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at week 10.036 10^9 *cells per literStandard Deviation 0.0963
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at week 40.441 10^9 *cells per literStandard Deviation 1.2814
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at follow-up visit16.3 10^9 *cells per literStandard Deviation 37.13
PF-06700841 0.1% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at follow-up visit0.021 10^9 *cells per literStandard Deviation 0.0824
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at week 1-0.177 10^9 *cells per literStandard Deviation 1.0805
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at week 6-0.362 10^9 *cells per literStandard Deviation 1.3154
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at week 2-0.009 10^9 *cells per literStandard Deviation 0.0276
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at follow-up visit-0.114 10^9 *cells per literStandard Deviation 1.4545
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at week 1-0.007 10^9 *cells per literStandard Deviation 0.0349
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at week 6-6.6 10^9 *cells per literStandard Deviation 41.66
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at week 40.013 10^9 *cells per literStandard Deviation 0.1234
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at follow-up visit-8.5 10^9 *cells per literStandard Deviation 30.15
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at week 2-0.003 10^9 *cells per literStandard Deviation 0.0724
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at week 1-0.051 10^9 *cells per literStandard Deviation 1.2403
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at follow-up visit0.030 10^9 *cells per literStandard Deviation 0.1467
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at week 2-0.288 10^9 *cells per literStandard Deviation 1.6842
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at week 10.030 10^9 *cells per literStandard Deviation 0.0987
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at week 40.189 10^9 *cells per literStandard Deviation 1.3534
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at follow-up visit-0.023 10^9 *cells per literStandard Deviation 0.1196
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at week 6-0.505 10^9 *cells per literStandard Deviation 1.6474
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at week 6-0.025 10^9 *cells per literStandard Deviation 0.1351
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at follow-up visit-0.048 10^9 *cells per literStandard Deviation 2.0206
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at week 2-8.1 10^9 *cells per literStandard Deviation 41.92
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at week 10.107 10^9 *cells per literStandard Deviation 0.313
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at week 40.008 10^9 *cells per literStandard Deviation 0.1325
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at week 20.010 10^9 *cells per literStandard Deviation 0.4115
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at week 1-3.3 10^9 *cells per literStandard Deviation 32.39
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at week 2-0.023 10^9 *cells per literStandard Deviation 0.0809
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at week 40.135 10^9 *cells per literStandard Deviation 0.44
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at week 1-0.004 10^9 *cells per literStandard Deviation 0.1092
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at week 6-0.079 10^9 *cells per literStandard Deviation 0.4826
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at follow-up visit0.065 10^9 *cells per literStandard Deviation 0.6042
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at week 6-0.025 10^9 *cells per literStandard Deviation 0.1191
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at follow-up visit-0.007 10^9 *cells per literStandard Deviation 0.0321
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at week 4-2.4 10^9 *cells per literStandard Deviation 37.68
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at week 6-0.012 10^9 *cells per literStandard Deviation 0.0313
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at week 2-0.261 10^9 *cells per literStandard Deviation 1.3969
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at week 4-0.002 10^9 *cells per literStandard Deviation 0.03
PF-06700841 0.3% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at week 40.036 10^9 *cells per literStandard Deviation 1.1595
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at week 60.237 10^9 *cells per literStandard Deviation 1.4501
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at week 2-0.136 10^9 *cells per literStandard Deviation 1.0669
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at week 60.104 10^9 *cells per literStandard Deviation 0.4337
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at week 6-0.005 10^9 *cells per literStandard Deviation 0.1021
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at follow-up visit-0.004 10^9 *cells per literStandard Deviation 0.181
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at week 40.085 10^9 *cells per literStandard Deviation 1.3541
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at follow-up visit0.007 10^9 *cells per literStandard Deviation 0.0407
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at week 2-0.094 10^9 *cells per literStandard Deviation 1.2877
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at week 10.009 10^9 *cells per literStandard Deviation 0.0879
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at follow-up visit0.343 10^9 *cells per literStandard Deviation 1.3049
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at follow-up visit-0.022 10^9 *cells per literStandard Deviation 0.4419
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at week 4-0.3 10^9 *cells per literStandard Deviation 36.27
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at week 40.001 10^9 *cells per literStandard Deviation 0.0256
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at week 10.407 10^9 *cells per literStandard Deviation 1.2225
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at week 2-0.014 10^9 *cells per literStandard Deviation 0.1055
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at follow-up visit0.005 10^9 *cells per literStandard Deviation 0.0887
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at follow-up visit0.1 10^9 *cells per literStandard Deviation 32.36
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at week 40.096 10^9 *cells per literStandard Deviation 1.3199
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at week 10.319 10^9 *cells per literStandard Deviation 1.0276
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at week 6-2.3 10^9 *cells per literStandard Deviation 32.7
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at week 60.008 10^9 *cells per literStandard Deviation 0.0344
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at week 60.112 10^9 *cells per literStandard Deviation 1.224
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at week 4-0.003 10^9 *cells per literStandard Deviation 0.1092
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at week 20.009 10^9 *cells per literStandard Deviation 0.098
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at week 10.010 10^9 *cells per literStandard Deviation 0.0258
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at week 20.044 10^9 *cells per literStandard Deviation 0.4225
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at week 2-0.1 10^9 *cells per literStandard Deviation 32.45
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at week 10.081 10^9 *cells per literStandard Deviation 0.3839
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at week 11.0 10^9 *cells per literStandard Deviation 25.76
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at week 40.012 10^9 *cells per literStandard Deviation 0.4596
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at week 4-0.019 10^9 *cells per literStandard Deviation 0.1102
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at follow-up visit0.329 10^9 *cells per literStandard Deviation 1.3938
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at week 1-0.011 10^9 *cells per literStandard Deviation 0.093
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at week 20.001 10^9 *cells per literStandard Deviation 0.0197
PF-06700841 1.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at week 60.018 10^9 *cells per literStandard Deviation 0.1387
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at week 10.019 10^9 *cells per literStandard Deviation 0.1055
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at week 18.5 10^9 *cells per literStandard Deviation 41.61
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at week 25.0 10^9 *cells per literStandard Deviation 31.39
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at week 4-5.9 10^9 *cells per literStandard Deviation 37.47
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at week 6-5.2 10^9 *cells per literStandard Deviation 38.53
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at follow-up visit10.2 10^9 *cells per literStandard Deviation 47.3
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at week 10.259 10^9 *cells per literStandard Deviation 1.129
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at week 2-0.116 10^9 *cells per literStandard Deviation 1.0364
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at week 4-0.074 10^9 *cells per literStandard Deviation 1.0641
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at week 6-0.244 10^9 *cells per literStandard Deviation 1.2763
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at follow-up visit0.123 10^9 *cells per literStandard Deviation 0.8496
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at week 10.186 10^9 *cells per literStandard Deviation 0.384
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at week 20.012 10^9 *cells per literStandard Deviation 0.4251
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at week 40.139 10^9 *cells per literStandard Deviation 0.3977
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at week 60.068 10^9 *cells per literStandard Deviation 0.3168
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at follow-up visit0.130 10^9 *cells per literStandard Deviation 0.4277
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at week 10.069 10^9 *cells per literStandard Deviation 1.0706
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at week 2-0.109 10^9 *cells per literStandard Deviation 0.9653
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at week 4-0.190 10^9 *cells per literStandard Deviation 1.0404
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at week 6-0.250 10^9 *cells per literStandard Deviation 1.172
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at follow-up visit-0.020 10^9 *cells per literStandard Deviation 0.7731
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at week 10.003 10^9 *cells per literStandard Deviation 0.0361
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at week 2-0.005 10^9 *cells per literStandard Deviation 0.0394
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at week 4-0.007 10^9 *cells per literStandard Deviation 0.0495
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at week 6-0.015 10^9 *cells per literStandard Deviation 0.0415
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at follow-up visit-0.015 10^9 *cells per literStandard Deviation 0.0426
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at week 1-0.014 10^9 *cells per literStandard Deviation 0.1216
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at week 2-0.029 10^9 *cells per literStandard Deviation 0.0915
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at week 4-0.032 10^9 *cells per literStandard Deviation 0.104
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at week 6-0.027 10^9 *cells per literStandard Deviation 0.1125
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at follow-up visit0.008 10^9 *cells per literStandard Deviation 0.127
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at week 20.017 10^9 *cells per literStandard Deviation 0.0865
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at week 40.009 10^9 *cells per literStandard Deviation 0.0986
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at week 6-0.019 10^9 *cells per literStandard Deviation 0.0726
PF-06700841 3.0% Cream QDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at follow-up visit0.021 10^9 *cells per literStandard Deviation 0.0739
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at week 60.004 10^9 *cells per literStandard Deviation 0.0847
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at week 2-0.003 10^9 *cells per literStandard Deviation 0.3165
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at week 2-4.9 10^9 *cells per literStandard Deviation 31.84
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at week 2-0.006 10^9 *cells per literStandard Deviation 0.0621
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at week 6-0.004 10^9 *cells per literStandard Deviation 0.0188
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at week 10.006 10^9 *cells per literStandard Deviation 0.0877
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at week 2-0.007 10^9 *cells per literStandard Deviation 1.2637
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at week 4-0.001 10^9 *cells per literStandard Deviation 0.0255
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at week 10.051 10^9 *cells per literStandard Deviation 0.3557
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at follow-up visit-0.008 10^9 *cells per literStandard Deviation 0.2483
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at week 16.6 10^9 *cells per literStandard Deviation 33.4
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at week 4-0.012 10^9 *cells per literStandard Deviation 0.0832
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at follow-up visit-0.093 10^9 *cells per literStandard Deviation 1.234
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at week 40.398 10^9 *cells per literStandard Deviation 1.5999
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at week 44.4 10^9 *cells per literStandard Deviation 37.79
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at follow-up visit-0.117 10^9 *cells per literStandard Deviation 1.4856
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at week 6-0.269 10^9 *cells per literStandard Deviation 1.0761
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at week 40.338 10^9 *cells per literStandard Deviation 1.3577
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at follow-up visit-0.035 10^9 *cells per literStandard Deviation 0.4054
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at week 6-0.007 10^9 *cells per literStandard Deviation 0.1025
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at week 40.035 10^9 *cells per literStandard Deviation 0.0978
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at week 6-0.228 10^9 *cells per literStandard Deviation 0.9681
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at follow-up visit-0.005 10^9 *cells per literStandard Deviation 0.0269
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at week 2-0.015 10^9 *cells per literStandard Deviation 1.1305
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at follow-up visit0.018 10^9 *cells per literStandard Deviation 0.1047
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at week 10.001 10^9 *cells per literStandard Deviation 0.0191
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at week 6-0.033 10^9 *cells per literStandard Deviation 0.3092
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at week 60.2 10^9 *cells per literStandard Deviation 37.28
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at week 20.003 10^9 *cells per literStandard Deviation 0.0244
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at week 20.013 10^9 *cells per literStandard Deviation 0.0983
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at week 1-0.008 10^9 *cells per literStandard Deviation 0.1148
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at week 10.017 10^9 *cells per literStandard Deviation 1.1291
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at follow-up visit-5.2 10^9 *cells per literStandard Deviation 40.7
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at week 40.039 10^9 *cells per literStandard Deviation 0.4169
Vehicle Cream Twice Daily (BID)Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at week 10.068 10^9 *cells per literStandard Deviation 1.2929
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at week 2-0.003 10^9 *cells per literStandard Deviation 0.0433
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at week 4-0.005 10^9 *cells per literStandard Deviation 0.9958
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at week 20.288 10^9 *cells per literStandard Deviation 1.7822
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at follow-up visit0.029 10^9 *cells per literStandard Deviation 0.1788
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at week 4-0.001 10^9 *cells per literStandard Deviation 0.0337
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at week 10.030 10^9 *cells per literStandard Deviation 1.3015
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at week 6-0.009 10^9 *cells per literStandard Deviation 0.0373
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at follow-up visit0.050 10^9 *cells per literStandard Deviation 0.4699
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at week 60.003 10^9 *cells per literStandard Deviation 0.1097
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at follow-up visit0.001 10^9 *cells per literStandard Deviation 0.0295
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at week 60.027 10^9 *cells per literStandard Deviation 0.2455
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at week 40.127 10^9 *cells per literStandard Deviation 0.263
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at week 10.068 10^9 *cells per literStandard Deviation 0.0959
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at week 20.070 10^9 *cells per literStandard Deviation 0.4603
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at week 20.022 10^9 *cells per literStandard Deviation 0.0762
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at week 10.089 10^9 *cells per literStandard Deviation 0.432
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at week 40.042 10^9 *cells per literStandard Deviation 0.1076
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at follow-up visit0.210 10^9 *cells per literStandard Deviation 1.7456
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at week 6-0.048 10^9 *cells per literStandard Deviation 1.3823
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at week 1-2.1 10^9 *cells per literStandard Deviation 31.94
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at week 6-0.001 10^9 *cells per literStandard Deviation 0.0812
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at week 40.168 10^9 *cells per literStandard Deviation 1.0902
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at follow-up visit0.048 10^9 *cells per literStandard Deviation 0.152
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at week 20.422 10^9 *cells per literStandard Deviation 1.8986
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at week 10.238 10^9 *cells per literStandard Deviation 1.4993
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at week 10.051 10^9 *cells per literStandard Deviation 0.1244
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at follow-up visit5.8 10^9 *cells per literStandard Deviation 48.55
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at week 20.049 10^9 *cells per literStandard Deviation 0.1471
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at week 6-1.8 10^9 *cells per literStandard Deviation 37.05
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at week 40.007 10^9 *cells per literStandard Deviation 0.1008
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at week 40.7 10^9 *cells per literStandard Deviation 36.51
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at follow-up visit0.088 10^9 *cells per literStandard Deviation 1.4614
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at week 10.002 10^9 *cells per literStandard Deviation 0.0299
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at week 6-0.064 10^9 *cells per literStandard Deviation 1.2422
PF-06700841 0.3% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at week 27.5 10^9 *cells per literStandard Deviation 37.94
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at week 20.005 10^9 *cells per literStandard Deviation 0.1256
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at week 1-0.251 10^9 *cells per literStandard Deviation 2.2421
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at week 10.011 10^9 *cells per literStandard Deviation 0.1195
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at week 20.169 10^9 *cells per literStandard Deviation 0.5319
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at follow-up visit2.5 10^9 *cells per literStandard Deviation 58.75
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at week 2-0.012 10^9 *cells per literStandard Deviation 0.0428
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at week 1-0.006 10^9 *cells per literStandard Deviation 0.1165
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at follow-up visit-0.006 10^9 *cells per literStandard Deviation 0.1282
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at week 6-0.012 10^9 *cells per literStandard Deviation 0.12
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at week 10.002 10^9 *cells per literStandard Deviation 0.0343
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at week 20.025 10^9 *cells per literStandard Deviation 0.1496
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at week 68.6 10^9 *cells per literStandard Deviation 47.85
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at week 6-0.376 10^9 *cells per literStandard Deviation 2.1125
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at week 40.176 10^9 *cells per literStandard Deviation 0.6274
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at week 411.0 10^9 *cells per literStandard Deviation 46.26
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at follow-up visit-0.019 10^9 *cells per literStandard Deviation 0.0361
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at week 60.079 10^9 *cells per literStandard Deviation 0.3846
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at week 2-0.190 10^9 *cells per literStandard Deviation 2.0749
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitMonocytes: change at week 40.038 10^9 *cells per literStandard Deviation 0.1331
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at week 4-0.004 10^9 *cells per literStandard Deviation 0.0323
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at follow-up visit0.195 10^9 *cells per literStandard Deviation 0.4663
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at week 6-0.022 10^9 *cells per literStandard Deviation 0.1415
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at week 6-0.347 10^9 *cells per literStandard Deviation 2.1442
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at week 40.041 10^9 *cells per literStandard Deviation 2.1647
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at follow-up visit-0.562 10^9 *cells per literStandard Deviation 2.3227
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at week 4-0.012 10^9 *cells per literStandard Deviation 0.1499
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at week 112.6 10^9 *cells per literStandard Deviation 44.08
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at follow-up visit-0.404 10^9 *cells per literStandard Deviation 2.4817
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitNeutrophils: change at week 4-0.158 10^9 *cells per literStandard Deviation 2.0005
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitEosinophils: change at follow-up visit-0.011 10^9 *cells per literStandard Deviation 0.1945
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at week 2-0.006 10^9 *cells per literStandard Deviation 2.3428
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitBasophils: change at week 6-0.015 10^9 *cells per literStandard Deviation 0.0383
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLymphocytes: change at week 10.223 10^9 *cells per literStandard Deviation 0.3849
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitLeukocytes: change at week 1-0.025 10^9 *cells per literStandard Deviation 2.3529
PF-06700841 1.0% Cream BIDChange From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up VisitPlatelets: change at week 214.8 10^9 *cells per literStandard Deviation 50.99
Secondary

Change From Baseline in Lipids Profile Values at Week 6

Lipid parameters that were assessed: high density lipoprotein (HDL) cholesterol, triglycerides, cholesterol, low density lipoprotein (LDL) cholesterol.

Time frame: Baseline, Week 6

Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, Overall Number of Participants Analyzed signifies participants evaluable for this outcome measure and number analyzed signifies participants evaluable for the each specified time point.

ArmMeasureGroupValue (MEAN)Dispersion
Vehicle Cream Once Daily (QD)Change From Baseline in Lipids Profile Values at Week 6Cholesterol-3.5 Microgram per deciliterStandard Deviation 16.39
Vehicle Cream Once Daily (QD)Change From Baseline in Lipids Profile Values at Week 6LDL Cholesterol-3.4 Microgram per deciliterStandard Deviation 14.45
Vehicle Cream Once Daily (QD)Change From Baseline in Lipids Profile Values at Week 6Triglycerides3.3 Microgram per deciliterStandard Deviation 38.84
Vehicle Cream Once Daily (QD)Change From Baseline in Lipids Profile Values at Week 6HDL cholesterol-2.8 Microgram per deciliterStandard Deviation 6.65
PF-06700841 0.1% Cream QDChange From Baseline in Lipids Profile Values at Week 6Cholesterol-5.6 Microgram per deciliterStandard Deviation 27.59
PF-06700841 0.1% Cream QDChange From Baseline in Lipids Profile Values at Week 6HDL cholesterol0.1 Microgram per deciliterStandard Deviation 5.34
PF-06700841 0.1% Cream QDChange From Baseline in Lipids Profile Values at Week 6LDL Cholesterol-6.3 Microgram per deciliterStandard Deviation 25.28
PF-06700841 0.1% Cream QDChange From Baseline in Lipids Profile Values at Week 6Triglycerides-4.2 Microgram per deciliterStandard Deviation 59.3
PF-06700841 0.3% Cream QDChange From Baseline in Lipids Profile Values at Week 6Cholesterol-12.8 Microgram per deciliterStandard Deviation 20.53
PF-06700841 0.3% Cream QDChange From Baseline in Lipids Profile Values at Week 6Triglycerides-6.5 Microgram per deciliterStandard Deviation 37.3
PF-06700841 0.3% Cream QDChange From Baseline in Lipids Profile Values at Week 6LDL Cholesterol-12.1 Microgram per deciliterStandard Deviation 16.44
PF-06700841 0.3% Cream QDChange From Baseline in Lipids Profile Values at Week 6HDL cholesterol-1.3 Microgram per deciliterStandard Deviation 7.74
PF-06700841 1.0% Cream QDChange From Baseline in Lipids Profile Values at Week 6Triglycerides1.8 Microgram per deciliterStandard Deviation 60.74
PF-06700841 1.0% Cream QDChange From Baseline in Lipids Profile Values at Week 6HDL cholesterol2.7 Microgram per deciliterStandard Deviation 8.33
PF-06700841 1.0% Cream QDChange From Baseline in Lipids Profile Values at Week 6LDL Cholesterol2.1 Microgram per deciliterStandard Deviation 20.13
PF-06700841 1.0% Cream QDChange From Baseline in Lipids Profile Values at Week 6Cholesterol6.8 Microgram per deciliterStandard Deviation 24.09
PF-06700841 3.0% Cream QDChange From Baseline in Lipids Profile Values at Week 6Triglycerides-18.9 Microgram per deciliterStandard Deviation 56.78
PF-06700841 3.0% Cream QDChange From Baseline in Lipids Profile Values at Week 6HDL cholesterol1.9 Microgram per deciliterStandard Deviation 11.18
PF-06700841 3.0% Cream QDChange From Baseline in Lipids Profile Values at Week 6LDL Cholesterol-11.0 Microgram per deciliterStandard Deviation 29.06
PF-06700841 3.0% Cream QDChange From Baseline in Lipids Profile Values at Week 6Cholesterol-10.4 Microgram per deciliterStandard Deviation 30.79
Vehicle Cream Twice Daily (BID)Change From Baseline in Lipids Profile Values at Week 6LDL Cholesterol-0.8 Microgram per deciliterStandard Deviation 14.48
Vehicle Cream Twice Daily (BID)Change From Baseline in Lipids Profile Values at Week 6Cholesterol-0.2 Microgram per deciliterStandard Deviation 18.7
Vehicle Cream Twice Daily (BID)Change From Baseline in Lipids Profile Values at Week 6HDL cholesterol0.0 Microgram per deciliterStandard Deviation 6.76
Vehicle Cream Twice Daily (BID)Change From Baseline in Lipids Profile Values at Week 6Triglycerides-8.1 Microgram per deciliterStandard Deviation 50.41
PF-06700841 0.3% Cream BIDChange From Baseline in Lipids Profile Values at Week 6Triglycerides-7.0 Microgram per deciliterStandard Deviation 58.36
PF-06700841 0.3% Cream BIDChange From Baseline in Lipids Profile Values at Week 6HDL cholesterol1.2 Microgram per deciliterStandard Deviation 4.12
PF-06700841 0.3% Cream BIDChange From Baseline in Lipids Profile Values at Week 6Cholesterol5.3 Microgram per deciliterStandard Deviation 30.58
PF-06700841 0.3% Cream BIDChange From Baseline in Lipids Profile Values at Week 6LDL Cholesterol4.4 Microgram per deciliterStandard Deviation 23.55
PF-06700841 1.0% Cream BIDChange From Baseline in Lipids Profile Values at Week 6HDL cholesterol0.3 Microgram per deciliterStandard Deviation 8.56
PF-06700841 1.0% Cream BIDChange From Baseline in Lipids Profile Values at Week 6LDL Cholesterol-1.1 Microgram per deciliterStandard Deviation 16.29
PF-06700841 1.0% Cream BIDChange From Baseline in Lipids Profile Values at Week 6Triglycerides-4.4 Microgram per deciliterStandard Deviation 55.66
PF-06700841 1.0% Cream BIDChange From Baseline in Lipids Profile Values at Week 6Cholesterol-0.9 Microgram per deciliterStandard Deviation 19.86
Secondary

Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6

Time frame: Baseline, Weeks 2 and 6

Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, number analyzed signifies participants evaluable for the each specified time point.

ArmMeasureGroupValue (MEAN)Dispersion
Vehicle Cream Once Daily (QD)Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QRS interval: change at week 2-1.4 MillisecondsStandard Deviation 8.02
Vehicle Cream Once Daily (QD)Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QTCF interval: change at week 6-4.1 MillisecondsStandard Deviation 14.61
Vehicle Cream Once Daily (QD)Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6PR interval: baseline161.9 MillisecondsStandard Deviation 23.3
Vehicle Cream Once Daily (QD)Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QRS interval: baseline92.5 MillisecondsStandard Deviation 9.36
Vehicle Cream Once Daily (QD)Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QTCF interval: baseline407.7 MillisecondsStandard Deviation 17.78
Vehicle Cream Once Daily (QD)Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6PR interval: change at week 6-0.9 MillisecondsStandard Deviation 10.16
Vehicle Cream Once Daily (QD)Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QT interval: baseline395.2 MillisecondsStandard Deviation 31.53
Vehicle Cream Once Daily (QD)Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QT interval: change at week 6-4.9 MillisecondsStandard Deviation 19.54
Vehicle Cream Once Daily (QD)Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QRS interval: change at week 6-1.9 MillisecondsStandard Deviation 6.55
Vehicle Cream Once Daily (QD)Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6PR interval: change at week 20.8 MillisecondsStandard Deviation 14.41
Vehicle Cream Once Daily (QD)Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QTCF interval: change at week 2-5.7 MillisecondsStandard Deviation 11.86
Vehicle Cream Once Daily (QD)Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QT interval: change at week 2-5.9 MillisecondsStandard Deviation 23.16
PF-06700841 0.1% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QTCF interval: baseline397.9 MillisecondsStandard Deviation 15.98
PF-06700841 0.1% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QRS interval: baseline91.5 MillisecondsStandard Deviation 9.71
PF-06700841 0.1% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QRS interval: change at week 2-0.4 MillisecondsStandard Deviation 5.34
PF-06700841 0.1% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QT interval: change at week 61.3 MillisecondsStandard Deviation 18.11
PF-06700841 0.1% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QT interval: baseline385.3 MillisecondsStandard Deviation 23.64
PF-06700841 0.1% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6PR interval: change at week 2-0.9 MillisecondsStandard Deviation 15.92
PF-06700841 0.1% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QTCF interval: change at week 6-0.5 MillisecondsStandard Deviation 14.93
PF-06700841 0.1% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QRS interval: change at week 61.4 MillisecondsStandard Deviation 5.62
PF-06700841 0.1% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6PR interval: change at week 6-0.1 MillisecondsStandard Deviation 13.81
PF-06700841 0.1% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QTCF interval: change at week 2-1.5 MillisecondsStandard Deviation 13.7
PF-06700841 0.1% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6PR interval: baseline160.2 MillisecondsStandard Deviation 24.01
PF-06700841 0.1% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QT interval: change at week 2-1.3 MillisecondsStandard Deviation 17.73
PF-06700841 0.3% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QT interval: baseline388.8 MillisecondsStandard Deviation 33.66
PF-06700841 0.3% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QTCF interval: baseline403.8 MillisecondsStandard Deviation 22.43
PF-06700841 0.3% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QT interval: change at week 60.9 MillisecondsStandard Deviation 16.11
PF-06700841 0.3% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QTCF interval: change at week 2-3.9 MillisecondsStandard Deviation 15.6
PF-06700841 0.3% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6PR interval: change at week 20.7 MillisecondsStandard Deviation 18.54
PF-06700841 0.3% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QT interval: change at week 2-1.1 MillisecondsStandard Deviation 19.31
PF-06700841 0.3% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6PR interval: change at week 62.8 MillisecondsStandard Deviation 19.66
PF-06700841 0.3% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QRS interval: baseline91.1 MillisecondsStandard Deviation 9.29
PF-06700841 0.3% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6PR interval: baseline161.4 MillisecondsStandard Deviation 27.59
PF-06700841 0.3% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QRS interval: change at week 2-1.3 MillisecondsStandard Deviation 3.46
PF-06700841 0.3% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QTCF interval: change at week 6-1.9 MillisecondsStandard Deviation 14.37
PF-06700841 0.3% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QRS interval: change at week 6-0.5 MillisecondsStandard Deviation 4.76
PF-06700841 1.0% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QRS interval: change at week 2-0.8 MillisecondsStandard Deviation 5.64
PF-06700841 1.0% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6PR interval: baseline162.5 MillisecondsStandard Deviation 22.04
PF-06700841 1.0% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QTCF interval: change at week 60.3 MillisecondsStandard Deviation 17.19
PF-06700841 1.0% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6PR interval: change at week 20.3 MillisecondsStandard Deviation 10.13
PF-06700841 1.0% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QT interval: baseline401.0 MillisecondsStandard Deviation 25.23
PF-06700841 1.0% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6PR interval: change at week 62.9 MillisecondsStandard Deviation 13.63
PF-06700841 1.0% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QT interval: change at week 23.5 MillisecondsStandard Deviation 21.06
PF-06700841 1.0% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QTCF interval: baseline408.5 MillisecondsStandard Deviation 18.42
PF-06700841 1.0% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QRS interval: change at week 6-0.9 MillisecondsStandard Deviation 4.04
PF-06700841 1.0% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QTCF interval: change at week 22.6 MillisecondsStandard Deviation 16.2
PF-06700841 1.0% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QRS interval: baseline93.0 MillisecondsStandard Deviation 11.13
PF-06700841 1.0% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QT interval: change at week 6-4.1 MillisecondsStandard Deviation 23.42
PF-06700841 3.0% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QTCF interval: change at week 2-0.6 MillisecondsStandard Deviation 12.75
PF-06700841 3.0% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6PR interval: baseline160.7 MillisecondsStandard Deviation 24.2
PF-06700841 3.0% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6PR interval: change at week 21.1 MillisecondsStandard Deviation 14.42
PF-06700841 3.0% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6PR interval: change at week 63.5 MillisecondsStandard Deviation 21.88
PF-06700841 3.0% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QRS interval: baseline93.1 MillisecondsStandard Deviation 8.69
PF-06700841 3.0% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QRS interval: change at week 20.1 MillisecondsStandard Deviation 4.79
PF-06700841 3.0% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QRS interval: change at week 6-1.3 MillisecondsStandard Deviation 4
PF-06700841 3.0% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QTCF interval: baseline401.0 MillisecondsStandard Deviation 16.29
PF-06700841 3.0% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QTCF interval: change at week 6-1.4 MillisecondsStandard Deviation 14.93
PF-06700841 3.0% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QT interval: baseline392.0 MillisecondsStandard Deviation 27.36
PF-06700841 3.0% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QT interval: change at week 2-4.5 MillisecondsStandard Deviation 15.75
PF-06700841 3.0% Cream QDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QT interval: change at week 6-0.9 MillisecondsStandard Deviation 20.12
Vehicle Cream Twice Daily (BID)Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6PR interval: change at week 64.0 MillisecondsStandard Deviation 14.56
Vehicle Cream Twice Daily (BID)Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QRS interval: change at week 60.9 MillisecondsStandard Deviation 6.37
Vehicle Cream Twice Daily (BID)Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QRS interval: baseline92.2 MillisecondsStandard Deviation 13
Vehicle Cream Twice Daily (BID)Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QT interval: baseline390.9 MillisecondsStandard Deviation 24.87
Vehicle Cream Twice Daily (BID)Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QT interval: change at week 67.8 MillisecondsStandard Deviation 24.11
Vehicle Cream Twice Daily (BID)Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6PR interval: change at week 26.0 MillisecondsStandard Deviation 14.79
Vehicle Cream Twice Daily (BID)Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QTCF interval: change at week 21.4 MillisecondsStandard Deviation 15.56
Vehicle Cream Twice Daily (BID)Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QRS interval: change at week 21.5 MillisecondsStandard Deviation 9.29
Vehicle Cream Twice Daily (BID)Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6PR interval: baseline156.4 MillisecondsStandard Deviation 22.65
Vehicle Cream Twice Daily (BID)Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QTCF interval: change at week 64.6 MillisecondsStandard Deviation 14.27
Vehicle Cream Twice Daily (BID)Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QTCF interval: baseline403.0 MillisecondsStandard Deviation 16.65
Vehicle Cream Twice Daily (BID)Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QT interval: change at week 21.2 MillisecondsStandard Deviation 24.03
PF-06700841 0.3% Cream BIDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QRS interval: change at week 60.6 MillisecondsStandard Deviation 5.49
PF-06700841 0.3% Cream BIDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QTCF interval: change at week 22.4 MillisecondsStandard Deviation 10.32
PF-06700841 0.3% Cream BIDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QRS interval: change at week 20.2 MillisecondsStandard Deviation 8.07
PF-06700841 0.3% Cream BIDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QTCF interval: change at week 62.0 MillisecondsStandard Deviation 11.94
PF-06700841 0.3% Cream BIDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QRS interval: baseline92.4 MillisecondsStandard Deviation 13.3
PF-06700841 0.3% Cream BIDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QT interval: baseline383.8 MillisecondsStandard Deviation 30.79
PF-06700841 0.3% Cream BIDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6PR interval: change at week 66.5 MillisecondsStandard Deviation 19.15
PF-06700841 0.3% Cream BIDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6PR interval: change at week 21.2 MillisecondsStandard Deviation 16.06
PF-06700841 0.3% Cream BIDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QT interval: change at week 6-1.4 MillisecondsStandard Deviation 20.47
PF-06700841 0.3% Cream BIDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QT interval: change at week 2-2.3 MillisecondsStandard Deviation 18.69
PF-06700841 0.3% Cream BIDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6PR interval: baseline157.9 MillisecondsStandard Deviation 23.55
PF-06700841 0.3% Cream BIDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QTCF interval: baseline397.7 MillisecondsStandard Deviation 17.05
PF-06700841 1.0% Cream BIDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QTCF interval: baseline405.0 MillisecondsStandard Deviation 20.38
PF-06700841 1.0% Cream BIDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QTCF interval: change at week 6-0.2 MillisecondsStandard Deviation 9.67
PF-06700841 1.0% Cream BIDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QRS interval: change at week 60.7 MillisecondsStandard Deviation 5.67
PF-06700841 1.0% Cream BIDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QT interval: change at week 2-4.6 MillisecondsStandard Deviation 25.76
PF-06700841 1.0% Cream BIDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6PR interval: baseline157.8 MillisecondsStandard Deviation 23.15
PF-06700841 1.0% Cream BIDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6PR interval: change at week 65.7 MillisecondsStandard Deviation 16.11
PF-06700841 1.0% Cream BIDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QTCF interval: change at week 2-4.6 MillisecondsStandard Deviation 15.43
PF-06700841 1.0% Cream BIDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QT interval: baseline390.6 MillisecondsStandard Deviation 32.43
PF-06700841 1.0% Cream BIDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QT interval: change at week 64.0 MillisecondsStandard Deviation 27.74
PF-06700841 1.0% Cream BIDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QRS interval: baseline91.5 MillisecondsStandard Deviation 11.68
PF-06700841 1.0% Cream BIDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6PR interval: change at week 22.1 MillisecondsStandard Deviation 7.98
PF-06700841 1.0% Cream BIDChange From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6QRS interval: change at week 21.0 MillisecondsStandard Deviation 5.63
Secondary

Change From Baseline in Ratio of LDL Cholesterol to HDL Cholesterol Lipids Profile at Week 6

Mean change in total cholesterol/HDL cholesterol ratio was assessed and reported.

Time frame: Baseline, Week 6

Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, Overall Number of Participants Analyzed signifies participants evaluable for this outcome measure.

ArmMeasureValue (MEAN)Dispersion
Vehicle Cream Once Daily (QD)Change From Baseline in Ratio of LDL Cholesterol to HDL Cholesterol Lipids Profile at Week 60.0 RatioStandard Deviation 0.31
PF-06700841 0.1% Cream QDChange From Baseline in Ratio of LDL Cholesterol to HDL Cholesterol Lipids Profile at Week 6-0.1 RatioStandard Deviation 0.48
PF-06700841 0.3% Cream QDChange From Baseline in Ratio of LDL Cholesterol to HDL Cholesterol Lipids Profile at Week 6-0.2 RatioStandard Deviation 0.4
PF-06700841 1.0% Cream QDChange From Baseline in Ratio of LDL Cholesterol to HDL Cholesterol Lipids Profile at Week 6-0.0 RatioStandard Deviation 0.32
PF-06700841 3.0% Cream QDChange From Baseline in Ratio of LDL Cholesterol to HDL Cholesterol Lipids Profile at Week 6-0.3 RatioStandard Deviation 0.77
Vehicle Cream Twice Daily (BID)Change From Baseline in Ratio of LDL Cholesterol to HDL Cholesterol Lipids Profile at Week 6-0.0 RatioStandard Deviation 0.35
PF-06700841 0.3% Cream BIDChange From Baseline in Ratio of LDL Cholesterol to HDL Cholesterol Lipids Profile at Week 60.0 RatioStandard Deviation 0.46
PF-06700841 1.0% Cream BIDChange From Baseline in Ratio of LDL Cholesterol to HDL Cholesterol Lipids Profile at Week 6-0.0 RatioStandard Deviation 0.42
Secondary

Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6

Blood pressure included supine and sitting systolic and diastolic BP.

Time frame: Baseline, Weeks 2 and 6

Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, Overall Number of Participants Analyzed signifies participants evaluable for this outcome measure and number analyzed signifies participants evaluable for the each specified time point.

ArmMeasureGroupValue (MEAN)Dispersion
Vehicle Cream Once Daily (QD)Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting systolic BP: Baseline117.7 Millimeters of mercuryStandard Deviation 13.05
Vehicle Cream Once Daily (QD)Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting diastolic BP: change at week 60.8 Millimeters of mercuryStandard Deviation 9.9
Vehicle Cream Once Daily (QD)Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting diastolic BP: change at week 2-1.6 Millimeters of mercuryStandard Deviation 8.49
Vehicle Cream Once Daily (QD)Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine systolic BP: change at week 6-0.2 Millimeters of mercuryStandard Deviation 12.98
Vehicle Cream Once Daily (QD)Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine systolic BP: Baseline123.3 Millimeters of mercuryStandard Deviation 12.01
Vehicle Cream Once Daily (QD)Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting systolic BP: change at week 60.6 Millimeters of mercuryStandard Deviation 12.24
Vehicle Cream Once Daily (QD)Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine diastolic BP: Baseline77.7 Millimeters of mercuryStandard Deviation 9.28
Vehicle Cream Once Daily (QD)Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine diastolic BP: change at week 20.5 Millimeters of mercuryStandard Deviation 7.51
Vehicle Cream Once Daily (QD)Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine systolic BP: change at week 20.3 Millimeters of mercuryStandard Deviation 11.55
Vehicle Cream Once Daily (QD)Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine diastolic BP: change at week 6-2.5 Millimeters of mercuryStandard Deviation 7.69
Vehicle Cream Once Daily (QD)Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting systolic BP: change at week 21.3 Millimeters of mercuryStandard Deviation 12.12
Vehicle Cream Once Daily (QD)Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting diastolic BP: Baseline76.5 Millimeters of mercuryStandard Deviation 9.28
PF-06700841 0.1% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine diastolic BP: change at week 20.6 Millimeters of mercuryStandard Deviation 6.47
PF-06700841 0.1% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine diastolic BP: Baseline75.2 Millimeters of mercuryStandard Deviation 8.79
PF-06700841 0.1% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting diastolic BP: change at week 60.0 Millimeters of mercuryStandard Deviation 5.79
PF-06700841 0.1% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine systolic BP: change at week 2-1.4 Millimeters of mercuryStandard Deviation 9.61
PF-06700841 0.1% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine systolic BP: change at week 61.1 Millimeters of mercuryStandard Deviation 10.06
PF-06700841 0.1% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting diastolic BP: change at week 20.7 Millimeters of mercuryStandard Deviation 7.93
PF-06700841 0.1% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting systolic BP: Baseline120.8 Millimeters of mercuryStandard Deviation 10.26
PF-06700841 0.1% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine systolic BP: Baseline123.2 Millimeters of mercuryStandard Deviation 12.35
PF-06700841 0.1% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting diastolic BP: Baseline80.1 Millimeters of mercuryStandard Deviation 6.76
PF-06700841 0.1% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting systolic BP: change at week 2-1.9 Millimeters of mercuryStandard Deviation 11.86
PF-06700841 0.1% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine diastolic BP: change at week 61.5 Millimeters of mercuryStandard Deviation 7.61
PF-06700841 0.1% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting systolic BP: change at week 6-7.5 Millimeters of mercuryStandard Deviation 8.67
PF-06700841 0.3% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting diastolic BP: change at week 6-1.6 Millimeters of mercuryStandard Deviation 11.97
PF-06700841 0.3% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting systolic BP: change at week 6-9.4 Millimeters of mercuryStandard Deviation 8.95
PF-06700841 0.3% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine diastolic BP: change at week 6-0.7 Millimeters of mercuryStandard Deviation 8.32
PF-06700841 0.3% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine diastolic BP: Baseline78.8 Millimeters of mercuryStandard Deviation 8.39
PF-06700841 0.3% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting diastolic BP: change at week 20.0 Millimeters of mercuryStandard Deviation 9.44
PF-06700841 0.3% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine diastolic BP: change at week 2-0.4 Millimeters of mercuryStandard Deviation 8.5
PF-06700841 0.3% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine systolic BP: change at week 62.0 Millimeters of mercuryStandard Deviation 14.05
PF-06700841 0.3% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine systolic BP: change at week 20.5 Millimeters of mercuryStandard Deviation 14.73
PF-06700841 0.3% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting systolic BP: Baseline120.2 Millimeters of mercuryStandard Deviation 12.43
PF-06700841 0.3% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting systolic BP: change at week 2-3.9 Millimeters of mercuryStandard Deviation 14.54
PF-06700841 0.3% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting diastolic BP: Baseline77.8 Millimeters of mercuryStandard Deviation 10.02
PF-06700841 0.3% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine systolic BP: Baseline123.0 Millimeters of mercuryStandard Deviation 13.89
PF-06700841 1.0% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting diastolic BP: Baseline69.6 Millimeters of mercuryStandard Deviation 11.48
PF-06700841 1.0% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting systolic BP: Baseline116.9 Millimeters of mercuryStandard Deviation 17.76
PF-06700841 1.0% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting systolic BP: change at week 61.0 Millimeters of mercuryStandard Deviation 14.63
PF-06700841 1.0% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine systolic BP: change at week 22.3 Millimeters of mercuryStandard Deviation 6.99
PF-06700841 1.0% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine diastolic BP: Baseline74.5 Millimeters of mercuryStandard Deviation 8.26
PF-06700841 1.0% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting systolic BP: change at week 21.3 Millimeters of mercuryStandard Deviation 13.59
PF-06700841 1.0% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting diastolic BP: change at week 61.1 Millimeters of mercuryStandard Deviation 15.61
PF-06700841 1.0% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine diastolic BP: change at week 60.5 Millimeters of mercuryStandard Deviation 7.96
PF-06700841 1.0% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine systolic BP: change at week 60.2 Millimeters of mercuryStandard Deviation 9.13
PF-06700841 1.0% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine systolic BP: Baseline119.7 Millimeters of mercuryStandard Deviation 9.08
PF-06700841 1.0% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine diastolic BP: change at week 21.6 Millimeters of mercuryStandard Deviation 10.33
PF-06700841 1.0% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting diastolic BP: change at week 21.6 Millimeters of mercuryStandard Deviation 12
PF-06700841 3.0% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine diastolic BP: change at week 21.2 Millimeters of mercuryStandard Deviation 8.32
PF-06700841 3.0% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine systolic BP: Baseline122.6 Millimeters of mercuryStandard Deviation 12.76
PF-06700841 3.0% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine systolic BP: change at week 2-0.3 Millimeters of mercuryStandard Deviation 10.25
PF-06700841 3.0% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine systolic BP: change at week 6-3.4 Millimeters of mercuryStandard Deviation 11.02
PF-06700841 3.0% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting systolic BP: Baseline124.6 Millimeters of mercuryStandard Deviation 11.25
PF-06700841 3.0% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting systolic BP: change at week 2-2.4 Millimeters of mercuryStandard Deviation 11.76
PF-06700841 3.0% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting systolic BP: change at week 6-8.4 Millimeters of mercuryStandard Deviation 10.81
PF-06700841 3.0% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine diastolic BP: Baseline75.9 Millimeters of mercuryStandard Deviation 8.78
PF-06700841 3.0% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine diastolic BP: change at week 6-0.9 Millimeters of mercuryStandard Deviation 10.65
PF-06700841 3.0% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting diastolic BP: Baseline80.9 Millimeters of mercuryStandard Deviation 8.21
PF-06700841 3.0% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting diastolic BP: change at week 2-2.9 Millimeters of mercuryStandard Deviation 10.77
PF-06700841 3.0% Cream QDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting diastolic BP: change at week 6-5.3 Millimeters of mercuryStandard Deviation 9.27
Vehicle Cream Twice Daily (BID)Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine systolic BP: change at week 6-1.4 Millimeters of mercuryStandard Deviation 10.49
Vehicle Cream Twice Daily (BID)Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting systolic BP: change at week 6-0.6 Millimeters of mercuryStandard Deviation 14.4
Vehicle Cream Twice Daily (BID)Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting systolic BP: Baseline119.4 Millimeters of mercuryStandard Deviation 12.96
Vehicle Cream Twice Daily (BID)Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting diastolic BP: Baseline75.1 Millimeters of mercuryStandard Deviation 5.77
Vehicle Cream Twice Daily (BID)Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting diastolic BP: change at week 6-2.8 Millimeters of mercuryStandard Deviation 12.6
Vehicle Cream Twice Daily (BID)Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine systolic BP: Baseline123.1 Millimeters of mercuryStandard Deviation 12.4
Vehicle Cream Twice Daily (BID)Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine diastolic BP: change at week 2-2.8 Millimeters of mercuryStandard Deviation 6.69
Vehicle Cream Twice Daily (BID)Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting systolic BP: change at week 2-3.1 Millimeters of mercuryStandard Deviation 10.46
Vehicle Cream Twice Daily (BID)Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine systolic BP: change at week 2-0.3 Millimeters of mercuryStandard Deviation 8.02
Vehicle Cream Twice Daily (BID)Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine diastolic BP: change at week 6-1.6 Millimeters of mercuryStandard Deviation 6.22
Vehicle Cream Twice Daily (BID)Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine diastolic BP: Baseline77.5 Millimeters of mercuryStandard Deviation 8.71
Vehicle Cream Twice Daily (BID)Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting diastolic BP: change at week 21.7 Millimeters of mercuryStandard Deviation 8.2
PF-06700841 0.3% Cream BIDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting systolic BP: change at week 6-3.6 Millimeters of mercuryStandard Deviation 8.37
PF-06700841 0.3% Cream BIDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine diastolic BP: change at week 21.6 Millimeters of mercuryStandard Deviation 8.89
PF-06700841 0.3% Cream BIDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting systolic BP: change at week 21.1 Millimeters of mercuryStandard Deviation 9.81
PF-06700841 0.3% Cream BIDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine diastolic BP: change at week 61.9 Millimeters of mercuryStandard Deviation 9.72
PF-06700841 0.3% Cream BIDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting systolic BP: Baseline122.9 Millimeters of mercuryStandard Deviation 15.25
PF-06700841 0.3% Cream BIDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting diastolic BP: Baseline77.1 Millimeters of mercuryStandard Deviation 12
PF-06700841 0.3% Cream BIDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine systolic BP: change at week 62.1 Millimeters of mercuryStandard Deviation 12.41
PF-06700841 0.3% Cream BIDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine systolic BP: change at week 23.5 Millimeters of mercuryStandard Deviation 13.65
PF-06700841 0.3% Cream BIDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting diastolic BP: change at week 6-0.3 Millimeters of mercuryStandard Deviation 7.89
PF-06700841 0.3% Cream BIDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting diastolic BP: change at week 24.5 Millimeters of mercuryStandard Deviation 5.8
PF-06700841 0.3% Cream BIDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine systolic BP: Baseline117.1 Millimeters of mercuryStandard Deviation 14.07
PF-06700841 0.3% Cream BIDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine diastolic BP: Baseline74.4 Millimeters of mercuryStandard Deviation 8.2
PF-06700841 1.0% Cream BIDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine diastolic BP: Baseline73.7 Millimeters of mercuryStandard Deviation 8.59
PF-06700841 1.0% Cream BIDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine diastolic BP: change at week 60.5 Millimeters of mercuryStandard Deviation 6.32
PF-06700841 1.0% Cream BIDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting systolic BP: change at week 6-1.5 Millimeters of mercuryStandard Deviation 5.8
PF-06700841 1.0% Cream BIDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting diastolic BP: change at week 2-1.2 Millimeters of mercuryStandard Deviation 6.49
PF-06700841 1.0% Cream BIDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting diastolic BP: change at week 60.4 Millimeters of mercuryStandard Deviation 8.41
PF-06700841 1.0% Cream BIDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine systolic BP: change at week 60.6 Millimeters of mercuryStandard Deviation 10.31
PF-06700841 1.0% Cream BIDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine systolic BP: Baseline118.9 Millimeters of mercuryStandard Deviation 12.43
PF-06700841 1.0% Cream BIDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting diastolic BP: Baseline80.3 Millimeters of mercuryStandard Deviation 7.83
PF-06700841 1.0% Cream BIDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine diastolic BP: change at week 21.4 Millimeters of mercuryStandard Deviation 7.74
PF-06700841 1.0% Cream BIDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting systolic BP: Baseline125.6 Millimeters of mercuryStandard Deviation 12.21
PF-06700841 1.0% Cream BIDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Supine systolic BP: change at week 22.9 Millimeters of mercuryStandard Deviation 8.48
PF-06700841 1.0% Cream BIDChange From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6Sitting systolic BP: change at week 24.4 Millimeters of mercuryStandard Deviation 11.68
Secondary

Change From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6

Time frame: Baseline, Weeks 2 and 6

Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, number analyzed signifies participants evaluable for the each specified time point.

ArmMeasureGroupValue (MEAN)Dispersion
Vehicle Cream Once Daily (QD)Change From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6Baseline69.6 Beats per minuteStandard Deviation 12.58
Vehicle Cream Once Daily (QD)Change From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6Change at week 62.1 Beats per minuteStandard Deviation 10.59
Vehicle Cream Once Daily (QD)Change From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6Change at week 20.5 Beats per minuteStandard Deviation 10.41
PF-06700841 0.1% Cream QDChange From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6Change at week 60.3 Beats per minuteStandard Deviation 8.04
PF-06700841 0.1% Cream QDChange From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6Change at week 20.2 Beats per minuteStandard Deviation 8.11
PF-06700841 0.1% Cream QDChange From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6Baseline69.5 Beats per minuteStandard Deviation 9.82
PF-06700841 0.3% Cream QDChange From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6Change at week 6-1.4 Beats per minuteStandard Deviation 11.9
PF-06700841 0.3% Cream QDChange From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6Baseline72.9 Beats per minuteStandard Deviation 14.3
PF-06700841 0.3% Cream QDChange From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6Change at week 2-2.5 Beats per minuteStandard Deviation 9.66
PF-06700841 1.0% Cream QDChange From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6Baseline67.9 Beats per minuteStandard Deviation 9.31
PF-06700841 1.0% Cream QDChange From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6Change at week 21.1 Beats per minuteStandard Deviation 9.13
PF-06700841 1.0% Cream QDChange From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6Change at week 60.9 Beats per minuteStandard Deviation 9.71
PF-06700841 3.0% Cream QDChange From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6Change at week 20.5 Beats per minuteStandard Deviation 6.54
PF-06700841 3.0% Cream QDChange From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6Baseline68.8 Beats per minuteStandard Deviation 11.76
PF-06700841 3.0% Cream QDChange From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6Change at week 61.8 Beats per minuteStandard Deviation 8.73
Vehicle Cream Twice Daily (BID)Change From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6Change at week 23.7 Beats per minuteStandard Deviation 9.47
Vehicle Cream Twice Daily (BID)Change From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6Baseline69.4 Beats per minuteStandard Deviation 11.15
Vehicle Cream Twice Daily (BID)Change From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6Change at week 64.1 Beats per minuteStandard Deviation 6.76
PF-06700841 0.3% Cream BIDChange From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6Change at week 22.8 Beats per minuteStandard Deviation 8.28
PF-06700841 0.3% Cream BIDChange From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6Baseline70.1 Beats per minuteStandard Deviation 11.18
PF-06700841 0.3% Cream BIDChange From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6Change at week 60.5 Beats per minuteStandard Deviation 9.12
PF-06700841 1.0% Cream BIDChange From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6Baseline68.2 Beats per minuteStandard Deviation 9.59
PF-06700841 1.0% Cream BIDChange From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6Change at week 24.1 Beats per minuteStandard Deviation 9.16
PF-06700841 1.0% Cream BIDChange From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6Change at week 61.8 Beats per minuteStandard Deviation 8.64
Secondary

Change From Baseline in Vital Signs- Temperature at Weeks 2 and 6

Time frame: Baseline, Weeks 2 and 6

Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, number analyzed signifies participants evaluable for the each specified time point.

ArmMeasureGroupValue (MEAN)Dispersion
Vehicle Cream Once Daily (QD)Change From Baseline in Vital Signs- Temperature at Weeks 2 and 6Change at week 2-0.1 Degree CelsiusStandard Deviation 0.41
Vehicle Cream Once Daily (QD)Change From Baseline in Vital Signs- Temperature at Weeks 2 and 6Change at week 6-0.0 Degree CelsiusStandard Deviation 0.4
Vehicle Cream Once Daily (QD)Change From Baseline in Vital Signs- Temperature at Weeks 2 and 6Baseline36.5 Degree CelsiusStandard Deviation 0.33
PF-06700841 0.1% Cream QDChange From Baseline in Vital Signs- Temperature at Weeks 2 and 6Change at week 6-0.0 Degree CelsiusStandard Deviation 0.29
PF-06700841 0.1% Cream QDChange From Baseline in Vital Signs- Temperature at Weeks 2 and 6Baseline36.5 Degree CelsiusStandard Deviation 0.43
PF-06700841 0.1% Cream QDChange From Baseline in Vital Signs- Temperature at Weeks 2 and 6Change at week 2-0.1 Degree CelsiusStandard Deviation 0.3
PF-06700841 0.3% Cream QDChange From Baseline in Vital Signs- Temperature at Weeks 2 and 6Baseline36.6 Degree CelsiusStandard Deviation 0.44
PF-06700841 0.3% Cream QDChange From Baseline in Vital Signs- Temperature at Weeks 2 and 6Change at week 60.0 Degree CelsiusStandard Deviation 0.38
PF-06700841 0.3% Cream QDChange From Baseline in Vital Signs- Temperature at Weeks 2 and 6Change at week 20.0 Degree CelsiusStandard Deviation 0.38
PF-06700841 1.0% Cream QDChange From Baseline in Vital Signs- Temperature at Weeks 2 and 6Change at week 2-0.0 Degree CelsiusStandard Deviation 0.43
PF-06700841 1.0% Cream QDChange From Baseline in Vital Signs- Temperature at Weeks 2 and 6Baseline36.6 Degree CelsiusStandard Deviation 0.33
PF-06700841 1.0% Cream QDChange From Baseline in Vital Signs- Temperature at Weeks 2 and 6Change at week 60.1 Degree CelsiusStandard Deviation 0.32
PF-06700841 3.0% Cream QDChange From Baseline in Vital Signs- Temperature at Weeks 2 and 6Change at week 20.1 Degree CelsiusStandard Deviation 0.35
PF-06700841 3.0% Cream QDChange From Baseline in Vital Signs- Temperature at Weeks 2 and 6Baseline36.5 Degree CelsiusStandard Deviation 0.37
PF-06700841 3.0% Cream QDChange From Baseline in Vital Signs- Temperature at Weeks 2 and 6Change at week 60.0 Degree CelsiusStandard Deviation 0.29
Vehicle Cream Twice Daily (BID)Change From Baseline in Vital Signs- Temperature at Weeks 2 and 6Change at week 2-0.0 Degree CelsiusStandard Deviation 0.38
Vehicle Cream Twice Daily (BID)Change From Baseline in Vital Signs- Temperature at Weeks 2 and 6Baseline36.5 Degree CelsiusStandard Deviation 0.29
Vehicle Cream Twice Daily (BID)Change From Baseline in Vital Signs- Temperature at Weeks 2 and 6Change at week 60.1 Degree CelsiusStandard Deviation 0.5
PF-06700841 0.3% Cream BIDChange From Baseline in Vital Signs- Temperature at Weeks 2 and 6Change at week 20.0 Degree CelsiusStandard Deviation 0.34
PF-06700841 0.3% Cream BIDChange From Baseline in Vital Signs- Temperature at Weeks 2 and 6Baseline36.6 Degree CelsiusStandard Deviation 0.41
PF-06700841 0.3% Cream BIDChange From Baseline in Vital Signs- Temperature at Weeks 2 and 6Change at week 60.0 Degree CelsiusStandard Deviation 0.37
PF-06700841 1.0% Cream BIDChange From Baseline in Vital Signs- Temperature at Weeks 2 and 6Baseline36.6 Degree CelsiusStandard Deviation 0.29
PF-06700841 1.0% Cream BIDChange From Baseline in Vital Signs- Temperature at Weeks 2 and 6Change at week 20.0 Degree CelsiusStandard Deviation 0.41
PF-06700841 1.0% Cream BIDChange From Baseline in Vital Signs- Temperature at Weeks 2 and 6Change at week 6-0.0 Degree CelsiusStandard Deviation 0.46
Secondary

Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings

Clinically significant ECG criteria included PR interval: value greater than (\>) 280 millisecond (msec), percentage change greater than equal to (\>=) 25/50 percentage, QRS interval: value \>120 msec, percentage change \>= 50% and QT interval corrected using the Fridericia's formula (QTCF) value 450 msec and 30\<=change\<60.

Time frame: Baseline up to Week 6

Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, Overall Number of Participants Analyzed signifies participants evaluable for this outcome measure.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Vehicle Cream Once Daily (QD)Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsQTCF: 30<=Change<600 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsPR interval : value >280 msec0 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsPR interval : %change>=25/50%0 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsQRS interval: value >120 msec0 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsQTCF: 450 msec0 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsQRS interval: %Change>=50%0 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsQRS interval: value >120 msec0 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsPR interval : value >280 msec0 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsQRS interval: %Change>=50%0 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsQTCF: 30<=Change<601 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsPR interval : %change>=25/50%1 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsQTCF: 450 msec0 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsQTCF: 450 msec1 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsQRS interval: value >120 msec0 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsPR interval : %change>=25/50%1 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsQRS interval: %Change>=50%0 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsQTCF: 30<=Change<601 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsPR interval : value >280 msec0 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsQTCF: 450 msec1 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsPR interval : value >280 msec0 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsPR interval : %change>=25/50%0 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsQRS interval: value >120 msec0 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsQRS interval: %Change>=50%0 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsQTCF: 30<=Change<601 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsQTCF: 450 msec0 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsPR interval : %change>=25/50%1 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsQTCF: 30<=Change<601 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsPR interval : value >280 msec1 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsQRS interval: %Change>=50%0 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsQRS interval: value >120 msec0 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsQRS interval: value >120 msec0 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsQRS interval: %Change>=50%1 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsPR interval : %change>=25/50%0 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsQTCF: 450 msec1 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsPR interval : value >280 msec0 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsQTCF: 30<=Change<602 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsQRS interval: %Change>=50%0 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsQTCF: 450 msec0 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsPR interval : value >280 msec0 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsQRS interval: value >120 msec1 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsQTCF: 30<=Change<601 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsPR interval : %change>=25/50%2 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsQRS interval: %Change>=50%0 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsQRS interval: value >120 msec1 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsQTCF: 30<=Change<600 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsQTCF: 450 msec0 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsPR interval : value >280 msec0 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Clinically Significant Change in Electrocardiogram (ECG) FindingsPR interval : %change>=25/50%0 Participants
Secondary

Number of Participants With Each Severity Grade in Local Tolerability Assessments

Local tolerability skin assessments were performed by the investigator and graded based on severity from grade 0 to 4 as: grade 0=none (no evidence of local intolerance); grade 1=mild (minimal erythema and/or oedema, slight glazed appearance); grade 2= moderate (definite erythema and/or oedema with peeling and/or cracking but needs no adaptation of posology) grade 3=severe (erythema, oedema glazing with fissures, few vesicles or papules consider removing topical agent \[if still in place\]) and grade 4= very severe (strong reaction spreading beyond the treated area, bullous reaction, erosions: removal of topical agent \[if still in place\]). Higher grades indicated worsening of condition. Only those categories in which at least 1 participant had data were reported.

Time frame: Day 1 and any day on of Week 1, 2, 4, 6: pre dose (before application of IP) and post dose (after application of IP); Follow up visit (28 days after last dose of study drug = maximum up to Day 71) and Early termination (anytime within week 11)

Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability before: none26 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability before: none31 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsFollow Up: tolerability: severe0 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsFollow Up: tolerability: none22 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability before: moderate2 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsFollow Up: tolerability: moderate1 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability after: none33 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsEarly termination:tolerability: mild0 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability after: moderate1 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability before: moderate1 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability after: mild1 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsFollow Up: tolerability: mild1 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability after: none28 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability after: none28 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability after: mild2 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability after: none24 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability before: none29 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability before: mild0 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability after: moderate1 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsEarly termination:tolerability: none6 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability after: mild1 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability before: moderate2 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsEarly termination:tolerability: severe1 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability after: moderate0 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability before: moderate0 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability after: moderate1 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability after: moderate2 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability after: mild0 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability after: mild1 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability before: mild1 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability before: moderate1 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability before: mild1 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability before: none35 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability before: mild3 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsEarly termination:tolerability: moderate2 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability before: none27 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability after: none25 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability before: mild0 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability after: mild2 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability before: moderate0 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability before: none26 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsFollow Up: tolerability: severe0 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability before: none28 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability before: none25 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability after: mild2 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability before: moderate2 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability before: mild2 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsFollow Up: tolerability: none26 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability after: none26 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsEarly termination:tolerability: mild2 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsFollow Up: tolerability: moderate0 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability after: moderate0 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability before: mild2 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability after: none36 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability before: none35 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsEarly termination:tolerability: moderate0 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability after: moderate1 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability after: moderate0 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability before: moderate0 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsFollow Up: tolerability: mild0 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsEarly termination:tolerability: severe1 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability after: mild0 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability before: moderate0 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability before: mild0 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability after: moderate0 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability after: moderate0 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability after: none29 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability after: mild3 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability before: mild1 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability before: moderate0 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsEarly termination:tolerability: none5 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability before: mild2 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability after: none26 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability after: none24 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability after: mild1 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability before: none28 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability before: moderate3 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability after: none29 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability after: moderate2 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability before: none26 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability after: moderate1 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability before: moderate3 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability before: mild2 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsEarly termination:tolerability: mild0 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability before: moderate1 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsEarly termination:tolerability: none3 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability after: none30 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability after: moderate1 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability after: mild2 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability after: moderate0 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability after: mild3 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability before: none29 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsEarly termination:tolerability: moderate0 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability after: none28 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability before: none31 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsFollow Up: tolerability: severe1 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability before: mild1 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability before: moderate4 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability before: none30 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsFollow Up: tolerability: moderate1 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability after: none30 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsFollow Up: tolerability: mild2 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability after: mild1 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsFollow Up: tolerability: none25 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability after: moderate3 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability before: none28 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsEarly termination:tolerability: severe0 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability before: mild3 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability before: moderate2 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability before: mild2 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability after: none29 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability after: mild2 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability after: mild2 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability before: mild2 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability before: mild3 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsFollow Up: tolerability: severe0 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability after: mild1 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability before: none30 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability before: none33 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability after: mild3 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability after: none29 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability before: moderate1 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability before: none30 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsEarly termination:tolerability: moderate0 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability before: none30 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability before: mild3 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsEarly termination:tolerability: mild0 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability before: moderate1 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability after: moderate0 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability after: mild0 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability after: mild1 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability after: moderate1 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability after: none31 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability before: moderate0 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability after: none30 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability before: mild1 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability before: mild2 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsEarly termination:tolerability: none2 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability after: moderate1 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability before: moderate0 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability after: moderate0 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability after: mild2 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsFollow Up: tolerability: none25 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability after: none30 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsFollow Up: tolerability: mild0 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability before: none30 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability before: mild2 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability after: moderate1 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability after: none33 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability before: moderate1 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsFollow Up: tolerability: moderate4 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsEarly termination:tolerability: severe1 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability after: none29 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability after: moderate0 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability before: none30 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability before: mild0 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability before: moderate1 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability after: none29 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability after: mild0 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability after: moderate1 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability before: none30 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability before: none36 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability before: mild0 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability before: moderate0 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability after: none35 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability after: mild0 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability after: moderate0 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability before: none30 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability before: mild3 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability before: moderate0 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability after: none28 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability after: mild2 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability after: moderate0 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability before: none30 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability before: mild1 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability before: moderate0 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability after: mild1 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability before: mild0 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsEarly termination:tolerability: severe1 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsFollow Up: tolerability: none28 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsFollow Up: tolerability: mild0 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsFollow Up: tolerability: moderate1 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsFollow Up: tolerability: severe0 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability before: moderate0 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability after: none29 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability after: mild0 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability after: moderate0 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsEarly termination:tolerability: none2 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsEarly termination:tolerability: mild0 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsEarly termination:tolerability: moderate0 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability after: moderate0 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability before: moderate1 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability after: none34 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability after: moderate1 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsFollow Up: tolerability: mild1 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability before: mild1 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability after: none22 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability before: none21 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability before: mild1 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability before: moderate0 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability before: none35 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability before: moderate0 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsFollow Up: tolerability: moderate1 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsEarly termination:tolerability: none9 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability before: moderate1 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability before: moderate1 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability before: mild1 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsFollow Up: tolerability: severe0 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability after: none23 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability before: none24 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability before: mild1 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability after: none24 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability after: none27 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability before: none30 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability after: moderate1 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsEarly termination:tolerability: mild0 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsEarly termination:tolerability: severe0 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability before: mild0 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsEarly termination:tolerability: moderate1 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability after: mild2 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability after: moderate0 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability after: mild0 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability after: moderate1 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability before: none23 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsFollow Up: tolerability: none25 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability after: mild3 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability after: mild0 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability after: mild2 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability after: none30 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability after: none32 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability after: none32 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability after: mild0 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability before: moderate0 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability before: mild0 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability before: mild1 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability before: none33 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsEarly termination:tolerability: severe0 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability after: moderate0 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability after: mild4 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsEarly termination:tolerability: mild0 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsFollow Up: tolerability: none26 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability after: none32 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsFollow Up: tolerability: mild1 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability before: moderate0 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability before: none31 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsFollow Up: tolerability: moderate0 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability before: mild2 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability before: none34 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsFollow Up: tolerability: severe0 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability before: moderate0 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability before: none30 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability after: moderate1 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability after: moderate0 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability after: mild0 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability after: mild1 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability after: none31 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability after: moderate0 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability before: moderate0 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsEarly termination:tolerability: moderate0 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsEarly termination:tolerability: none2 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability before: mild1 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability before: mild0 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability before: none31 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability before: moderate1 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability after: moderate0 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability after: mild1 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability after: mild0 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability after: none33 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsFollow Up: tolerability: none28 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability before: mild0 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability after: mild0 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability before: none33 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability after: mild1 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability after: none30 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability after: mild1 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsEarly termination:tolerability: severe0 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability after: moderate0 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability before: moderate0 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability after: moderate0 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability before: none33 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability before: moderate0 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability after: moderate0 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability before: mild1 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability before: none31 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability before: mild1 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 1: tolerability after: none31 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability before: none36 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsEarly termination:tolerability: none1 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsFollow Up: tolerability: severe0 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability after: moderate0 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsFollow Up: tolerability: moderate0 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability before: mild1 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability before: moderate0 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability before: mild0 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability before: none32 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability after: none30 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsDay 1: tolerability before: moderate1 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsEarly termination:tolerability: moderate0 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsFollow Up: tolerability: mild1 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability after: mild1 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 6: tolerability after: none30 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 4: tolerability after: moderate0 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsWeek 2: tolerability before: moderate0 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Each Severity Grade in Local Tolerability AssessmentsEarly termination:tolerability: mild1 Participants
Secondary

Number of Participants With Laboratory Abnormalities

Hemoglobin (HGB),hematocrit,erythrocytes (ery.),HDL cholesterol (chl.)\<0.8\*lower limit of normal(LLN);reticulocytes (ret.), ret./ery. (%)\<0.5\*LLN,\>1.5\*upper limit of normal (ULN);ery. mean corpuscular (EMC) volume,EMC HGB,EMC HGB concentration,potassium,chloride,calcium,bicarbonate\<0.9\*LLN,\>1.1\*ULN;platelets\<0.5\*LLN,\>1.75\*ULN;leukocytes (leu.),glucose\<0.6\*LLN,\>1.5\*ULN;lymphocytes (lym.), lym./leu.(%), neutrophils (neu.), neu./leu. (%), protein,albumin \<0.8\*LLN,\>1.2\*ULN;basophils (bas.), bas./leu.(%), eosinophils (eos.), eos./leu., monocytes (mon.), mon./leu.(%), urate \>1.2\*ULN;bilirubin (total, direct, indirect)\>1.5\*ULN;aspartate/alanine aminotransferase, gamma glutamyl transferase, lactate dehydrogenase, alkaline phosphatase\>3.0\*ULN;urea nitrogen, creatinine, triglycerides, chl.\>1.3\*ULN; sodium \<0.95\*LLN,\>1.05\*ULN; creatine kinase \>2.0\*ULN;Urine: pH\<4.5,\>8;glucose, ketones, protein, HGB, urobilinogen,bilirubin,nitrite,leukocyte esterase\>=1;ery., leu.\>= 20;hyaline casts\>1;bacteria\>20.

Time frame: Baseline (Day 1) up to at least 28 days after last dose of study drug (approximately up to Week 11)

Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, Overall Number of Participants Analyzed signifies participants evaluable for this outcome measure.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Vehicle Cream Once Daily (QD)Number of Participants With Laboratory Abnormalities26 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Laboratory Abnormalities22 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Laboratory Abnormalities23 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Laboratory Abnormalities22 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Laboratory Abnormalities16 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Laboratory Abnormalities21 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Laboratory Abnormalities24 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Laboratory Abnormalities24 Participants
Secondary

Number of Participants With Pre-defined Criteria For Vital Signs

Pre-defined criteria included: 1) Diastolic blood pressure (DBP), a) sitting DBP: change of \>= 20 millimeter of mercury (mmHg) increase, b) sitting DBP: change of \>=20mmHg decrease, c) supine DBP: less than (\<) 50 mmHg, d) supine DBP: change of \>= 20mmHg increase, e) supine DBP: change of \>= 20mmHg decrease; 2) Systolic blood pressure (SBP), a) sitting SBP: \<90 mmHg, b) sitting SBP: change of \>=30mmHg increase, c) sitting SBP: change of \>=30mmHg decrease, d) supine SBP: change of \>=30mmHg increase, e) supine SBP: change of \>=30mmHg decrease and f) Supine SBP: value \<90mmHg.

Time frame: Baseline up to Week 6

Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, Overall Number of Participants Analyzed signifies participants evaluable for this outcome measure and number analyzed signifies participants evaluable for the each specified time point.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Vehicle Cream Once Daily (QD)Number of Participants With Pre-defined Criteria For Vital SignsSitting SBP: <90mmHg0 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Pre-defined Criteria For Vital SignsSupine SBP: Change >= 30mmHg decrease0 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Pre-defined Criteria For Vital SignsSupine SBP: Value <90mmHg0 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Pre-defined Criteria For Vital SignsSitting DBP: Change >= 20 mm Hg increase0 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Pre-defined Criteria For Vital SignsSupine SBP: Change >= 30mmHg increase1 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Pre-defined Criteria For Vital SignsSupine DBP: Value <50 mmHg0 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Pre-defined Criteria For Vital SignsSitting DBP: Change >= 20mmHg decrease1 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Pre-defined Criteria For Vital SignsSitting SBP: change >= 30mmHg increase0 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Pre-defined Criteria For Vital SignsSupine DBP: Change >= 20mmHg increase0 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Pre-defined Criteria For Vital SignsSupine DBP: Change >= 20mmHg decrease0 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Pre-defined Criteria For Vital SignsSitting SBP: change >= 30mmHg decrease0 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSitting SBP: change >= 30mmHg increase0 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSupine DBP: Change >= 20mmHg increase1 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSitting SBP: change >= 30mmHg decrease0 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSupine SBP: Change >= 30mmHg increase0 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSitting DBP: Change >= 20 mm Hg increase0 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSupine SBP: Value <90mmHg1 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSitting DBP: Change >= 20mmHg decrease0 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSitting SBP: <90mmHg0 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSupine DBP: Value <50 mmHg0 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSupine DBP: Change >= 20mmHg decrease0 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSupine SBP: Change >= 30mmHg decrease0 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSitting DBP: Change >= 20mmHg decrease0 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSitting SBP: change >= 30mmHg increase0 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSupine SBP: Value <90mmHg1 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSitting DBP: Change >= 20 mm Hg increase1 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSupine DBP: Value <50 mmHg0 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSupine SBP: Change >= 30mmHg decrease1 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSupine DBP: Change >= 20mmHg increase1 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSupine SBP: Change >= 30mmHg increase1 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSupine DBP: Change >= 20mmHg decrease0 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSitting SBP: change >= 30mmHg decrease0 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSitting SBP: <90mmHg0 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSupine DBP: Value <50 mmHg0 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSitting SBP: change >= 30mmHg increase1 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSupine DBP: Change >= 20mmHg decrease0 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSupine SBP: Value <90mmHg0 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSupine SBP: Change >= 30mmHg decrease0 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSitting SBP: change >= 30mmHg decrease0 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSitting SBP: <90mmHg1 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSupine SBP: Change >= 30mmHg increase0 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSitting DBP: Change >= 20mmHg decrease1 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSupine DBP: Change >= 20mmHg increase2 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSitting DBP: Change >= 20 mm Hg increase2 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSupine SBP: Change >= 30mmHg decrease0 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSitting DBP: Change >= 20 mm Hg increase0 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSitting DBP: Change >= 20mmHg decrease0 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSupine DBP: Value <50 mmHg0 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSupine DBP: Change >= 20mmHg increase1 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSupine DBP: Change >= 20mmHg decrease0 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSitting SBP: <90mmHg0 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSitting SBP: change >= 30mmHg increase0 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSitting SBP: change >= 30mmHg decrease1 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSupine SBP: Change >= 30mmHg increase0 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Pre-defined Criteria For Vital SignsSupine SBP: Value <90mmHg0 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Pre-defined Criteria For Vital SignsSitting DBP: Change >= 20 mm Hg increase0 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Pre-defined Criteria For Vital SignsSupine DBP: Change >= 20mmHg increase0 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Pre-defined Criteria For Vital SignsSupine DBP: Change >= 20mmHg decrease0 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Pre-defined Criteria For Vital SignsSupine SBP: Change >= 30mmHg increase1 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Pre-defined Criteria For Vital SignsSitting SBP: <90mmHg0 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Pre-defined Criteria For Vital SignsSitting SBP: change >= 30mmHg increase0 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Pre-defined Criteria For Vital SignsSupine SBP: Value <90mmHg0 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Pre-defined Criteria For Vital SignsSitting DBP: Change >= 20mmHg decrease1 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Pre-defined Criteria For Vital SignsSupine DBP: Value <50 mmHg1 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Pre-defined Criteria For Vital SignsSitting SBP: change >= 30mmHg decrease0 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Pre-defined Criteria For Vital SignsSupine SBP: Change >= 30mmHg decrease0 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Pre-defined Criteria For Vital SignsSitting DBP: Change >= 20mmHg decrease0 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Pre-defined Criteria For Vital SignsSupine SBP: Change >= 30mmHg decrease2 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Pre-defined Criteria For Vital SignsSitting SBP: change >= 30mmHg decrease0 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Pre-defined Criteria For Vital SignsSitting DBP: Change >= 20 mm Hg increase0 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Pre-defined Criteria For Vital SignsSitting SBP: <90mmHg0 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Pre-defined Criteria For Vital SignsSitting SBP: change >= 30mmHg increase0 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Pre-defined Criteria For Vital SignsSupine DBP: Change >= 20mmHg increase1 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Pre-defined Criteria For Vital SignsSupine SBP: Value <90mmHg0 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Pre-defined Criteria For Vital SignsSupine SBP: Change >= 30mmHg increase1 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Pre-defined Criteria For Vital SignsSupine DBP: Change >= 20mmHg decrease1 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Pre-defined Criteria For Vital SignsSupine DBP: Value <50 mmHg0 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Pre-defined Criteria For Vital SignsSupine SBP: Change >= 30mmHg increase0 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Pre-defined Criteria For Vital SignsSupine DBP: Change >= 20mmHg decrease0 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Pre-defined Criteria For Vital SignsSitting SBP: change >= 30mmHg decrease0 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Pre-defined Criteria For Vital SignsSupine DBP: Change >= 20mmHg increase0 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Pre-defined Criteria For Vital SignsSitting SBP: change >= 30mmHg increase1 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Pre-defined Criteria For Vital SignsSupine DBP: Value <50 mmHg0 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Pre-defined Criteria For Vital SignsSitting DBP: Change >= 20mmHg decrease0 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Pre-defined Criteria For Vital SignsSupine SBP: Change >= 30mmHg decrease0 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Pre-defined Criteria For Vital SignsSitting DBP: Change >= 20 mm Hg increase0 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Pre-defined Criteria For Vital SignsSitting SBP: <90mmHg0 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Pre-defined Criteria For Vital SignsSupine SBP: Value <90mmHg0 Participants
Secondary

Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs)

An AE was any untoward medical occurrence in a participant who received investigational product without regard to possibility of causal relationship. SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly; medically important events. Treatment-emergent were events between first dose of investigational product and up to 28 days after the last dose of investigational product that were absent before treatment or that worsened relative to pretreatment state. AEs included both SAEs and all non-SAEs.

Time frame: Baseline (Day 1) up to at least 28 days after last dose of study drug (approximately up to Week 11)

Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Vehicle Cream Once Daily (QD)Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs)SAEs0 Participants
Vehicle Cream Once Daily (QD)Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs)TEAEs18 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs)TEAEs17 Participants
PF-06700841 0.1% Cream QDNumber of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs)SAEs0 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs)TEAEs11 Participants
PF-06700841 0.3% Cream QDNumber of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs)SAEs0 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs)TEAEs12 Participants
PF-06700841 1.0% Cream QDNumber of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs)SAEs0 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs)SAEs0 Participants
PF-06700841 3.0% Cream QDNumber of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs)TEAEs10 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs)SAEs0 Participants
Vehicle Cream Twice Daily (BID)Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs)TEAEs17 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs)TEAEs9 Participants
PF-06700841 0.3% Cream BIDNumber of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs)SAEs0 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs)TEAEs14 Participants
PF-06700841 1.0% Cream BIDNumber of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs)SAEs0 Participants
Secondary

Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation

The severity of itch (pruritus) due to AD was assessed using a horizontal NRS. Participants at specified time points were asked the following question: How would you rate your itch due to AD at the worst moment during the previous 24 hours? The scale ranged from 0-10, where 0= no itch and 10= worst itch imaginable. Higher scores indicated worse itch.

Time frame: Baseline, Weeks 1, 2, 3, 4 and 6

Population: Full analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, Overall Number of Participants Analyzed signifies participants evaluable for this outcome measure. NRI method: participants with missing values were considered to be non-responders.

ArmMeasureGroupValue (NUMBER)
Vehicle Cream Once Daily (QD)Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 116.2 Percentage of participants
Vehicle Cream Once Daily (QD)Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 640.5 Percentage of participants
Vehicle Cream Once Daily (QD)Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 435.1 Percentage of participants
Vehicle Cream Once Daily (QD)Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 321.6 Percentage of participants
Vehicle Cream Once Daily (QD)Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 224.3 Percentage of participants
PF-06700841 0.1% Cream QDPercentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 230.6 Percentage of participants
PF-06700841 0.1% Cream QDPercentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 438.9 Percentage of participants
PF-06700841 0.1% Cream QDPercentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 641.7 Percentage of participants
PF-06700841 0.1% Cream QDPercentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 338.9 Percentage of participants
PF-06700841 0.1% Cream QDPercentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 116.7 Percentage of participants
PF-06700841 0.3% Cream QDPercentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 242.9 Percentage of participants
PF-06700841 0.3% Cream QDPercentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 651.4 Percentage of participants
PF-06700841 0.3% Cream QDPercentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 120.0 Percentage of participants
PF-06700841 0.3% Cream QDPercentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 451.4 Percentage of participants
PF-06700841 0.3% Cream QDPercentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 348.6 Percentage of participants
PF-06700841 1.0% Cream QDPercentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 359.5 Percentage of participants
PF-06700841 1.0% Cream QDPercentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 656.8 Percentage of participants
PF-06700841 1.0% Cream QDPercentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 129.7 Percentage of participants
PF-06700841 1.0% Cream QDPercentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 248.6 Percentage of participants
PF-06700841 1.0% Cream QDPercentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 462.2 Percentage of participants
PF-06700841 3.0% Cream QDPercentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 358.3 Percentage of participants
PF-06700841 3.0% Cream QDPercentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 144.4 Percentage of participants
PF-06700841 3.0% Cream QDPercentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 261.1 Percentage of participants
PF-06700841 3.0% Cream QDPercentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 458.3 Percentage of participants
PF-06700841 3.0% Cream QDPercentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 661.1 Percentage of participants
Vehicle Cream Twice Daily (BID)Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 333.3 Percentage of participants
Vehicle Cream Twice Daily (BID)Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 430.6 Percentage of participants
Vehicle Cream Twice Daily (BID)Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 225.0 Percentage of participants
Vehicle Cream Twice Daily (BID)Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 113.9 Percentage of participants
Vehicle Cream Twice Daily (BID)Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 630.6 Percentage of participants
PF-06700841 0.3% Cream BIDPercentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 351.4 Percentage of participants
PF-06700841 0.3% Cream BIDPercentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 128.6 Percentage of participants
PF-06700841 0.3% Cream BIDPercentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 245.7 Percentage of participants
PF-06700841 0.3% Cream BIDPercentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 660.0 Percentage of participants
PF-06700841 0.3% Cream BIDPercentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 460.0 Percentage of participants
PF-06700841 1.0% Cream BIDPercentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 660.0 Percentage of participants
PF-06700841 1.0% Cream BIDPercentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 460.0 Percentage of participants
PF-06700841 1.0% Cream BIDPercentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 125.7 Percentage of participants
PF-06700841 1.0% Cream BIDPercentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 357.1 Percentage of participants
PF-06700841 1.0% Cream BIDPercentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 237.1 Percentage of participants
Comparison: At Week 1: Risk difference = difference in percentage of participants.p-value: 0.524690% CI: [-14.7, 16.4]Chan and Zhang Exact Method
Comparison: At Week 1: Risk difference = difference in percentage of participants.p-value: 0.390690% CI: [-12.5, 19.9]Chan and Zhang Exact Method
Comparison: At Week 1: Risk difference = difference in percentage of participants.p-value: 0.119390% CI: [-3.2, 30.6]Chan and Zhang Exact Method
Comparison: At Week 1: Risk difference = difference in percentage of participants.p-value: 0.004890% CI: [8.8, 45.5]Chan and Zhang Exact Method
Comparison: At Week 1: Risk difference = difference in percentage of participants.p-value: 0.077790% CI: [-2, 31.1]Chan and Zhang Exact Method
Comparison: At Week 1: Risk difference = difference in percentage of participants.p-value: 0.124590% CI: [-4.3, 28]Chan and Zhang Exact Method
Comparison: At Week 2: Risk difference = difference in percentage of participants.p-value: 0.332290% CI: [-12.2, 24.4]Chan and Zhang Exact Method
Comparison: At Week 2: Risk difference = difference in percentage of participants.p-value: 0.053590% CI: [-0.3, 36.5]Chan and Zhang Exact Method
Comparison: At Week 2: Risk difference = difference in percentage of participants.p-value: 0.015990% CI: [4.5, 41.9]Chan and Zhang Exact Method
Comparison: At Week 2: Risk difference = difference in percentage of participants.p-value: 0.000890% CI: [15.4, 54]Chan and Zhang Exact Method
Comparison: At Week 2: Risk difference = difference in percentage of participants.p-value: 0.038690% CI: [1.5, 38.8]Chan and Zhang Exact Method
Comparison: At Week 2: Risk difference = difference in percentage of participants.p-value: 0.148590% CI: [-6.4, 30.3]Chan and Zhang Exact Method
Comparison: At Week 3: Risk difference = difference in percentage of participants.p-value: 0.06290% CI: [-0.8, 34.8]Chan and Zhang Exact Method
Comparison: At Week 3: Risk difference = difference in percentage of participants.p-value: 0.008990% CI: [6.5, 44.4]Chan and Zhang Exact Method
Comparison: At Week 3: Risk difference = difference in percentage of participants.p-value: 0.000590% CI: [17.5, 54.7]Chan and Zhang Exact Method
Comparison: At Week 3: Risk difference = difference in percentage of participants.p-value: 0.000790% CI: [15.4, 54]Chan and Zhang Exact Method
Comparison: At Week 3: Risk difference = difference in percentage of participants.p-value: 0.071190% CI: [-2, 37.5]Chan and Zhang Exact Method
Comparison: At Week 3: Risk difference = difference in percentage of participants.p-value: 0.026690% CI: [2.7, 42.5]Chan and Zhang Exact Method
Comparison: At week 4: Risk difference = difference in percentage of participants.p-value: 0.417390% CI: [-15.3, 23.1]Chan and Zhang Exact Method
Comparison: At Week 4: Risk difference = difference in percentage of participants.p-value: 0.109690% CI: [-4.3, 35.6]Chan and Zhang Exact Method
Comparison: At Week 4: Risk difference = difference in percentage of participants.p-value: 0.013390% CI: [6.1, 45.7]Chan and Zhang Exact Method
Comparison: At Week 4: Risk difference = difference in percentage of participants.p-value: 0.030490% CI: [2.6, 41.7]Chan and Zhang Exact Method
Comparison: At Week 4: Risk difference = difference in percentage of participants.p-value: 0.007890% CI: [7.2, 47.6]Chan and Zhang Exact Method
Comparison: At Week 4: Risk difference = difference in percentage of participants.p-value: 0.007890% CI: [7.2, 47.6]Chan and Zhang Exact Method
Comparison: At Week 6: Risk difference = difference in percentage of participants.p-value: 0.496690% CI: [-18.4, 20.4]Chan and Zhang Exact Method
Comparison: At Week 6: Risk difference = difference in percentage of participants.p-value: 0.275390% CI: [-9.3, 30.1]Chan and Zhang Exact Method
Comparison: At Week 6: Risk difference = difference in percentage of participants.p-value: 0.103690% CI: [-4.2, 35.7]Chan and Zhang Exact Method
Comparison: At Week 6: Risk difference = difference in percentage of participants.p-value: 0.045790% CI: [0.4, 39.6]Chan and Zhang Exact Method
Comparison: At Week 6: Risk difference = difference in percentage of participants.p-value: 0.007890% CI: [7.2, 47.6]Chan and Zhang Exact Method
Comparison: At Week 6: Risk difference = difference in percentage of participants.p-value: 0.007890% CI: [7.2, 47.6]Chan and Zhang Exact Method
Secondary

Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation

The severity of itch (pruritus) due to AD was assessed using a horizontal NRS. Participants at specified time points were asked the following question: How would you rate your itch due to AD at the worst moment during the previous 24 hours? The scale ranged from 0-10, where 0= no itch and 10= worst itch imaginable. Higher scores indicated worse itch.

Time frame: Baseline, Weeks 1, 2, 3, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71)

Population: Full analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, Overall Number of Participants Analyzed signifies participants evaluable for this outcome measure. NRI method: participants with missing values were considered to be non-responders.

ArmMeasureGroupValue (NUMBER)
Vehicle Cream Once Daily (QD)Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 10.0 Percentage of participants
Vehicle Cream Once Daily (QD)Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 418.2 Percentage of participants
Vehicle Cream Once Daily (QD)Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 618.2 Percentage of participants
Vehicle Cream Once Daily (QD)Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Follow-up visit9.1 Percentage of participants
Vehicle Cream Once Daily (QD)Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 312.1 Percentage of participants
Vehicle Cream Once Daily (QD)Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 29.1 Percentage of participants
PF-06700841 0.1% Cream QDPercentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 630.0 Percentage of participants
PF-06700841 0.1% Cream QDPercentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 210.0 Percentage of participants
PF-06700841 0.1% Cream QDPercentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 323.3 Percentage of participants
PF-06700841 0.1% Cream QDPercentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Follow-up visit30.0 Percentage of participants
PF-06700841 0.1% Cream QDPercentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 426.7 Percentage of participants
PF-06700841 0.1% Cream QDPercentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 13.3 Percentage of participants
PF-06700841 0.3% Cream QDPercentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 634.4 Percentage of participants
PF-06700841 0.3% Cream QDPercentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 13.1 Percentage of participants
PF-06700841 0.3% Cream QDPercentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 315.6 Percentage of participants
PF-06700841 0.3% Cream QDPercentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 428.1 Percentage of participants
PF-06700841 0.3% Cream QDPercentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 29.4 Percentage of participants
PF-06700841 0.3% Cream QDPercentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Follow-up visit21.9 Percentage of participants
PF-06700841 1.0% Cream QDPercentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 332.3 Percentage of participants
PF-06700841 1.0% Cream QDPercentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 645.2 Percentage of participants
PF-06700841 1.0% Cream QDPercentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 435.5 Percentage of participants
PF-06700841 1.0% Cream QDPercentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Follow-up visit19.4 Percentage of participants
PF-06700841 1.0% Cream QDPercentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 116.1 Percentage of participants
PF-06700841 1.0% Cream QDPercentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 219.4 Percentage of participants
PF-06700841 3.0% Cream QDPercentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 332.1 Percentage of participants
PF-06700841 3.0% Cream QDPercentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Follow-up visit21.4 Percentage of participants
PF-06700841 3.0% Cream QDPercentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 450.0 Percentage of participants
PF-06700841 3.0% Cream QDPercentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 650.0 Percentage of participants
PF-06700841 3.0% Cream QDPercentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 225.0 Percentage of participants
PF-06700841 3.0% Cream QDPercentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 110.7 Percentage of participants
Vehicle Cream Twice Daily (BID)Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 210.0 Percentage of participants
Vehicle Cream Twice Daily (BID)Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 616.7 Percentage of participants
Vehicle Cream Twice Daily (BID)Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Follow-up visit20.0 Percentage of participants
Vehicle Cream Twice Daily (BID)Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 13.3 Percentage of participants
Vehicle Cream Twice Daily (BID)Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 310.0 Percentage of participants
Vehicle Cream Twice Daily (BID)Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 410.0 Percentage of participants
PF-06700841 0.3% Cream BIDPercentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 320.0 Percentage of participants
PF-06700841 0.3% Cream BIDPercentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Follow-up visit20.0 Percentage of participants
PF-06700841 0.3% Cream BIDPercentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 430.0 Percentage of participants
PF-06700841 0.3% Cream BIDPercentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 633.3 Percentage of participants
PF-06700841 0.3% Cream BIDPercentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 13.3 Percentage of participants
PF-06700841 0.3% Cream BIDPercentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 213.3 Percentage of participants
PF-06700841 1.0% Cream BIDPercentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Follow-up visit7.4 Percentage of participants
PF-06700841 1.0% Cream BIDPercentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 111.1 Percentage of participants
PF-06700841 1.0% Cream BIDPercentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 337.0 Percentage of participants
PF-06700841 1.0% Cream BIDPercentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 437.0 Percentage of participants
PF-06700841 1.0% Cream BIDPercentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 640.7 Percentage of participants
PF-06700841 1.0% Cream BIDPercentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder ImputationAt Week 233.3 Percentage of participants
Comparison: At Week 1: Risk difference = difference in percentage of participants.p-value: 0.24590% CI: [-5.4, 14.9]Chan and Zhang Exact Method
Comparison: At Week 1: Risk difference = difference in percentage of participants.p-value: 0.257590% CI: [-5.3, 14]Chan and Zhang Exact Method
Comparison: At Week 1: Risk difference = difference in percentage of participants.p-value: 0.008790% CI: [5.7, 31]Chan and Zhang Exact Method
Comparison: At Week 1: Risk difference = difference in percentage of participants.p-value: 0.039290% CI: [0.8, 25.4]Chan and Zhang Exact Method
Comparison: At Week 1: Risk difference = difference in percentage of participants.p-value: 190% CI: [-11.2, 11.2]Chan and Zhang Exact Method
Comparison: At Week 1: Risk difference = difference in percentage of participants.p-value: 0.152890% CI: [-4.9, 22.5]Chan and Zhang Exact Method
Comparison: At Week 2: Risk difference = difference in percentage of participants.p-value: 0.498990% CI: [-12.7, 15.2]Chan and Zhang Exact Method
Comparison: At Week 2: Risk difference = difference in percentage of participants.p-value: 0.541990% CI: [-13.6, 14.2]Chan and Zhang Exact Method
Comparison: At Week 2: Risk difference = difference in percentage of participants.p-value: 0.136290% CI: [-5, 26.2]Chan and Zhang Exact Method
Comparison: At Week 2: Risk difference = difference in percentage of participants.p-value: 0.054190% CI: [-0.4, 33.9]Chan and Zhang Exact Method
Comparison: At Week 2: Risk difference = difference in percentage of participants.p-value: 0.394590% CI: [-12, 19.5]Chan and Zhang Exact Method
Comparison: At Week 2: Risk difference = difference in percentage of participants.p-value: 0.020190% CI: [3.9, 41.8]Chan and Zhang Exact Method
Comparison: At Week 3: Risk difference = difference in percentage of participants.p-value: 0.137290% CI: [-5.4, 28.2]Chan and Zhang Exact Method
Comparison: At Week 3: Risk difference = difference in percentage of participants.p-value: 0.392490% CI: [-11.6, 19.1]Chan and Zhang Exact Method
Comparison: At Week 3: Risk difference = difference in percentage of participants.p-value: 0.031190% CI: [2.4, 38.3]Chan and Zhang Exact Method
Comparison: At Week 3: Risk difference = difference in percentage of participants.p-value: 0.039290% CI: [0.8, 38.1]Chan and Zhang Exact Method
Comparison: At Week 3: Risk difference = difference in percentage of participants.p-value: 0.154190% CI: [-6.2, 26.4]Chan and Zhang Exact Method
Comparison: At Week 3: Risk difference = difference in percentage of participants.p-value: 0.009190% CI: [6.8, 45.4]Chan and Zhang Exact Method
Comparison: At Week 4: Risk difference = difference in percentage of participants.p-value: 0.283590% CI: [-9.5, 27]Chan and Zhang Exact Method
Comparison: At Week 4: Risk difference = difference in percentage of participants.p-value: 0.2790% CI: [-8.7, 27.8]Chan and Zhang Exact Method
Comparison: At Week 4: Risk difference = difference in percentage of participants.p-value: 0.066290% CI: [-1.4, 36.2]Chan and Zhang Exact Method
Comparison: At Week 4: Risk difference = difference in percentage of participants.p-value: 0.00590% CI: [9.2, 50.4]Chan and Zhang Exact Method
Comparison: At Week 4: Risk difference = difference in percentage of participants.p-value: 0.030290% CI: [2.2, 38.3]Chan and Zhang Exact Method
Comparison: At Week 4: Risk difference = difference in percentage of participants.p-value: 0.009190% CI: [6.8, 45.4]Chan and Zhang Exact Method
Comparison: At Week 6: Risk difference = difference in percentage of participants.p-value: 0.156190% CI: [-6.5, 30.2]Chan and Zhang Exact Method
Comparison: At Week 6: Risk difference = difference in percentage of participants.p-value: 0.075390% CI: [-2.7, 34.8]Chan and Zhang Exact Method
Comparison: At Week 6: Risk difference = difference in percentage of participants.p-value: 0.010890% CI: [5.7, 46]Chan and Zhang Exact Method
Comparison: At Week 6: Risk difference = difference in percentage of participants.p-value: 0.00590% CI: [9.2, 50.4]Chan and Zhang Exact Method
Comparison: At Week 6: Risk difference = difference in percentage of participants.p-value: 0.077590% CI: [-2.9, 35.7]Chan and Zhang Exact Method
Comparison: At Week 6: Risk difference = difference in percentage of participants.p-value: 0.024390% CI: [3.4, 43.4]Chan and Zhang Exact Method
Comparison: At follow-up visit: Risk difference = difference in percentage of participants.p-value: 0.023490% CI: [3.5, 38.8]Chan and Zhang Exact Method
Comparison: At follow-up visit: Risk difference = difference in percentage of participants.p-value: 0.113490% CI: [-2.8, 29.3]Chan and Zhang Exact Method
Comparison: At follow-up visit: Risk difference = difference in percentage of participants.p-value: 0.136290% CI: [-5, 26.2]Chan and Zhang Exact Method
Comparison: At follow-up visit: Risk difference = difference in percentage of participants.p-value: 0.102990% CI: [-3.4, 29.8]Chan and Zhang Exact Method
Comparison: At follow-up visit: Risk difference = difference in percentage of participants.p-value: 190% CI: [-17.9, 17.9]Chan and Zhang Exact Method
Comparison: At follow-up visit: Risk difference = difference in percentage of participants.p-value: 0.897290% CI: [-28.8, 3.5]Chan and Zhang Exact Method
Secondary

Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation

EASI evaluates severity of participant's AD (excluded scalp, palms, soles) based on severity of AD clinical signs and % of body surface area (BSA) affected. Severity of clinical signs of AD (erythema, induration/papulation, excoriation and lichenification) scored separately for each of 4 body regions(head and neck, upper limbs, trunk \[including axillae and groin\] and lower limbs \[including buttocks\]) on4-point scale: 0= absent; 1= mild; 2= moderate; 3= severe. EASI area score was based upon % BSA with AD in each 4 body region: 0 (0%), 1 (\>0 to \<10%), 2 (10 to \<30%), 3 (30 to \<50%), 4 (50 to \<70%), 5 (70 to \<90%) and 6 (90 to 100%). Total EASI score =0.1\*Ah\*(Eh+Ih+Exh+Lh) + 0.2\*Au\*(Eu+Iu+ExU+Lu) + 0.3\*At\*(Et+It+Ext+Lt) + 0.4\*Al\*(El+Il+Exl+Ll); A = EASI area score; E = erythema; I = induration/papulation; Ex = excoriation; L = lichenification; h = head and neck; u = upper limbs; t = trunk; l = lower limbs. Total EASI score ranged from 0.0 to 72.0, higher scores = greater severity of AD.

Time frame: Baseline, Weeks 1, 2, 3, 4 and 6

Population: Full analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. NRI method: participants with missing values were considered to be non-responders.

ArmMeasureGroupValue (NUMBER)
Vehicle Cream Once Daily (QD)Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 15.4 Percentage of participants
Vehicle Cream Once Daily (QD)Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 635.1 Percentage of participants
Vehicle Cream Once Daily (QD)Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 424.3 Percentage of participants
Vehicle Cream Once Daily (QD)Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 35.4 Percentage of participants
Vehicle Cream Once Daily (QD)Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 28.1 Percentage of participants
PF-06700841 0.1% Cream QDPercentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 210.8 Percentage of participants
PF-06700841 0.1% Cream QDPercentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 421.6 Percentage of participants
PF-06700841 0.1% Cream QDPercentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 632.4 Percentage of participants
PF-06700841 0.1% Cream QDPercentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 316.2 Percentage of participants
PF-06700841 0.1% Cream QDPercentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 10.0 Percentage of participants
PF-06700841 0.3% Cream QDPercentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 227.8 Percentage of participants
PF-06700841 0.3% Cream QDPercentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 652.8 Percentage of participants
PF-06700841 0.3% Cream QDPercentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 119.4 Percentage of participants
PF-06700841 0.3% Cream QDPercentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 438.9 Percentage of participants
PF-06700841 0.3% Cream QDPercentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 336.1 Percentage of participants
PF-06700841 1.0% Cream QDPercentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 343.2 Percentage of participants
PF-06700841 1.0% Cream QDPercentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 654.1 Percentage of participants
PF-06700841 1.0% Cream QDPercentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 15.4 Percentage of participants
PF-06700841 1.0% Cream QDPercentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 224.3 Percentage of participants
PF-06700841 1.0% Cream QDPercentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 443.2 Percentage of participants
PF-06700841 3.0% Cream QDPercentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 341.7 Percentage of participants
PF-06700841 3.0% Cream QDPercentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 116.7 Percentage of participants
PF-06700841 3.0% Cream QDPercentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 238.9 Percentage of participants
PF-06700841 3.0% Cream QDPercentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 450.0 Percentage of participants
PF-06700841 3.0% Cream QDPercentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 650.0 Percentage of participants
Vehicle Cream Twice Daily (BID)Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 319.4 Percentage of participants
Vehicle Cream Twice Daily (BID)Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 422.2 Percentage of participants
Vehicle Cream Twice Daily (BID)Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 213.9 Percentage of participants
Vehicle Cream Twice Daily (BID)Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 10.0 Percentage of participants
Vehicle Cream Twice Daily (BID)Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 616.7 Percentage of participants
PF-06700841 0.3% Cream BIDPercentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 319.4 Percentage of participants
PF-06700841 0.3% Cream BIDPercentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 113.9 Percentage of participants
PF-06700841 0.3% Cream BIDPercentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 225.0 Percentage of participants
PF-06700841 0.3% Cream BIDPercentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 636.1 Percentage of participants
PF-06700841 0.3% Cream BIDPercentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 436.1 Percentage of participants
PF-06700841 1.0% Cream BIDPercentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 651.4 Percentage of participants
PF-06700841 1.0% Cream BIDPercentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 448.6 Percentage of participants
PF-06700841 1.0% Cream BIDPercentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 121.6 Percentage of participants
PF-06700841 1.0% Cream BIDPercentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 343.2 Percentage of participants
PF-06700841 1.0% Cream BIDPercentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder ImputationAt Week 232.4 Percentage of participants
Comparison: At Week 1: Risk difference = difference in percentage of participants.p-value: 0.070890% CI: [-1.4, 25]Chan and Zhang Exact Method
Comparison: At Week 1: Risk difference = difference in percentage of participants.p-value: 0.896490% CI: [-16.1, 2]Chan and Zhang Exact Method
Comparison: At Week 1: Risk difference = difference in percentage of participants.p-value: 0.039190% CI: [1, 28.2]Chan and Zhang Exact Method
Comparison: At Week 1: Risk difference = difference in percentage of participants.p-value: 190% CI: [-10.8, 10.8]Chan and Zhang Exact Method
Comparison: At Week 1: Risk difference = difference in percentage of participants.p-value: 0.012290% CI: [4.7, 27]Chan and Zhang Exact Method
Comparison: At Week 1: Risk difference = difference in percentage of participants.p-value: 0.001690% CI: [11, 35.6]Chan and Zhang Exact Method
Comparison: At Week 2: Risk difference = difference in percentage of participants.p-value: 0.39590% CI: [-9.8, 16.1]Chan and Zhang Exact Method
Comparison: At Week 2: Risk difference = difference in percentage of participants.p-value: 0.017390% CI: [4.2, 35.6]Chan and Zhang Exact Method
Comparison: At Week 2: Risk difference = difference in percentage of participants.p-value: 0.032790% CI: [1.4, 31]Chan and Zhang Exact Method
Comparison: At Week 2: Risk difference = difference in percentage of participants.p-value: 0.001190% CI: [13.2, 46.6]Chan and Zhang Exact Method
Comparison: At Week 2: Risk difference = difference in percentage of participants.p-value: 0.134890% CI: [-5, 27.2]Chan and Zhang Exact Method
Comparison: At Week 2: Risk difference = difference in percentage of participants.p-value: 0.032890% CI: [1.5, 34.8]Chan and Zhang Exact Method
Comparison: At Week 3: Risk difference = difference in percentage of participants.p-value: 0.076990% CI: [-1.8, 24.4]Chan and Zhang Exact Method
Comparison: At Week 3: Risk difference = difference in percentage of participants.p-value: 0.000590% CI: [13.2, 46]Chan and Zhang Exact Method
Comparison: At Week 3: Risk difference = difference in percentage of participants.p-value: <0.000190% CI: [22.1, 53.1]Chan and Zhang Exact Method
Comparison: At Week 3: Risk difference = difference in percentage of participants.p-value: 0.000190% CI: [19.7, 51.8]Chan and Zhang Exact Method
Comparison: At Week 3: Risk difference = difference in percentage of participants.p-value: 190% CI: [-16.5, 16.5]Chan and Zhang Exact Method
Comparison: At Week 3: Risk difference = difference in percentage of participants.p-value: 0.017390% CI: [4.5, 41.5]Chan and Zhang Exact Method
Comparison: At Week 4: Risk difference = difference in percentage of participants.p-value: 0.566390% CI: [-19.9, 14.2]Chan and Zhang Exact Method
Comparison: At Week 4: Risk difference = difference in percentage of participants.p-value: 0.124390% CI: [-3.8, 32.6]Chan and Zhang Exact Method
Comparison: At Week 4: Risk difference = difference in percentage of participants.p-value: 0.04690% CI: [-0.5, 36.6]Chan and Zhang Exact Method
Comparison: At Week 4: Risk difference = difference in percentage of participants.p-value: 0.01390% CI: [4.8, 43.3]Chan and Zhang Exact Method
Comparison: At Week 4: Risk difference = difference in percentage of participants.p-value: 0.119490% CI: [-4.2, 31.4]Chan and Zhang Exact Method
Comparison: At Week 4: Risk difference = difference in percentage of participants.p-value: 0.009790% CI: [6.5, 44.4]Chan and Zhang Exact Method
Comparison: At Week 6: Risk difference = difference in percentage of participants.p-value: 0.555690% CI: [-21, 16.1]Chan and Zhang Exact Method
Comparison: At Week 6: Risk difference = difference in percentage of participants.p-value: 0.076190% CI: [-2.5, 36.5]Chan and Zhang Exact Method
Comparison: At Week 6: Risk difference = difference in percentage of participants.p-value: 0.058390% CI: [-0.8, 37.6]Chan and Zhang Exact Method
Comparison: At Week 6: Risk difference = difference in percentage of participants.p-value: 0.124590% CI: [-5, 33.7]Chan and Zhang Exact Method
Comparison: At Week 6: Risk difference = difference in percentage of participants.p-value: 0.038290% CI: [1.5, 36.5]Chan and Zhang Exact Method
Comparison: At Week 6: Risk difference = difference in percentage of participants.p-value: 0.001190% CI: [13.2, 51.4]Chan and Zhang Exact Method
Secondary

Percentage of Participants Achieving Investigator's Global Assessment (IGA) Score Clear (0) or Almost Clear (1) and a Reduction From Baseline of Greater Than or Equal to ( >=2) Points at Week 6: Non-responder Imputation

IGA assesses severity of participant's AD on a 5 point scale. 0= clear, no inflammatory signs of AD; 1= almost clear, AD not fully cleared- light pink residual lesions (except post-inflammatory hyperpigmentation), just perceptible erythema, papulation/induration lichenification, excoriation, and no oozing/crusting; 2= mild AD with light red lesions, slight but definite erythema, papulation/induration, lichenification, excoriation and no oozing/crusting; 3= moderate AD with red lesions, moderate erythema, papulation/induration, lichenification, excoriation and slight oozing/crusting and 4= severe AD with deep dark red lesions, severe erythema, papulation/induration, lichenification, excoriation and moderate to severe oozing/crusting. Higher scores indicating more severity of AD. Assessment excluded soles, palms and scalp.

Time frame: Baseline, Week 6

Population: Full analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Non-Responder Imputation (NRI) method: participants with missing values were considered to be non-responders.

ArmMeasureValue (NUMBER)
Vehicle Cream Once Daily (QD)Percentage of Participants Achieving Investigator's Global Assessment (IGA) Score Clear (0) or Almost Clear (1) and a Reduction From Baseline of Greater Than or Equal to ( >=2) Points at Week 6: Non-responder Imputation10.8 Percentage of participants
PF-06700841 0.1% Cream QDPercentage of Participants Achieving Investigator's Global Assessment (IGA) Score Clear (0) or Almost Clear (1) and a Reduction From Baseline of Greater Than or Equal to ( >=2) Points at Week 6: Non-responder Imputation29.7 Percentage of participants
PF-06700841 0.3% Cream QDPercentage of Participants Achieving Investigator's Global Assessment (IGA) Score Clear (0) or Almost Clear (1) and a Reduction From Baseline of Greater Than or Equal to ( >=2) Points at Week 6: Non-responder Imputation33.3 Percentage of participants
PF-06700841 1.0% Cream QDPercentage of Participants Achieving Investigator's Global Assessment (IGA) Score Clear (0) or Almost Clear (1) and a Reduction From Baseline of Greater Than or Equal to ( >=2) Points at Week 6: Non-responder Imputation40.5 Percentage of participants
PF-06700841 3.0% Cream QDPercentage of Participants Achieving Investigator's Global Assessment (IGA) Score Clear (0) or Almost Clear (1) and a Reduction From Baseline of Greater Than or Equal to ( >=2) Points at Week 6: Non-responder Imputation44.4 Percentage of participants
Vehicle Cream Twice Daily (BID)Percentage of Participants Achieving Investigator's Global Assessment (IGA) Score Clear (0) or Almost Clear (1) and a Reduction From Baseline of Greater Than or Equal to ( >=2) Points at Week 6: Non-responder Imputation13.9 Percentage of participants
PF-06700841 0.3% Cream BIDPercentage of Participants Achieving Investigator's Global Assessment (IGA) Score Clear (0) or Almost Clear (1) and a Reduction From Baseline of Greater Than or Equal to ( >=2) Points at Week 6: Non-responder Imputation33.3 Percentage of participants
PF-06700841 1.0% Cream BIDPercentage of Participants Achieving Investigator's Global Assessment (IGA) Score Clear (0) or Almost Clear (1) and a Reduction From Baseline of Greater Than or Equal to ( >=2) Points at Week 6: Non-responder Imputation27.0 Percentage of participants
Comparison: Risk difference = difference in percentage of participants.p-value: 0.024490% CI: [2.4, 34.7]Chan and Zhang Exact Method
Comparison: Risk difference = difference in percentage of participants.p-value: 0.011390% CI: [4.8, 38.6]Chan and Zhang Exact Method
Comparison: Risk difference = difference in percentage of participants.p-value: 0.001890% CI: [11, 45.7]Chan and Zhang Exact Method
Comparison: Risk difference = difference in percentage of participants.p-value: 0.000790% CI: [13.7, 49.9]Chan and Zhang Exact Method
Comparison: Risk difference = difference in percentage of participants.p-value: 0.028990% CI: [1.8, 36.5]Chan and Zhang Exact Method
Comparison: Risk difference = difference in percentage of participants.p-value: 0.114590% CI: [-2.9, 29.6]Chan and Zhang Exact Method
Secondary

Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit

4 body regions were evaluated: head and neck, upper limbs, trunk (including axillae and groin) and lower limbs (including buttocks). Scalp, palms and soles were excluded. BSA was calculated using handprint method. Number of handprints (size of participant's full palmer hand) fitting in the affected area of a body region was estimated. Maximum number of handprints were 10 for head and neck, 20 for upper limbs, 30 for trunk and 40 for lower limbs. Surface area of body region equivalent to 1 handprint: 1 handprint was equal to 10% for head and neck, 5% for upper limbs, 3.33% for trunk and 2.5% for lower limbs. Percent BSA for a body region was calculated as = total number of handprints in a body region \* % surface area equivalent to 1 handprint. Overall % BSA for an individual: arithmetic mean of % BSA of all 4 body regions, ranged from 0 to 100%, with higher values representing greater severity of AD.

Time frame: Baseline, Weeks 1, 2, 3, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71)

Population: Full analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, Overall Number of Participants Analyzed signifies participants evaluable for this outcome measure and number analyzed signifies participants evaluable for the each specified time point.

ArmMeasureGroupValue (LEAST_SQUARES_MEAN)
Vehicle Cream Once Daily (QD)Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Follow-up visit-23.6 Percent change
Vehicle Cream Once Daily (QD)Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 1-2.4 Percent change
Vehicle Cream Once Daily (QD)Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 2-15.3 Percent change
Vehicle Cream Once Daily (QD)Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 3-17.1 Percent change
Vehicle Cream Once Daily (QD)Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 6-21.6 Percent change
Vehicle Cream Once Daily (QD)Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 4-25.9 Percent change
PF-06700841 0.1% Cream QDPercent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 3-13.1 Percent change
PF-06700841 0.1% Cream QDPercent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 1-2.9 Percent change
PF-06700841 0.1% Cream QDPercent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 4-20.1 Percent change
PF-06700841 0.1% Cream QDPercent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Follow-up visit-24.5 Percent change
PF-06700841 0.1% Cream QDPercent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 2-7.2 Percent change
PF-06700841 0.1% Cream QDPercent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 6-39.4 Percent change
PF-06700841 0.3% Cream QDPercent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 6-59.4 Percent change
PF-06700841 0.3% Cream QDPercent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 3-50.6 Percent change
PF-06700841 0.3% Cream QDPercent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 2-38.1 Percent change
PF-06700841 0.3% Cream QDPercent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 4-55.8 Percent change
PF-06700841 0.3% Cream QDPercent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Follow-up visit-42.7 Percent change
PF-06700841 0.3% Cream QDPercent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 1-16.2 Percent change
PF-06700841 1.0% Cream QDPercent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 6-63.6 Percent change
PF-06700841 1.0% Cream QDPercent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 1-19.9 Percent change
PF-06700841 1.0% Cream QDPercent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 2-43.6 Percent change
PF-06700841 1.0% Cream QDPercent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 3-55.9 Percent change
PF-06700841 1.0% Cream QDPercent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 4-57.9 Percent change
PF-06700841 1.0% Cream QDPercent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Follow-up visit-37.0 Percent change
PF-06700841 3.0% Cream QDPercent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 6-60.3 Percent change
PF-06700841 3.0% Cream QDPercent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 2-39.0 Percent change
PF-06700841 3.0% Cream QDPercent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Follow-up visit-55.2 Percent change
PF-06700841 3.0% Cream QDPercent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 1-23.0 Percent change
PF-06700841 3.0% Cream QDPercent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 4-56.7 Percent change
PF-06700841 3.0% Cream QDPercent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 3-49.2 Percent change
Vehicle Cream Twice Daily (BID)Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 3-25.2 Percent change
Vehicle Cream Twice Daily (BID)Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 4-34.7 Percent change
Vehicle Cream Twice Daily (BID)Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 2-2.5 Percent change
Vehicle Cream Twice Daily (BID)Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 6-31.2 Percent change
Vehicle Cream Twice Daily (BID)Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 18.5 Percent change
Vehicle Cream Twice Daily (BID)Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Follow-up visit-26.3 Percent change
PF-06700841 0.3% Cream BIDPercent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 4-46.4 Percent change
PF-06700841 0.3% Cream BIDPercent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 6-48.9 Percent change
PF-06700841 0.3% Cream BIDPercent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 1-16.5 Percent change
PF-06700841 0.3% Cream BIDPercent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 3-39.8 Percent change
PF-06700841 0.3% Cream BIDPercent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Follow-up visit-31.6 Percent change
PF-06700841 0.3% Cream BIDPercent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 2-34.2 Percent change
PF-06700841 1.0% Cream BIDPercent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 4-57.7 Percent change
PF-06700841 1.0% Cream BIDPercent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 3-44.0 Percent change
PF-06700841 1.0% Cream BIDPercent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Follow-up visit-24.6 Percent change
PF-06700841 1.0% Cream BIDPercent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 6-65.0 Percent change
PF-06700841 1.0% Cream BIDPercent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 1-17.0 Percent change
PF-06700841 1.0% Cream BIDPercent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up VisitAt Week 2-43.1 Percent change
Comparison: At Week 1: Mixed Model Repeated Measure (MMRM) contained fixed factors of treatment, visit, treatment-by-visit interaction and baseline value.p-value: 0.478190% CI: [-14.2, 13.3]Mixed Model Repeated Measure
Comparison: At Week 1: MMRM contained fixed factors of treatment, visit, treatment-by-visit interaction and baseline value.p-value: 0.052290% CI: [-27.8, 0.2]Mixed Model Repeated Measure
Comparison: At Week 1: MMRM contained fixed factors of treatment, visit, treatment-by-visit interaction and baseline value.p-value: 0.018790% CI: [-31.4, -3.7]Mixed Model Repeated Measure
Comparison: At Week 1: MMRM contained fixed factors of treatment, visit, treatment-by-visit interaction and baseline value.p-value: 0.00890% CI: [-34.5, -6.6]Mixed Model Repeated Measure
Comparison: At Week 1: MMRM contained fixed factors of treatment, visit, treatment-by-visit interaction and baseline value.p-value: 0.040190% CI: [-48.6, -1.5]Mixed Model Repeated Measure
Comparison: At Week 1: MMRM contained fixed factors of treatment, visit, treatment-by-visit interaction and baseline value.p-value: 0.037990% CI: [-49.2, -1.9]Mixed Model Repeated Measure
Comparison: At Week 2: MMRM contained fixed factors of treatment, visit(Weeks 1, 2, 3, 4, 6 and follow up), treatment-by-visit interaction and baseline value.p-value: 0.767890% CI: [-10.1, 26.3]Mixed Model Repeated Measure
Comparison: At Week 2: MMRM contained fixed factors of treatment, visit, treatment-by-visit interaction and baseline value.p-value: 0.019390% CI: [-40.9, -4.7]Mixed Model Repeated Measure
Comparison: At Week 2:MMRM contained fixed factors of treatment, visit, treatment-by-visit interaction and baseline value.p-value: 0.005290% CI: [-46.5, -10.2]Mixed Model Repeated Measure
Comparison: At Week 2: MMRM contained fixed factors of treatment, visit, treatment-by-visit interaction and baseline value.p-value: 0.016490% CI: [-42, -5.5]Mixed Model Repeated Measure
Comparison: At Week 2: MMRM contained fixed factors of treatment, visit, treatment-by-visit interaction and baseline value.p-value: 0.000890% CI: [-47.8, -15.6]Mixed Model Repeated Measure
Comparison: At Week 2: MMRM contained fixed factors of treatment, visit, treatment-by-visit interaction and baseline value.p-value: <0.000190% CI: [-57, -24.3]Mixed Model Repeated Measure
Comparison: At Week 3: MMRM contained fixed factors of treatment, visit, treatment-by-visit interaction and baseline value.p-value: 0.626990% CI: [-16.1, 23.9]Mixed Model Repeated Measure
Comparison: At Week 3: MMRM contained fixed factors of treatment, visit, treatment-by-visit interaction and baseline value.p-value: 0.002790% CI: [-53.1, -13.8]Mixed Model Repeated Measure
Comparison: At Week 3: MMRM contained fixed factors of treatment, visit, treatment-by-visit interaction and baseline value.p-value: 0.000790% CI: [-58.5, -19.2]Mixed Model Repeated Measure
Comparison: At Week 3: MMRM contained fixed factors of treatment, visit, treatment-by-visit interaction and baseline value.p-value: 0.004190% CI: [-51.9, -12.3]Mixed Model Repeated Measure
Comparison: At Week 3: MMRM contained fixed factors of treatment, visit, treatment-by-visit interaction and baseline value.p-value: 0.105490% CI: [-33.9, 4.6]Mixed Model Repeated Measure
Comparison: At Week 3: MMRM contained fixed factors of treatment, visit, treatment-by-visit interaction and baseline value.p-value: 0.054290% CI: [-38.1, 0.5]Mixed Model Repeated Measure
Comparison: At Week 4: MMRM contained fixed factors of treatment, visit, treatment-by-visit interaction and baseline value.p-value: 0.684790% CI: [-14.2, 25.9]Mixed Model Repeated Measure
Comparison: At Week 4: MMRM contained fixed factors of treatment, visit, treatment-by-visit interaction and baseline value.p-value: 0.006290% CI: [-49.4, -10.3]Mixed Model Repeated Measure
Comparison: At Week 4: MMRM contained fixed factors of treatment, visit, treatment-by-visit interaction and baseline value.p-value: 0.00490% CI: [-51.6, -12.3]Mixed Model Repeated Measure
Comparison: At Week 4: MMRM contained fixed factors of treatment, visit, treatment-by-visit interaction and baseline value.p-value: 0.005490% CI: [-50.6, -11]Mixed Model Repeated Measure
Comparison: At Week 4: MMRM contained fixed factors of treatment, visit, treatment-by-visit interaction and baseline value.p-value: 0.107690% CI: [-27.2, 3.9]Mixed Model Repeated Measure
Comparison: At Week 4: MMRM contained fixed factors of treatment, visit, treatment-by-visit interaction and baseline value.p-value: 0.008290% CI: [-38.6, -7.3]Mixed Model Repeated Measure
Comparison: At Week 6: MMRM contained fixed factors of treatment, visit, treatment-by-visit interaction and baseline value.p-value: 0.105190% CI: [-41.2, 5.6]Mixed Model Repeated Measure
Comparison: At Week 6: MMRM contained fixed factors of treatment, visit, treatment-by-visit interaction and baseline value.p-value: 0.003490% CI: [-60.6, -15]Mixed Model Repeated Measure
Comparison: At Week 6: MMRM contained fixed factors of treatment, visit, treatment-by-visit interaction and baseline value.p-value: 0.001490% CI: [-64.8, -19]Mixed Model Repeated Measure
Comparison: At Week 6: MMRM contained fixed factors of treatment, visit, treatment-by-visit interaction and baseline value.p-value: 0.00390% CI: [-61.6, -15.6]Mixed Model Repeated Measure
Comparison: At Week 6: MMRM contained fixed factors of treatment, visit(Weeks 1, 2, 3, 4, 6 and follow up), treatment-by-visit interaction and baseline value.p-value: 0.028990% CI: [-33, -2.4]Mixed Model Repeated Measure
Comparison: At Week 6: MMRM contained fixed factors of treatment, visit, treatment-by-visit interaction and baseline value.p-value: 0.000290% CI: [-49.2, -18.4]Mixed Model Repeated Measure
Comparison: At follow-up visit: MMRM contained fixed factors of treatment, visit, treatment-by-visit interaction and baseline value.p-value: 0.473990% CI: [-23.9, 22]Mixed Model Repeated Measure
Comparison: At follow-up visit: MMRM contained fixed factors of treatment, visit, treatment-by-visit interaction and baseline value.p-value: 0.078990% CI: [-41.3, 3.2]Mixed Model Repeated Measure
Comparison: At follow-up visit: MMRM contained fixed factors of treatment, visit, treatment-by-visit interaction and baseline value.p-value: 0.161190% CI: [-35.7, 8.9]Mixed Model Repeated Measure
Comparison: At follow-up visit: MMRM contained fixed factors of treatment, visit, treatment-by-visit interaction and baseline value.p-value: 0.012490% CI: [-54.7, -8.5]Mixed Model Repeated Measure
Comparison: At follow-up visit: MMRM contained fixed factors of treatment, visit, treatment-by-visit interaction and baseline value.p-value: 0.382890% CI: [-34.7, 24.1]Mixed Model Repeated Measure
Comparison: At follow-up visit: MMRM contained fixed factors of treatment, visit, treatment-by-visit interaction and baseline value.p-value: 0.538390% CI: [-27.9, 31.3]Mixed Model Repeated Measure

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026